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Abstract  
Milling and co-milling are well known techniques that have potential to enhance the solubility and/or 
dissolution rate of poorly soluble drugs. There are broadly two aims for this project. The first was to 
develop an understanding of how individual and combination of techniques may be used to explore 
the impact of milling on particle characteristics (including phase changes, fractures and change in 
particle size) as a function of milling time/speed, for a range of single powder materials. Anhydrous 
(lactose, sucrose), monohydrate (lactose) and dihydrate (trehalose) excipients and a poorly soluble 
drug (ibuprofen), were chosen as model substrates. Each material was micronized by ball-milling (for 
various time durations and milling speeds) and then characterized by a range of techniques, 
specifically, SEM, DSC, TGA, THz and dielectric spectroscopy. The second aim of the project was to 
investigate the impact of milling and co-milling on the solubility and dissolution rate of ibuprofen 
after co-milling with a variety of excipients (polymer and surfactants). 
The principle findings of this programme of work can be summarized as follows: i) ball milling of 
lactose monohydrate produces nano-structured systems with a mixture of damaged crystals and 
amorphous phase, that can be characterised by dielectric relaxation spectroscopy (DRS), ii) THz 
spectroscopy provides estimates for residual crystallinity in lactose monohydrate that were much 
lower than the estimates from the thermal techniques. Such estimates of residual crystallinity are 
considered to be more reliable given the fact that the spectroscopic measurement characterizes the 
material in its native state, whereas thermal techniques require a heating process, which tend to 
induce de-vitrification and mutarotation of lactose. In case of anhydrous materials, while there was 
agreement between thermal and THz techniques at long milling times, it was shown that the THz 
technique was susceptible to moisture absorption and crystallization at short milling times, iii) In the 
molecular dynamics of milled sugars studied by DRS, the structural relaxation is not visible in the 
vicinity of glass transition, however the secondary relaxation (β) process is equally capable and 
provided molecular dynamics in term of activation energy changes. The activation energies of beta 
process of both lactose and sucrose are least affected by milling time, but the higher activation 
energies for sucrose as compared with lactose show that sucrose has lower propensity to re-
crystallize than lactose during post milling storage, iv) Ibuprofen can be assayed by UV-method in the 
presence of interfering (in absorption) substance by applying multivariate method involving the 
calculation of concentration factors and v) Co-milling with soluplus has increased the in the solubility 
of ibuprofen by ~20% and dissolution rate ~50% in 30 min, while these values are ~5% and 30%, 
respectively in case of co-milling with HPMC. 
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1 Introduction 
1.1 The Issues Related with Poor Solubility of New Drugs 
In recent years, the majority of newly discovered active pharmaceutical ingredients (APIs) 
have poor aqueous solubility owing to their lipophilic nature (Venkatramana M.Rao, 2009). 
Approximately 40% of the marketed oral immediate-release drugs belong to the class that 
are practically insoluble (Lipinski et al., 2001). Many of the APIs even do not enter into the 
clinical development phase because of their poor aqueous solubility which may be 
compensated by adding high doses in the formulations which in turn leads to non-reliable 
efficacy, poor stability, higher side effects and increased cost (Koltzenburg, 2011). 
The aqueous solubility of a drug is one of the critical factors that influences the extent of 
drug absorption after administration and is directly related to its bioavailability. The 
absorption of drug across the membrane occurs by the way of passive or active diffusion or 
by the way of facilitated transport (Ganong and Barrett, 2005). For absorption to take place 
by passive transport (the major route of absorption), the drug needs to be in solution form 
at the absorption site from where the diffusion of drug molecules takes place down a 
concentration gradient. The trans-membrane diffusion of a drug substance can be described 
by Fick’s law given as Equation 1.1. 
𝐝𝐜
𝐝𝐭
=  
𝐉
(𝐂𝐬−𝐂𝒕)
   Equation 1.1 
where ‘dc/dt’ is the rate of diffusion, ‘J’ is the unidirectional flux and ‘Cs-Ct’ is the difference 
in concentration from the mucosal to the serosal side of the intestinal epithelium. 
Classification of drugs based on their aqueous solubility: Biopharmaceutics Classification 
System (BCS) is a system according to which the APIs are classified into four categories based 
on their aqueous solubility and intestinal permeability. According to this system; Class I 
contains drugs with high solubility and high permeability, Class II, includes the drugs with low 
solubility and high permeability, Class III, the drugs exhibiting high solubility and low 
permeability and Class IV, the drugs showing low solubility and low permeability (Amidon et 
al., 1995). The Class II drugs are approximately 70% of all newly discovered drugs; therefore 
these are the matter of special interest to the formulation scientists to develop strategies for 
the improvement of their aqueous solubility. 
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1.2 The Solubility Phenomenon/The Mechanism of Solution formation 
When a crystalline solid (solute) is placed in the solvent, the solute molecules break away 
from the surface and enter into the cavities formed within the solvent molecules (Figure 
1.1). This mixing is dependent on the relative affinities of solute and solvent molecules for 
themselves and with each other, and is affected by the temperature and pH of the solvent 
medium. The rate at which these solute molecules enter the bulk of the solvent is higher at 
the start of the process but at a certain point this becomes equal to the rate of re-deposition 
(i.e. a dynamic equilibrium is established). The concentration of solute in the solvent at 
dynamic equilibrium is known as the solubility. 
 
Figure 1.1: Diagrammatic representation of the mechanism of solution formation of a crystalline solid in the 
aqueous medium, adopted from (Qiu et al., 2009). 
Thus, the solubility is a thermodynamic constant which depends on the energetics of the 
crystal lattice (i.e. the bonding energies which define the melting point) and the balance 
between solute-solute and solute-solvent (solvation) interactions in the solution state. The 
solute solvent interactions may be changed through the cohesive and adhesive forces of the 
solvent. Therefore, the solubility is the intrinsic property of the material and is not affected 
until the properties of material (polymorphic transformation, salt formation and 
amorphization) or the solvent properties (pH, co-solvency, addition of surfactant) are 
changed. The terms solubility enhancement anywhere used in literature is therefore a 
misnomer in our opinion as there is only an apparent change in the equilibrium solubility, 
once the solution reaches the equilibrium it cannot take any more solute. 
In contrast, the rate at which the solute dissolves i.e. dissolution rate is a kinetic process, 
which is influenced by the features of the material such as the particle size distribution 
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(surface to volume ratio), surface tension (which influences the wettability of the surface) 
and the equilibrium thermodynamic solubility. It is important to note that in the case of an 
amorphous solid, it is possible to supersaturate the solution (i.e. exceed the thermodynamic 
equilibrium solubility limit) for a short time until the system has time for equilibrium to be 
restored (and the drug precipitates from solution). 
The solubility is usually expressed in the concentration units such as percentage on weight or 
volume basis, mole fraction, molarity, molality, parts. According to USP the chemical 
substances have been classified into seven categories based on their aqueous solubility 
profiles as described in Table 1.1. 
Table 1.1: Categories of drugs based on USP solubility definition (Stegemann et al., 2007) 
 
Parts of Solvent 
Required for 1 Part of 
Solute 
Solubility range 
(mg ml
-1
) 
Solubility assigned 
(mg ml
-1
) 
Very soluble Less than 1 >1000 1000 
Freely soluble From 1 to 10 100-1000 100 
Soluble From 10 to 30 33-100 33 
Sparingly soluble From 30 to 100 10-33 10 
Slightly soluble From 100 to 1,000 1-10 1 
Very slightly soluble From 1,000 to 10,000 0.1-1 0.1 
Practically insoluble, 
or Insoluble 
Greater than or 
equal to 10,000 
<0.1 0.01 
1.2.1 Thermodynamics of Solution Formation 
The overall tendency of the solute molecules to break away from the solid and to exist 
instead in the solution state can be explained in terms of free energy changes. In part, the 
free energy change on dissolving a crystalline substance  is related to the change in the 
overall enthalpy that arises from the net formation and breaking of individual bonds of the 
solute and solvent and in part from the net entropy change that occurs when an ordered 
crystalline solid is disrupted and the solute is solvated (Qiu et al., 2009).  
Some of these terms used to describe the thermodynamics of solution are now described in 
detail here. 
The Enthalpy (ΔH) of a pure component is the energy of a system at constant pressure while 
the enthalpy of solution of two components (the solute and solvent) is the difference 
between the sum of enthalpies of solute, solvent and of the mixture and can be described by 
Equation 1.2. 
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∆𝐇𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 =  ∆𝐇𝐦𝐢𝐱𝐭𝐮𝐫𝐞 − (∆𝐇𝐬𝐨𝐥𝐮𝐭𝐞 + ∆𝐇𝐬𝐨𝐥𝐯𝐞𝐧𝐭)  Equation 1.2 
where ∆H represents the enthalpies of solute, solvent and their mixture. The solution 
formation is favoured if ∆Hsolution is negative, which is known as the excess enthalpy and is 
liberated as heat on mixing the two components (i.e. the process is exothermic). 
The Entropy (S) of a system is the measure of randomness/disorder of its components. The 
entropy of a mixture depends on the number of ways (the degrees of freedom) in which the 
solute and solvent molecules can exist as pure forms and in the mixture. This can be 
described by Equation 1.3 
∆𝐒 =  𝐑 𝐥𝐧 [
𝛀𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧
𝛀𝐬𝐨𝐥𝐮𝐭𝐞+ 𝛀𝐬𝐨𝐥𝐯𝐞𝐧𝐭
]  Equation 1.3 
where ‘’ represents the number of ways a molecule is present itself in the system. 
Generally solution is always greater than solute+solvent, as the molecules have more freedom 
to move in solvent and as a consequence ‘∆S’ is generally positive (i.e. there is increased 
disorder in the mixture compared to the disorder within the individual pure components). 
Therefore, favorable processes have a decrease in enthalpy (–ΔH) and/or an increase in 
entropy (+ΔS) and vice versa for unfavorable process 
Free energy (ΔG) of the solution combines the effects of enthalpy (ΔH) and entropy (ΔS) and 
can be described by the Gibb’s equation (Equation 1.4). 
∆𝐆 =  ∆𝐇 − 𝐓. ∆𝐒  Equation 1.4 
where ‘T’ is the temperature measured on the Kelvin scale. Thus, the solution formation will 
be favourable only when the free energy is negative. Often there are the activation energy 
barriers to overcome before ‘a process’ may occur. The activation energy barrier in the case 
of the dissolution process is the energy required to disrupt (melt) the crystalline material. 
Once ‘melted’ then the interaction with the solvent may occur, which forms new bonds and 
releases energy. As described earlier, the net enthalpy change is a function of the energy 
required to disrupt the crystal (the molar heat of fusion) and the energy release when the 
solute interacts with the solvent (i.e. the enthalpy of solvation). Again, as intimated earlier, 
these enthalpy terms should not be considered in isolation of the impact of the changes in 
entropy that occur when an ordered solid is disrupted and the solute is free to mix with the 
solvent molecules. The transition from the ordered state to the disordered (dissolved state) 
inevitably results in a dramatic increase in the number of microstates and hence the entropy 
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of the system. Whilst this is favourable and one of the driving forces of the process, there is 
also a contribution from the ordering of the solvent around the solute (the process of 
solvation) which reduces the number of possible microstates (and hence reduces the 
entropy). On balance it is the sum of all such contributions to both the enthalpy and the 
entropy which defines whether the net free energy change is positive or negative. 
1.2.2 Relationship of Solubility and Crystallinity of the Solids 
The solubility of the crystalline solids is described by Van’t Hoff equation (Equation 1.5). 
−𝐥𝐨𝐠𝐗 =  
𝚫𝐇𝐦
𝟐.𝟑𝟎𝟑𝐑
[
𝐓𝟎−𝐓
𝐓 𝐓𝟎
] + 𝐥𝐨𝐠𝛄  Equation 1.5 
where, ‘X’ is the solubility of solute in mole fraction, ‘∆Hm’ is the heat of melting, ‘T0’ is the 
melting point of solute taken in degrees Kelvin, ‘T’ is the absolute temperature of the 
solution, and ‘’  is the activity coefficient which represents the intermolecular forces to be 
overcome to bring the solute in the solution. Stronger the solute-solute interaction, higher 
will be the value of ‘’. Therefore the solubility is mainly affected by the crystallinity and 
temperature of the solvent. However there are many other factors including salinity, pH, 
dissolved organic matter and co-solvents that can also affect the solubility of a solid. 
1.2.3 The Difference between Solubility and Dissolution 
Where the solubility is an equilibrium phenomenon (as described in Section 1.2), the 
dissolution is a dynamic process and is measured as a rate. Dissolution can be thus defined 
as the rate at which the equilibrium between solute and solution is reached under the given 
conditions of temperature and pH. 
1.3 Mechanism of Dissolution 
The basic mechanism of the dissolution process is the convective diffusion with a 
simultaneous solvation process. When a drug is added in the dissolution medium, an 
aqueous boundary layer (ABL) is formed at solid-liquid interface (Figure 1.2), which is the 
rate limiting step for dissolution. The concentration of drug in this layer is equal to the 
solubility of the drug and the linear concentration gradient that is also equal to solubility 
divided by thickness of this layer (Avdeef et al., 2007). There are several physicochemical 
factors which control the dissolution rate of a drug and these can be described by the Noyes-
Whitney equation (Equation 1.6). 
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𝐝𝐜
𝐝𝐭
=  
𝐀𝐃
𝐡
 (𝐂𝐬 − 𝐂𝒕)  Equation 1.6 
where ‘dc/dt’ is the rate at which a given substance dissolves in the medium, ‘A’ is the 
effective surface area of the substance available to dissolution medium, ‘D’ is the diffusion 
coefficient of the substance, ‘Cs’ is the solubility of the substance in the given dissolution 
medium, ‘Ct’ is the drug concentration in the medium at time ‘t’ and ‘h’ represents the 
thickness of the ABL surrounding the surface of the dissolving substance. Therefore, 
increasing the surface area of particles can be a key for enhancing the dissolution rate of 
poorly soluble drugs. 
 
Figure 1.2: Diagrammatic representation of the dissolution process showing the Noyes Whitney equation and 
the movement of drug molecules from the surface of particle (boundary layer) into the bulk of solvent as 
indicated by the arrow head, adopted from (Avdeef et al., 2007). 
1.4 Addressing the Problem of Poor Solubility 
The development of new strategies to deal with the poor solubility of drugs is a challenge for 
formulation scientists as ~95% of the newly discovered drugs belong to BCS class II and IV 
(70% and 25% respectively). The techniques commonly employed for the improvement of 
solubility and/or dissolution rate of these drug categories are; salt formation (Tao et al., 
2009), solid dispersion (Serajuddin†, 1999), polymorphism and co-crystals (Blagden et al., 
2007), complex formation (Rawat and Jain, 2004), amorphization (Murdande et al., 2011), 
size reduction by milling (Kawabata et al., 2011) and co-milling (Bahl and Bogner, 2008, Vogt 
et al., 2008b). Among these methodologies, the process of milling is the more versatile 
method for the improvement of solubility and/or dissolution rate owing to its applications in 
size reduction, amorphization (based on the nature of material and time of milling), crystal 
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modification i.e. co-crystal formation (Vishweshwar et al., 2005) and preparation of solid 
dispersion by milling with other materials (Arnum, 2010, Barzegar-Jalali et al., 2010). 
Therefore, the milling can improve the solubility and/or dissolution rate of drugs by multiple 
mechanisms. It may also provide additional opportunity e.g. the incorporation of an 
excipient that helps in the stabilization of amorphous phase (Watanabe et al., 2002). 
A literature summary of different techniques used for the improvement of solubility and/or 
dissolution rate has been given in Table 1.2 along with descriptions of the proposed 
mechanisms of such enhancement and advantages and disadvantages of each method. 
Table 1.2: Summary of techniques used in literature for the enhancement of solubility and/or dissolution 
rate of poorly soluble drugs. 
Technique 
Mechanisms for the increase in 
dissolution and/or solubility 
Advantages Disadvantages 
Co-solvency 
(Vemula et al., 
2010) 
combined solvent action of water 
and other miscible solvent 
Simple and quick 
method 
Toxicity of solvents. 
Precipitation/chemical stability 
Liposome and 
Emulsions 
(Mohammed et al., 
2004) 
Solubilization within lipid 
membrane  
Emulsion droplets readily cross 
membrane 
Improved tolerability 
QC testing complicated 
Limited applications 
Macro-emulsion  
(Humberstone and 
Charman, 1997) 
Self-emulsifying drug delivery 
systems (SEDDS) 
 
Easy to manufacture 
No dust formation  
Drug loading is low 
Interaction with food in GIT  
Complicated filling in soft gels 
Micro-emulsion  
(Krishnaiah, 2010) 
Lipid base drug delivery system 
(LBDDS) 
Easy to manufacture 
No interaction with 
food. 
Poor tolerability (synthetic 
surfactants)  
Solid dispersion 
(Biswal et al., 2008) 
Amorphous drug is stabilized in 
hydrophilic polymer matrix 
Potential to carry as 
final dosage form 
Unsuitable for thermolabile 
compounds 
Inclusion complex 
with Cyclodextrin  
(Baboota et al., 
2005) 
The exposed surface is hydrophilic 
while the interior lipophilic 
Improved stability 
Excellent solubility  
Pharmacokinetics of APIs 
altered  
Toxicity of cyclodextrins  
Milling 
(Elamin et al., 1994) 
Increased surface area  
Amorphous phase that has lower 
enthalpy  
Simple and versatile  
Drug stabilization by 
excipients (co-milling) 
Particle aggregation 
Stability problems  due to 
amorphization 
Co-crystals 
(Shiraki et al., 2008) 
The lattice energy increase as the 
co-former makes the weak bond 
with drug  
Easy to prepare 
Improved physical 
properties of API 
Not applicable to all drugs 
Stability problem 
Micelle formation 
(Kim et al., 2010) 
Surfactant core is lipophilic while 
outer side is hydrophilic 
Straightforward and 
scalable  
QC testing complicated 
Spray drying 
(Sahoo et al., 2011) 
Partial amorphization during spray 
drying 
Quick and Versatile 
method 
Toxic solvents. 
Process is sophisticated and 
costly 
Miscellaneous 
Supercritical fluid process (Perrut et al., 2005), Liquisolid techniques (Javadzadeh et al., 2007), 
Microwave (Maurya et al., 2010), 3D Macro-porous Silica (Hu et al., 2011), Micro-porous silica 
(Mehanna et al., 2011), Porous starch (Wu et al., 2011), Precipitation (Zhang et al., 2009), pH 
Adjustment (Vemula et al., 2010) 
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1.5 Milling of Solids – A Technique for Size Reduction 
Size reduction by milling is often called as micronization due to the fact that this process is 
considered to generate the particles in the size range of a few microns or less. Invariably, the 
rationale for micronization is to increase the dissolution rate especially for the sparingly 
soluble drugs due to the significant increase in surface area (Mosharraf and Nyström, 1995). 
The aim of milling is to achieve the desired particle size without degrading the material and 
in the shortest time (Colombo et al., 2009). Furthermore, the particle size is also important 
as it controls the sedimentation and flocculation rates in suspensions (Chikhalia et al., 2006), 
demonstrates the therapeutic efficacy of dry powder inhalers (DPIs) (Pilcer and Amighi, 
2010) and is responsible for the flowability and content uniformity in solid dosage forms 
(Mackin et al., 2002a). 
1.5.1 Types of Milling 
There are two major categories of milling based on the choice of milling medium, either 
liquid or air; i.e. wet milling and dry milling, respectively. In both of these methodologies, 
size reduction occurs by the collision of particles with each other and with the surfaces of 
milling chambers or balls. In wet milling the shearing of liquid and cavitation produced in the 
medium during milling provides an additional energy, therefore results in more effective size 
reduction, with the potential to produce particles in the nano-size range, as compared to the 
dry milling which usually produces micro-particles. Wet milling which involves, the milling of 
particles suspended in the liquid medium (slurry or dispersion depending on the amount of 
medium used) is advantageous for heat sensitive materials. However the development of 
static charge on the particles surface, interactions with the solvent and the dependence of 
the process on speed, density of slurry and temperature, make it a difficult process to 
control. 
On the other hand, dry milling is a versatile technique that is commonly used in the 
processing of solid dosage forms. The disadvantages of dry milling includes; the powder 
build in the milling containers and the heat degradation of the sensitive materials (Fisher, 
2007). 
Among dry milling there are a variety of techniques available but the ball milling and air jet 
milling are the most commonly used in the pharmaceutical industry (Rasenack and Müller, 
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2004). Milling in an air jet mill has been reported to produce 1-5 µm particles and is usually 
employed for the production of powdered drugs for pulmonary delivery (Saleem and Smyth, 
2010), while ball milling is probably the most aggressive size reduction technique, capable of 
creating even the sub-micron sized particles (Branham et al., 2012, Plakkot et al., 2011) and 
can be used for size reduction and amorphization. 
There are two major types of ball mills; planetary (a multiple ball mill) and vibratory (usually 
a single ball mill). The planetary ball mill applies attrition/grinding force while the vibratory 
mill grinds the particles by high velocity impacts of ball against the walls of milling jar. 
Therefore, the planetary ball mill is used for size reduction (usually micron-sized particles) 
and mixing of materials (except when used for long milling times it can generate an 
amorphous phase). On the other hand the vibratory mill is usually employed for size 
reduction (nano-particles) and for smashing the surfaces/crystal lattice to create a totally 
disordered amorphous phase (Singh and Lillard Jr, 2009) . However, a careful control of size 
of balls, feed size, speed and milling time is required in order to get the desired output 
without destroying the API (Peltonen and Hirvonen, 2010). 
1.5.2 Mechanism of Particle Breakage in Vibratory Ball Mill/ Energetics of Milling 
During, milling in a vibratory ball mill, the high velocity collisions of the ball against the wall 
of the mill (Figure 1.3) provide impact, shear and attrition forces together that serve to 
reduce the particle size (Chen et al., 2004). 
 
Figure 1.3: Cylinder of ball mill showing the ‘to and fro’ i.e. vibratory movement of the ball that impacts on 
the opposite walls to reduce the particle size, taken from (Chen et al., 2004).  
According to the Griffith theory (Equation 1.7), solid particles have structural weaknesses 
(flaws) that may develop into cracks under applied stress (Parrott, 1987) and the size 
reduction of particles occurs through crack propagation. 
𝐓 =  √
𝐘.∈
𝐜
   Equation 1.7 
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where ‘T’ is the tensile strength, ‘Y’ is young’s modulus, ‘∈’ is the surface energy and ‘c’ is 
critical crack length for the fracture. When the moving ball of the mill impacts the particle 
surface, it either fragments (if the scale length of crack exceeds of the critical length of 
fracture) or dissipates the absorbed energy to cause defects within the crystal lattice and 
thus increases the number and density of cracks. 
The energy dissipated by the particles can be best illustrated by the stress-strain curve 
(Figure 1.5); which describes the impact of the stress applied to the particles on the resultant 
strain (i.e. displacement). Hooke’s law describes that, at low stress the strain increases 
proportionally to the applied stress (as depicted by the initial portion of the curve in Figure 
1.4). As the stress is increased, the relationship between strain and stress becomes non-
linear at a point, which is called ‘yield point’. This point is a measure of the resistance of a 
material to the permanent or plastic deformation. An increase in stress beyond this point 
results into a region of irreversible plastic deformation which eventually causes the 
fragmentation of the solid at fracture point (Ghadiri and Zhang, 2002). 
 
Figure 1.4: Stress-strain curve as taken from (Nordin and Frankel, 2001). The initial linear part of the curve 
represents the elastic region, followed by a non-linear plastic region and finally the fragmentation of the 
particles at fracture point. 
If the process of milling is extended beyond few minutes, in addition to the above changes, 
the collisions of the balls with the walls of the mill can also increase the temperature (Chieng 
et al., 2006). This increased temperature may further contribute to the phase disruption of 
the crystal lattice and is partly responsible for the creation of amorphous domains.  
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1.5.3 Effect of Milling on the Solubility of Pharmaceuticals 
The process of milling causes many changes in the crystalline solids. These changes range 
from size reduction, alteration of phase e.g. disorder in the crystal structure through the 
introduction of defects (thus increasing the surface area) and a complete modification of 
phase i.e. polymorphic transition and/or amorphization. Such changes can increase the 
transient (non-equilibrium) solubility (by lowering the melting point) and dissolution rate (by 
increasing surface area), and ultimately increase the bioavailability of a drug (Dudognon et 
al., 2006). 
The increase in solubility on milling is not always linked with the lowering of melting point or 
increase in surface area; it has been shown in a milling study on griseofulvin that the 
solubility increases on milling even when the melting temperature or surface area of the 
particles remains unchanged. The reasons for this enhancement are; the increase in surface 
free energy and the reduction in the heat of solution that results from the disordering of the 
solid structure (Elamin et al., 1994). Another study involving a hydrophilic material has 
shown that the solubility (apparent) increases as the surface damage caused by milling 
increases. This is demonstrated in Figure 1.5 which shows that the amount of material 
needed to reach the saturation decreases as the surface damage increases (Mosharraf et al., 
1999). 
.  
Figure 1.5: An illustration showing the amount of solute required to reach the saturation decrease 
as the surfaces are damaged from fully crystalline (1), partially damaged (3, 4, 5 and 6) to fully 
disordered (2), taken from (Mosharraf et al., 1999).  
In case of hydrophobic material, wettability of particle surface by the solvent is also 
necessary to initiate the solubility process (Buckton et al., 1988). Therefore, there is a 
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requirement for the addition of excipient(s) during milling (i.e. co-milling) in order to 
improve the solubility of such materials. 
1.5.4 Un-desired Effects of Milling 
Despite certain applications, advantages and the favourable changes, the process of milling 
is not without disadvantages. The un-desirable effects of milling include: 
i. The instability of the amorphous phase, which tend to de-vitrify over time 
(especially at higher temperature and humidity conditions).  
ii. The development of charge on the surface of milled particles that leads to 
aggregation, which in turn results in an overall decrease in the specific surface area.  
iii. Degradation of thermo-labile drugs by heat generated during the milling process. 
iv. Polymorphic transformation that may affect the solubility or stability. 
1.6 Co-milling – A Technique for Process Optimization 
The term co-milling refers to the milling of a drug in the presence of excipient(s). It has been 
shown to be a simple, efficient and economical process that does not require any 
sophisticated equipment. It is also environment friendly as it does not involve the use of any 
organic solvent (Friedrich et al., 2005), as in the case of wet milling or solid dispersions 
(prepared by solvent evaporation method). Co-milling combines the advantages of particle 
size reduction and amorphization of milling with the additional benefits of improved 
solubilization/micellization provided by the co-milled excipient. Furthermore it can also 
overcome the disadvantages of milling i.e. i) minimize agglomeration by the surface 
coverage of charged particles, ii) stabilise the amorphous phase and iii) reduce the 
mechanical/thermal degradation of drugs by moderating the effect of heat (Lin et al., 2010) 
as demonstrated in Figure 1.6. 
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Figure 1.6: Graphical representation of the changes that occur on milling and co-milling of a solid and the 
effect of these on the solution kinetics. The added excipient in co-milling exerts its action by 
solubilization/micellization or the stabilization of the amorphous phase or by preventing the aggregation of 
particles, adopted from (Lin et al., 2010). 
In literature, the technique of co-milling has been used for the enhancement of solubility 
and dissolution rate of poorly soluble drugs such as chordiazepoxide (Nokhodchi et al., 
2007), indomethacin (Watanabe et al., 2003) , piroxicam (Al-Hamidi et al., 2012), nimodipine 
(Murali Mohan Babu et al., 2002) carbamazepine (Al-Hamidi et al., 2010), and gliclazide 
(Barzegar-Jalali et al., 2010). Co-milling has also been used for improving the processing 
properties of different drugs (Chattoraj et al., 2011, Shakhtshneider et al., 1996), and for the 
stabilization of amorphous powders, which are prone to heat degradation (Watanabe et al., 
2003). A summary of the recent literature on co-milling describing the type of excipient, mill 
type and proposed mechanism for the improvement of solubility and dissolution rate, is 
given in Table 1.3. 
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Table 1.3: Summary of applications of co-milling given in literature for improving the solubility and 
dissolution rate of drugs. 
Drug/Reference Excipient used 
Type of mill 
used 
Proposed mechanism for increase in 
dissolution/solubility 
Nimodipine 
(Murali Mohan Babu et 
al., 2002) 
Gum Karaya 
Ceramic 
mortar 
Reduction in crystallinity of drug 
Carbamazepine 
(Al-Hamidi et al., 2010) 
Glucosamine 
Planetary ball 
mill 
Polymorphic transformation, Reduction in 
crystallinity, Effect of hydrophilic carrier, decrease 
in particle size 
Piroxicam 
(Al-Hamidi et al., 2012) 
Glucosamine 
Planetary ball 
mill 
Polymorphic transition 
Fenofibrate 
(Vogt et al., 2008a) 
PVP,LMH,SLS Air jet mill 
Facilitate de-aggregation, 
Increase dispersibility 
Salbutamol sulphate 
(Balani et al., 2010b) 
PVP 
Planetary ball 
mill 
Hydrogen bonding, Increased dispersibility, 
Amorphization and Stabilization of amorphous 
Salbutamol sulphate 
(Balani et al., 2010a) 
PVP, LMH, Mg. 
Stearate, 
Planetary Ball 
mill 
Amorphization, 
Stabilization of this amorphous 
Accelofenac 
(Vadher et al., 2009) 
Neusiline US2 Rolling jar mill 
Increased Hydrogen bonding, Particle size 
reduction, Amorphization 
Albendazole, Danzole, 
Felodipine, EMD 
(Vogt et al., 2008b) 
LMH, Starch, PVP, 
HPMC 
Air jet mill 
Excipient and drug specific supersaturation(PVP, 
HPMC), No particle size reduction, No changes in 
crystallinity 
Gliclazide 
(Barzegar-Jalali et al., 
2010) 
PVP, MCC 
Vibration ball 
mill 
Improved wettability, de-aggregation by the 
carriers, Particle size reduction, Decrease in  
crystallinity 
Meloxicam 
(Kürti et al., 2011) 
PVP,PEG 
Planetary 
mono-mil 
Particle size reduction (Nano-particles) 
Amorphization 
Indomethacin 
(Bahl and Bogner, 2008) 
Silicates Rolling jar mill 
The presence of silicic acid and ions (Mg2+ and 
Al3+) in dissolution media, Amorphization 
Indomethacin 
(Watanabe et al., 2002) 
SiO2, Talc, Mg. 
Hydroxide 
Vibration ball 
mill 
Amorphization 
Stabilization of amorphous phase 
Pranlukast 
(Wongmekiat et al., 
2003) 
Cyclodextrin 
Vibration ball 
mill 
Generation of fine particles 
Glybuzole 
(Otsuka et al., 1998) 
Surfactant (SLS etc) 
Planetary ball 
mill 
Solubilization by the surfactant 
Amorphization 
Nifedipine 
(Sugimoto et al., 1998) 
PEG-HPMC 
Vibratory ball 
mill 
Enhanced wettability, particle size reduction 
Raloxifen 
(Garg et al., 2009) 
Plasodone, PVP Ball mill 
Surface erosion, Particle size reduction 
Reduction in crystallinity on co-milling 
Raloxifene 
(Jagadish et al., 2010) 
Super-disintegrants 
Planetary ball 
mill 
Reduction in crystallinity, 
Reduction in particle size 
Gabapentine 
(Lin et al., 2010) 
Mannitol, Starch, 
Magnesium stearate 
Oscillatory 
ball mill 
Stabilization of polymorphs 
Oxaprozin 
(Maestrelli et al., 2011) 
β-cyclodextrin, 
chitosan 
Ball mill Powerful solid-state interactions 
Ciprofloxacin 
(Xianwen Li, 2007) 
HPMC 
Mortar & 
Pestle 
Hydrogen bonding 
Naproxen–Cimetidine 
(Morten Allesø,2009) 
- 
Oscillatory 
ball mill 
Solid-state interaction between the imidazole ring 
of cimetidine and the carboxylic acid moiety of 
naproxen 
Budesonide 
(Dudognon et al., 2006) 
Excipient having high 
Tg- Alpha lactose 
Ball mill 
Formation of glass solution that increase Tg of the 
blend and so stabilize the vitreous phase. 
Ibuprofen 
(Mallick et al., 2008b) 
Aluminium hydroxide Ball mill Solid state interaction with AlOH2 
Ibuprofen 
(Han et al., 2011) 
Hydrophilic nano-
silica, PVP 
Fluid energy 
mill (FEM) 
Surface modification,  de-aggregation 
Improved  wettability, Increased surface area 
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1.7 Gap in the Knowledge/Opportunities for New Techniques 
The generally accepted mechanisms responsible for the improvement of solubility and 
dissolution rate by milling and co-milling include: 
i. Crystal damage and particle size reduction which increases the surface area and 
hence the dissolution rate. 
ii. Conversion of the drug to its amorphous phase that has greater surface area and 
reduced energy for solution formation. 
iii. Solubilization by surface active excipients which reduces the negative entropy 
change that is normally associated with attempts to dissolve hydrophobic drugs. 
iv. Prevention of aggregation and improvement of dispersibility of the drug by the 
added excipient. 
v. Improved wettability of drug by the wicking action provided by the added excipient. 
Among these, the first two (i.e. size reduction and amorphization) are the effects of milling 
where as others are principally the effects of added excipient during co-milling. The 
improvement in solubility and dissolution occur largely as a consequence of the two factors; 
first, the significant increase in surface area that is usually linked with the reduction in 
particle size and second is the disorder in the crystal lattice (resulting in a partly or wholly 
amorphous phase) which requires less energy to disperse the solute into the solvent phase. 
However, much less is known about the contribution of the other physical characteristics of 
individual particles e.g. internal cracks/fissures developed on milling that may provide an 
enormous surface area for the penetration of a solvent during dissolution and may also 
compromise the stability of the material by enhancing moisture uptake during the post 
milling storage. 
Nitrogen adsorption studies are usually employed for the measurement of specific surface 
areas of particles, including those cracks/defects that are either on or connected to the 
external faces of  the particles (Westermarck et al., 1998). However, this technique cannot 
measure the internalized cracks of milled materials due to the inability of the probe (i.e. 
nitrogen gas) to penetrate the micro scale pores. Nor can this method be used for crystal 
hydrates given the fact that the evacuation of the sample chamber results in desorption of 
the water of crystallization and the creation of new surfaces that are then explored by the 
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BET gas probe. Such limitations in quantifying the specific surface area of the milled 
materials, warrants the need for some new techniques. 
One novel element of this work (Chapter 2) is to explore the use of dielectric spectroscopy 
as a supplementary method for characterising the surface properties of the materials. 
Feldman’s work on porous materials has shown that the features of the hydration surface of 
internal pores in term of micro-clusters of water may be estimated from dielectric relaxation 
spectroscopy (DRS) measurements of percolation phenomenon (Gutina et al., 2003). In 
percolation, the surface moisture provides the charge carriers (protons) to percolate over 
the surface of the solid to provide an assessment of the fractal dimension of the percolation 
pathways and the porosity of the solid (Feldman et al., 2006). These studies thus provide an 
opportunity for measuring milling-induced defects as the probe of the dielectric method (i.e. 
water/proton) is relatively small and can penetrate through these internalized surfaces. 
Previous work at De Montfort University (Ermolina and Smith, 2011) on percolation 
phenomenon in lactose monohydrate and in the mixtures of crystalline material with 
amorphous freeze-dried lactose  has shown that there are two dielectric processes that are 
broadly relevant to the interfacial properties of ball-milled particles; the first is the 
percolation of protons across hard surfaces of the original particles or the fragments of 
particles (that have simply fractured across fault lines within the particle) and the second is 
the classic dielectric relaxation of amorphous phase. In the case of the first process, it may 
be expected that the size reduction of a material on ball milling results in a reduction in the 
percolation path for proton diffusion (associated with decreased particle size) but that the 
associated creation of amorphous domains effectively increases the effective scale length for 
charge percolation owing to the propagation of the protons within the ‘soft surfaces’ of 
particles. In the case of the second process, the creation of amorphous surface domains, on 
otherwise crystalline particles, give rise to the classic dielectric relaxation of amorphous 
phase but modulated by the fact that the material is ‘contained’ or confined within a nano-
scale surface volume. 
The second novel aspect of this work is the application of dielectric spectroscopy for the 
characterization of properties of the amorphous phase that is generated on milling (This is 
also covered in Chapter 2). The characterization of this amorphous phase is necessary in 
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order to optimize its advantage (in the improvement of solubility and dissolution) and to 
understand the risk of its stability (as it has tendency to de-vitrify).  
The third, novel aspect of this work involves the investigation of techniques for the 
quantification of crystallinity/amorphicity at various milling times and frequencies (Chapter 
3). Given the importance of the amorphization phases to the ease by which the saturated 
solubility may be achieved then it is essential that techniques are available for the 
assessment of the extent of amorphization so that the pharmaceutical manufacturing 
process may be controlled. Ideally techniques should be available which are adaptable for in-
line process measurements on the outflow from the mill so that adjustments may be made 
to the process in real time. THz spectroscopy, was shown to be such potential technique. 
The quantification of crystallinity/amorphicity in milled materials is very challenging 
because of the presence of crystallite seeds for de-vitrification and the enormous surface 
area linked with the defected crystals or amorphous phase that readily adsorbs moisture 
from the environment and tends to de-vitrify in time. Another problem encountered 
during milling is the creation of moisture (internal/external), which then drives the de-
vitrification of amorphous phase during post milling storage. The common techniques 
used for quantification of this amorphous content i.e. DSC, further accelerates the de-
vitrification by heat during the analysis. There are few, if any techniques which can 
measure the native/inherent amorphous phase in the materials, which exists immediately 
post milling and least influenced by moisture/temperature induced de-vitrification. 
The recent studies involving the use of Terahertz pulsed spectroscopy (TPS) in the 
crystallization phenomenon (Sibik et al., 2014, McIntosh et al., 2013) and quantification of 
crystallinity by of freeze-dried amino acids and sucrose by De Montfort University group 
(Darkwah et al., 2013, Ermolina et al., 2014) draw our attention to use this technique for 
the quantification of changes in crystallinity in milled materials. Although not explored in 
this thesis, the opportunity to use a spectroscopy such as terahertz for the in-line process 
monitoring is self-evident. 
Once the amorphous content has been quantified, it is necessary to look at the effect of 
milling time and energy inputs on the dynamics of amorphous phase which will reflect the 
stability of this phase. This is very important step as the stability of a product during shelf life 
will depends on the behaviour of amorphous phase.  
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The fourth novel aspect of this work is to use dielectric spectroscopy for the first time in the 
assessment of the dynamics of the amorphous phase in the milled material (Chapter 4). 
There are a range of techniques available for the analysis of molecular dynamics and thus 
stability of the amorphous phase. Parameters such as the structural relaxation time, 
enthalpy relaxation and/or fragility index (obtained from DSC or isothermal micro-
calorimetry techniques) have been used to provide certain measures of molecular mobility, 
which have some relationship with the stability of the amorphous phase (Liu et al., 2002, 
Pokharkar et al., 2006, Graeser et al., 2009). More recently, studies by dielectric 
spectroscopy have shown that the structural relaxation (in terms of the characteristics of the 
α-relaxation) reflects a level of molecular mobility that appears to underpin the de-
vitrification (and hence instability) of system containing amorphous phase (Kolodziejczyk et 
al., 2013, Rodrigues et al., 2013, Sailaja et al., 2013, Wojnarowska et al., 2013, Kothari et al., 
2014). 
In the final novel aspect of this work, the opportunity for using some new surfactants in 
co-milling with a poorly soluble drug, ibuprofen is explored with the aim of enhancing its 
solubility and dissolution rate in order to demonstrate the methodologies developed for 
the analysis of milled materials (Chapter 5). 
1.8 Aim of this Work 
The aim of this work is to develop the analytical methodologies to explain the physical and 
molecular mechanisms responsible for the milling induced improvement of solubility and/or 
dissolution rate of poorly soluble drugs, and the application of co-milling technique to 
sustain/overcome the effects of milling that contribute to the solubility and/or dissolution 
rate improvement. 
1.9 Objectives 
1. To appreciate, a theoretical background of the issue of poor solubility of drugs in 
formulation, milling induced changes affecting the solubility and dissolution rate of 
such drugs and how the co-milling can contribute to sustain these changes. 
2. To develop a qualitative analytical methodology for studying the impact of milling on 
generation of internalized surfaces which contributes to the specific surface and 
facilitates the dissolution of milled particles. Particle characteristics (including phase 
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change, damage to crystal habit and change in size) as a function of milling 
time/energy input, would be determined with the routinely used techniques (for 
comparison) and relatively new techniques i.e. dielectric relaxation spectroscopy. This 
technique can measure the newly created hydration surfaces by the percolation of 
protons. 
3. To develop analytical methodologies for quantitative estimation of the impact of 
milling on crystallinity. The changes in crystallinity of ball milled materials are 
estimated by; i) the changes in weight linked with desorption of the water of 
crystallization as estimated from TGA results of hydrated material, ii) changes in 
enthalpies of melting and crystallization from DSC data or iii) changes in the areas of 
the absorption peaks in THz spectra. 
4. To develop analytical methodologies for studying the molecular dynamics of 
amorphous phase in milled pharmaceutical materials which might then provide an 
understanding of relative stability of the amorphous phase. The DSC profile of milled 
samples would reflect the changes in glass transition temperature, crystallization and 
melting enthalpies. In dielectric relaxation spectroscopy, the amorphous surface 
domains created, on otherwise crystalline particles, by milling can give rise to the 
classical dielectric relaxation of amorphous phase and can be described in term of 
secondary relaxation below glass transition temperature (Tg) and the structural 
relaxation above Tg. 
5. To develop the method of analysis of a drug in the presence of excipients by 
Ultraviolet (UV) spectroscopy. The interference of excipient in the UV absorbance of 
drug (if any) would be determined and corrected or excluded. 
6. To evaluate the effect of co-milling with selected excipient on the solubility and/or 
dissolution rate of poorly soluble drug. The drug and selected excipients would be 
milled together and the resultant mixture is analysed for solubility and dissolution rate. 
7. To establish the mechanism of solubility and dissolution improvement keeping in views 
the effect of milling (analytical methodologies developed in first 3 sections) and the 
added excipient. The comparison of solubility and/or dissolution rate of milled drug, its 
physical and co-milled mixtures with that of un-milled drug would provide the 
information about the effect of milling the drug alone or with excipient(s). 
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1.10 Characteristics and Rationale for the Selection of Drug and Excipients 
1.10.1 Ibuprofen 
Ibuprofen, a non-steroidal anti-inflammatory drug is categorized in BCS Class II. This drug 
was selected as a model drug in the present study on the basis of its easy availability, simple 
and well established assay method (both spectrophotometric and HPLC) and less risks 
involved in its handling, etc. 
Chemically ibuprofen is 2-(4-(2-methylpropyl) phenyl) propionic acid (Figure 1.7a) that form 
dimer in the molecular packing (Figure 1.7b). 
OH
O
CH3
CH3
CH3
ibuprofen
 
 
a b 
Figure 1.7: a) Structural formula of ibuprofen b) molecular packing of ibuprofen (viewed on ‘b’ axis) showing 
hydrogen bonding and functional groups (red) for dimer formation. 
According to BP 2011, ibuprofen is a white or almost white crystalline powder having 
acicular shaped crystals with high cohesion tendency therefore it has poor flowability (Aly 
Nada, 2005). Ibuprofen is practically water insoluble, freely soluble in methanol, acetone, 
and methylene chloride. It also dissolves in dilute solutions of alkali hydroxides and 
carbonates. Its melting point is 75 °C – 78 °C, the absorption maxima at 221 nm, 264 nm and 
272 nm a and log-P 3.83 (calculated), and 3.50 (experimental). 
1.10.2 Candidate Excipients 
The commonly used sugars were selected to study the effects of milling on their physical and 
thermodynamic properties, while the surfactants/solubilizers and polymers were employed 
in the co-milling study. 
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1.10.2.1 Sugars 
Three sugars, including anhydrous (sucrose and lactose), monohydrate (lactose) and 
dihydrate (trehalose) were used in this study. The reasons for selecting these include; these 
are stable sugars, have a wide range of applications in pharmacy and are with known safety 
data. These sugars have a diverse milling behaviour and therefore are ideal compounds in 
the studies aimed to demonstrate the milling induced changes like the present one. The 
study of these sugars is also important to demonstrate the effect of crystalline water during 
the process of milling. 
Lactose is a disaccharide formed from the condensation of galactose and glucose linked 
through a β,1-4 glycosidic linkage (Figure 1.8). Its main use is as a diluent in tablet 
formulations (Pilcer and Amighi, 2010). Lactose is an ideal material for the demonstration of 
milling induced changes like reduction in particle size, increase in surface area, 
amorphization etc. The different forms of lactose (monohydrate, anhydrous) have entirely 
different milling behaviour, presenting it as a further useful material for milling studies.  
 
Figure 1.8: Molecular structures of sucrose, beta lactose, trehalose and alpha lactose monohydrate, taken 
from google images. 
The melting point of anhydrous α-Lactose is 223 °C, of α-Lactose monohydrate 202 °C and of 
-Lactose 252 °C (Raymond C Rowe, 2003). The commercially available forms alpha or beta 
lactose always contains some percentage of beta or alpha anomer as impurity. 
Sucrose in a disaccharide that consists of glucose and fructose units linked through a α,1-2 
glycosidic linkage (Figure 1.9). The milling of sucrose has shown that it is a brittle material 
having the breakage extent proportional to the square of the impact velocity. The breakage 
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of this sugar is influenced by the particle size of initial feed. Sucrose shows a greater extent 
of breakage as compared to the lactose (Yang et al., 2007). 
Trehalose is a disaccharides of α-glucose formed by an α,α-1,1-glucoside bond between the 
two units (Figure 1.9). It occurs as anhydrous and dihydrate form and mainly used as cryo-
protectants of biological drugs during freeze drying process (Crowe et al., 1996, Patist and 
Zoerb, 2005).  The milling of anhydrous trehalose induces a direct transformation from 
crystal to glass phase and used as a popular of way producing the amorphous state (Willart 
et al., 2001). The milling of dihydrate form does not amorphize it rather converts it to a 
structurally invariant form. These behaviours are ascribed to the plasticizing effect of the 
structural water which decreases the glass transition temperature below the milling 
temperature (Willart et al., 2010). 
1.10.3 Surfactants/Solubilizers 
1.10.3.1 Lutrol F-68® 
Lutrol® is also known as Poloxamer-188, Pluronic and Lutrol F-68. Poloxamers are the block 
co-polymeric non-ionic surfactant consisting of Polyoxyethylene-(PoE-) and 
Polyoxypropylene-(PoP-) units (a = ca. 79, b = ca. 28) as shown in Figure 1.9. The number 188 
is derived from 18 (molecular weight of PoP part 18x100=1800), 8 (percentage weight of EO 
part, 8x10=80) while, F-68 is derived from 6 (molecular weight 6x1000=6000), 8 (percent 
weight of EO part, 8x10=80 (Quadir, 2005). 
 
Figure 1.9: Molecular Structure of Lutrol F-68, taken from (Quadir, 2005) . 
Lutrol F-68 occurs as white micro-beads or prilled granules with an average particle size 150 
µm and a specific faint odor. Its melting point is 52 °C, hydrophilic lipophilic balance (HLB) 
value 29 and the bulk density ~ 1055 Kg m-3. It is freely soluble in water and ethanol. Its 
molecular weight is ~ 9000 dalton and enthalpy of melting is 121 J g-1. 
Lutrol has been categorized as dispersing agent, emulsifying and solubilizing agent and 
widely used (5-10% by weight) for these properties as well as a wetting and plasticizing 
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agent (Raymond C Rowe, 2003). The minimum aggregation concentration for Lutrol F-68 is ~ 
6.0 µmol L-1 (i.e. 0.054 mg ml-1). 
Solubilization Action of Lutrol®: The hydrophobic portion of a poloxamer is responsible for 
its solubilization action. In water, the molecules arrange themselves in an ‘umbrella like’ 
configuration (Figure 1.10) that incorporate the drug inside (Quadir, 2005). 
 
Figure 1.10: Diagrammatic representation of the solubilizing unit of Lutrol F-68 that incorporate the API, 
taken from (Quadir, 2005). 
Poloxamers are widely used as solubilizer for the enhancement of solubility and dissolution 
of poor soluble drugs by the way of solid dispersion (Shin and Cho, 1997, Passerini et al., 
2002). 
1.10.3.2 Soluplus® 
Soluplus is a relatively new solubilizer especially designed for preparing the solid solutions of 
poor water soluble drugs. Chemically, it is a graft co-polymer of polyvinyl caprolactam - 
polyvinyl acetate - polyethylene glycol. The structural formula (Figure 1.11) contains PEG-
6000 (n)/ caprolactam (I)/ vinyl acetate (m) in the ratios of (13/57/30). Its molecular weight 
is ~ 118000 dalton (Hardung et al., 2010). 
 
Figure 1.11: Molecular Structure of Soluplus®, taken from (Hardung et al., 2010). 
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Soluplus occurs as free flowing white or slightly yellowish granules, hygroscopic in nature. It 
is freely soluble in water and organic solvents. Its melting point is > 58 °C, HLB value is 8 - 14 
and glass transition temperature ~ 70 °C. It forms micelles with the critical micellization 
concentration (CMC) value in water at 23 °C equal to 7.6 µg ml-1. Its bulk density is 500 - 600 
Kg m-3 (Ali, 2010). 
Solubilization action of Soluplus: The vinyl-acetate and vinyl-caprolactam moieties of 
soluplus interact with the API incorporating it completely while the polyethylene glycol (PEG) 
moiety forms the backing of the complex (Ali et al., 2011) (Figure 1.12). 
 
Figure 1.12: Diagrammatic representation of the mechanism of solubilization of API by Soluplus, taken from 
(Ali et al., 2011).  
Because of its high flowability and excellent extrudability, soluplus has become an excellent 
candidate for solid dispersion especially in hot melt extrusion process (Djuric, 2011) . It has 
become extremely useful solubilizer since last few years and has been used for the 
enhancement of solubility of many pharmaceutical actives including itraconazole, 
fenofibrate, carbamazepine, danzole, clotrimazole, griseofulvin, and ketoconazole in buffer 
media (Smithey et al., 2010, Djuric et al., 2011). Its solubilizing capacity have shown to be 
robust toward different pH values and is superior to other commonly used solubilizers 
(Djuric and Kolter, 2010). 
1.10.4 Polymers 
1.10.4.1 Polyvinylpyrrolidone (PVP)  
PVP also called Polyvidone; is a water-soluble polymer consisting of N-vinyl-pyrrolidone 
monomers (Figure 1.13a). 
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a b 
Figure 1.13: Molecular structure of a) PVP and b) HPMC, taken from google images. 
PVP occurs as a light flaky powder that is hygroscopic in nature and readily absorbs 
atmospheric water up to 40% of its weight. It is soluble in water and other polar solvents. In 
solution, it has wetting properties and forms readily films, which makes it a good coating or 
an additive to coatings agents (Folttmann and Quadir, 2008). PVP has been used in many co-
milling studies with poorly soluble drugs for the stabilization of amorphous surfaces to 
enhance the solubility and dissolution rate of these drugs (Balani et al., 2010a, Balani et al., 
2010b). 
1.10.4.2 Hydroxy Propyl-Methyl Cellulose (HPMC) 
HPMC is cellulose 2-hydroxypropyl methyl ether (Figure 1.13b) that is widely used in 
pharmaceutical formulation as stabilizing agent, suspending agent, tablet binder and rate 
controlling polymer for sustained release drugs. It occurs as white, odourless and tasteless 
fibrous or granular powder. It melting point is 190 °C - 200 °C and glass transition 
temperature 170 °C - 180 °C. It is hygroscopic in nature and is soluble in water forming 
viscous colloidal solution (Raymond C Rowe, 2003). HPMC has been used in many co-milling 
studies for the improvement of dissolution of poorly water soluble drugs (Sugimoto et al., 
1998). 
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2 Surface Characterization of Milled Pharmaceuticals (Lactose 
Monohydrate) using Different Analytical Techniques – The Study 
of Percolation Phenomenon 
2.1 Background/Context 
The process of milling produces defects in the crystal lattice, such as the dislocation of 
crystal planes, which ultimately results in the fracturing of particles when the number of 
defects exceeds the critical limit (Bates et al., 2006). Milled materials, having high surface to 
volume ratios, are considered to be porous in the sense that there are likely to have 
channels (fissures and cracks) which run from the surface to some point towards the core of 
the particles. In consideration of the new surfaces that are formed on milling, it may be 
important to recognize ‘external’ and the ‘internal’ surface. The external surface is mostly 
the geometrical envelope of the discrete particles or aggregates and includes all the surfaces 
of those cracks which have more width than their depth, while the internal surface 
comprises the walls of all cracks, pores and cavities which are deeper than they are wide and 
which are accessible to the adsorptive probes (Sing et al., 1982). 
External surfaces have a diffusion layer controlling the dissolution rate, the thickness of 
which is a function of the rate of stirring/agitation within the dissolution medium. In 
contrast, the internal surfaces may indeed provide opportunities for the dissolution fluid to 
wick into the particle and allow for dissolution to occur. However, in a non-swelling particle 
this water will soon become saturated and therefore choke off any further dissolution of the 
particle. The direct contribution of this internalized dissolution process, to the overall 
dissolution rate, is likely to be insignificant. Instead, the role of these internal surfaces in 
promoting dissolution of the particle is more likely to be associated with the impact that the 
localized internal dissolution process have on the ‘bridges’ holding the partially fragmented 
particle together. The dissolution of these bridges and the creation of new external surfaces 
is most probable mechanism that explains the increased dissolution rate of a particle which 
is partially damaged. 
The requirement to distinguish between external and internal surfaces is a question of “rate 
limiting steps”. If the rate of conversion of the internal surface to an external surface (as a 
result of the break-up of a partially fractured particle) is faster than the rate of dissolution of 
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the external surfaces present then it might be considered that any internal surface is in 
effect contributing to the overall dissolution of the particle, in the same was as if it started 
out as an external surface. However, conversely, if the rate of particle break-up is much 
slower than the rate of dissolution of an external surface then there will be a need to 
differentiate between these two categories of surface, using appropriate measurement 
techniques, so that the impact of milling on the mechanism of dissolution rate enhancement 
may be more clearly understood. Given the potential criticality of the rate of break up to the 
resultant overall dissolution rate, then it may also be important to examine the factors which 
control the rate of break-up of partially damaged particles. Clearly, whether a particle swells 
on absorption of water into the internalized surfaces will be a key factor, as that in itself is 
likely to promote break-up of the particle. In other cases of non-swelling particles it may be a 
question of the number and strength of the bridges which hold the particle together that will 
control the rate of break-up of the particle. The mechanisms of dissolution are therefore 
potentially rather complex and may require multiple analytical technologies in order to 
establish the dominant processes. 
The techniques commonly applied for studying the impact of milling on crystalline particles 
includes; SEM for changes in particle shape (Rasenack and Müller, 2004), laser diffraction for 
particle size (Kwan et al., 2004), nitrogen adsorption studies for specific surface (Joshi et al., 
2002), PXRD for assessing the changes in crystallinity, DSC for measuring loss of crystallinity, 
FTIR for any structural change (Patterson et al., 2007, De Gusseme et al., 2008), (Michael 
Lee, 2011), IGC for measuring surface chemistry/energies (Heng et al., 2006); MT-DSC, 
micro-calorimetry and dynamic vapour sorption for determination of amorphous content 
(Mackin et al., 2002b, Guinot and Leveiller, 1999) and TGA for measuring the moisture 
content (Ward and Schultz, 1995). 
The measurement of specific surface area of the milled material is important in explaining 
the role of cracks and fissures in dissolution and water sorption because an assessment of 
particle size reduction, alone, is unlikely to be sufficient to explain the complete impact of 
milling on the dissolution rate. The surface area measuring techniques, such as nitrogen 
adsorption has the potential for assessing the entire surface contributions from both 
external and internal surfaces. The technique involves long pre-exposure of the milled 
sample to the elevated temperature (~60 °C) and reduced pressure before the measurement 
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is made. The issue with this approach of the surface area measurement for a crystal hydrate 
is that the process may result in the creation of new surfaces by the evaporation of the 
water of hydration (Raut et al., 2011). There are few, if any techniques, which can measure 
the native/inherent moisture content at the surfaces of the crystal and within the new 
amorphous phase, which exists immediately after milling.  
Recent work on porous materials has shown that the features of hydration surface, in term 
of micro-clusters of water, may be estimated from the dielectric measurements of 
percolation phenomenon; whereby the surface moisture provides the charge carriers, 
protons, that percolate over the surface of the solid to provide an assessment of the fractal 
dimension of the percolation pathways and the porosity of the solid (Feldman et al., 2006). 
The focus of the work presented in this Chapter is to investigate the surface changes 
(including the particle size, surface area, creation of amorphous surface domain and changes 
in the surface chemistry) after ball milling of a pharmaceutical material (lactose 
monohydrate, LMH). The measurement of these changes is important as they affect the 
behaviour of the milled pharmaceuticals during or post milling manipulations and storage. A 
special focus of study is the percolation phenomena estimated by broadband dielectric 
spectroscopy (BDS). The study offers the evaluation of a hydrated sugar by some routinely 
used techniques (SEM, TGA, BET, DVS and IGC) with the aim of highlighting the advantages 
and limitations of these techniques. Moreover the opportunities of using BDS in 
characterizing the surface defects of milled materials are explored. 
Lactose monohydrate was chosen, as it is one of the most commonly used excipients in the 
pharmaceutical industry, as a diluent in tablet formulations (Jivraj et al., 2000) and the 
carrier in dry powder inhalers (DPI) (Kou et al., 2012). Milling of LMH occurs through ductile 
fracture (high energy dissipation and lower fracture velocities) reduces its particle size, 
generates the disordered amorphous phase and converts a portion into the metastable β-
anomer (Willart et al., 2004). The loss or re-distribution of the water of hydration also occurs 
on the milling of this hydrated sugar (Thomsen et al., 2005). 
2.2 Materials and Methods 
Lactose monohydrate (EP/BP) was sieved at room temperature (~ 23 °C) and ~40% relative 
humidity. The particles that passed through an 80 mesh sieve and retained on a 100 mesh 
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sieve (corresponding to linear size between 150 and 180 µm), were taken for the analysis. 
The measured average particle size by SEM was ~172 µm. Laser diffraction technique has 
shown that 50% of particles (d50) were of the size less than 154 µm. 
2.2.1 Ball Milling 
The material was milled in the vibratory ball mill (MM 301, Retsch, Germany, Figure 2.1) 
equipped with two 50 ml stainless steel cylindrical jars each containing one stainless steel 
ball of 25 mm diameter (Figure 2.1). A weight of 2.5 g of LMH was loaded into each jar, 
which were then closed tightly and clamped in position of the mill. The mill was operated at 
frequency of 18 Hz for 15, 30, 45, 60, 90, 180, 270 and 360 min. The sample was collected 
into a glass vial and used immediately or stored in desiccator until used for further analysis. 
 
Figure 2.1: Vibratory ball mill (MM-301) with the milling jars and balls of different sizes. 
Note: The mill frequency of 18 Hz was selected after an initial screening of three speeds i.e. 
15, 18 and 25 Hz as previously used by (Kwan et al., 2004) based on the fact that this 
frequency had a significant impact on the crystallinity without a marked increase in the 
temperature of the mill. The temperature of milled material was ~40 °C, estimated by 
insertion of a thermocouple probe into the powder immediately after milling. 
2.2.2 Laser Diffraction Technique/Particle Size Determination 
The particle size distribution (PSD) of un-milled and milled lactose monohydrate was 
determined by dry dispersion laser diffraction technique according to the method described 
by (Krause et al., 2011). The powder was dispersed in compressed air at pressure of 3 ± 0.05 
bar using a dispersion unit, RODOS (Sympatec, Germany), dispensed at the feed rate of 60 
mm sec-1 using a micro-dosing unit, ASPIRO (Sympatec, Germany) and measured under the 
pressure of ~0.5 bar with a laser diffractometer (HELOS H1360, Sympatec, GmbH, Germany) 
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fitted with R5 lens (Sympatec) that measures the size between the range of 4.5 to 875 µm. 
The data analysis was performed with WINDOX 5 software and the parameters d50, and d90 
were calculated, that represent 50%, and 90% of the particles are lower than the given size, 
respectively. 
2.2.3 Scanning Electron Microscopy (SEM) 
The un-milled and milled samples of LMH were photographed by ZEISS EVO HD 15 scanning 
electron microscope (Carl Zeiss, NTS Ltd. Cambridge, UK) according to the method used by 
(Qiao et al., 2013). The samples were mounted on the carbon adhesive tape fixed on 
aluminium stubs (Agar Scientific Ltd., Stansted, UK), flushed with air and imaged at the 
voltage of 10 KV by using secondary electron and backscatter detectors. 
2.2.4 Thermogravimetric Analysis (TGA) 
TGA of un-milled and milled LMH was carried out in a TGA instrument with auto-sampler 
system (Perkin Elmer, US) according to the method already described by (Hurtta et al., 
2004). The empty aluminium pan was loaded into the TGA instrument and tarred. Then the 
sample was placed in the pan and the pan returned to the instrument. The weight of sample 
was recorded in the temperature range from 25 °C to 250 °C at the rate of 20 °C min-1. 
2.2.5 Brunaer Emmet Teller (BET) Surface Area Measurement 
The BET surface area of the milled samples of LMH were determined by nitrogen adsorption 
technique using ASAP 2420 (Micromeritics Instrument Corporation, USA). The samples were 
degassed at 60 °C under reduced pressure for 24 hours (this removes moisture and other 
dissolved gases). Helium was used to measure the free space, space of the sample tube left 
over from sample. The nitrogen adsorption isotherms were collected from 0.002 to 0.995 
p/po in liquid nitrogen (-162°C). 
2.2.6 Dynamic Vapour Sorption (DVS) 
DVS of milled lactose monohydrate were measured with a DVS Advantage automated 
moisture sorption instrument (Surface Measurement Systems Ltd., London, UK) at 25 °C with 
sample size of about 10 mg for each analysis. The working concentration range of the 
instrument was 0-98% p/po; and temperature stability of 0.1 °C. Prior to measure, the 
samples were dried at 25°C under a continuous flow of air to establish the dry mass. Then 
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exposed to the following typical partial pressure profile: 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 
95, 90, 80, 70, 60, 50, 40, 30, 20, 10 and 0% RH. A fixed time of 180 min was selected for all 
relative humidity steps. 
2.2.7 Inverse Gas Chromatography (IGC) 
The surface properties of milled lactose monohydrate were evaluated by measuring the BET 
surface area, surface energy profiles and the acid/base numbers. The measurements were 
made in a second generation IGC-SEA Analyser (Surface Measurement Systems Ltd., London, 
UK) having a flame ionization detector. The data were analysed using both standard and 
advanced SEA Analysis Software. 
The samples (67 to 980 mg) were packed into standard columns (30. 0.3 cm ID) employing a 
tapping machine. The sample column was pre-conditioned for 1 hour at 30 °C and 0% 
relative humidity with 10 ml min-1 helium as a carrier gas. The experiments were conducted 
at same temperature and humidity conditions during which the samples were run at a series 
of surface coverage with alkanes (Decane, Nonane, Octane, Heptane, Hexane, Pentane) and 
polar (Ethanol, Ethyl acetate, Acetone, Dichloromethane, Acetonitrile, Chloroform) probe 
molecules to determine the dispersive surface energy (S
D) as well as the acid-base free 
energy of adsorption (ΔGSP). The specific surface area of each sample was first determined 
by measuring the Octane or Heptane adsorption isotherms. The BET specific surface areas of 
the samples were calculated from the corresponding isotherms, within the partial pressure 
range of 5% to 35% p/p0. 
Note: DVS and IGC studies were conducted by Surface Measurement Systems, London, U.K, 
BET measurement by Nottingham University and the Laser diffraction studies is the courtesy 
of AstraZeneca, Macclesfield, UK. All these were included here as supplementary studies. 
2.2.8 Broadband Dielectric Spectroscopy (BDS) 
Dielectric measurements were performed in BDS Solartron 1296 instrument connected to a 
Solartron 1255 frequency response analyser (Figure 2.2a) according to the method taken 
from (Ermolina and Smith, 2011). The powder sample was placed between two electrodes of 
gold sample cell (Figure 2.2b) to form a uniform thin layer. The diameter and thickness of the 
sample were measured from the geometry of sample cell using vernier calliper. The sample 
cell was mounted in sample holder and placed in the Oxford Instruments Cryostat (Figure 
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2.2c) which provides the temperature control using liquid nitrogen. The sample was 
measured applying the frequencies between 0.1 Hz and 10 MHz and temperature range of 
−120 to +100 °C with 5 °C increments. 
 
 
 
a b c 
Figure 2.2: Solartron dielectric spectrometer showing a) frequency response analyser, b) sample cell 
containing two gold plated electrodes mounted in Teflon assembly and c) sample holder and cryostat 
assembly for the regulation of temperature during the measurements. 
Note: In order to maintain the uniformity that the same milled sample will used in all 
analytical techniques, each measurement was done once only. 
2.3 Results and Discussion 
2.3.1 Particle Size Distribution 
In un-milled lactose monohydrate, the cumulative particle size distribution plot has shown 
that majority of the particle (~90%) have the size greater than 80 µm (as indicated by the 
dotted lines ‘A’ & ‘B’ in Figure 2.3a while the the rest of particles are smaller than this value. 
The density distribution plot (Figure 2.3b) show a Guassian distribution that ranges between 
100 - 400 µm with the peak at ~160 µm. 
On the other hand, in case of milled samples of lactose monohydrate (15 min to 90 min), 
the cumulative plots show that the PSD shift towards smaller size with ~75% particles are of 
the size less than 80 µm in all milled samples (dotted line ‘A’ Figure 2.3a). The density 
distribution plots of these milled samples show that the size of particles spreads over the 
range of few micron to 400 µm with the density of ~0.5 (dotted line ‘D’ Figure 2.3b). These 
profiles presents three modalities of size distribution i.e ~7 µm, 50 µm and 200 µm 
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(indicated by arrow arrows in Figure 2.3b) which largely remain unchanged in lactose 
monohydrate milled for 15 min to 90 min. 
  
a  b 
Figure 2.3: Particle size distribution plots of un-milled and milled lactose monohydrate showing a) 
cumulative distribution and b) density distribution plots. The dotted lines represent cut off size (A & C) or 
frequency (B & D) for different samples. 
The parameters of PSD including d50 and d90 have been summarized in Table 2.1. The value 
of d50 that was ~155 µm for un-milled LMH, reduced to ~15 µm after 15 min of milling. It 
does not reduce further, rather it goes up slightly in 45 min milled sample (~30 µm) and ~20 
µm in 90 min milled sample. The values of d90 that decrease slightly in short milled sample 
(i.e.15 min milled), but increase again in 45 min and 90 min milled sample. 
Table 2.1: Particle size distribution of un-milled and milled lactose monohydrate showing the values of d50 
and d90 that represent the 50 and 90% particle less than the given size respectively. 
Milling time d50 (µm) d90 (µm) 
0 153.9 228.9 
15 14.8 206.9 
45 32.4 283.1 
90 21.4 247.2 
These results have indicated that the particle size is reduced on ball milling, with the 
greatest reduction occurring in the early few min of milling time (≤ 15 min) where there is 
more than 10 times reduction in particle size. After this significant reduction in particle size 
distribution there appears a little change in size on long milling times i.e. at 45 min and 90 
min. Rather there is some regain in particle size (as the d90 values of long milled samples are 
greater than that of un-milled samples). This probably represents the formation of clusters 
of particles which is investigated in SEM of these milled samples. It is also possible that 
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during the initial phase of milling most of the energy input is used in particle size reduction 
while on longer milling the energy input is dissipated in the generation of the amorphous 
phase with no further reduction in size. Given that the milling of lactose monohydrate 
releases the water of hydration there is still another possibility of re-crystallization of the 
amorphous phase generated in long milled samples. Thus, there is interplay between the 
size reduction, clustering/aggregation of particles and re-crystallization, which results in 
hardly any significant change in particle size between 15 min to 90 min of milling. These 
changes are further investigated by SEM, BET, TGA and DVS. 
2.3.2 Scanning Electron Microscopy Results 
The SEM micrographs of un-milled lactose monohydrate (Figure 2.4) showed that the 
particles are crystalline with well-defined cuboidal shapes and appear to be having the ‘hard’ 
surfaces which are not completely smooth. The sizes of these particles lie in the range of 50–
220 µm, which is consistent with the laser diffraction results (Section 2.3.1). 
In milled samples of lactose monohydrate, the large and small fragments of crystalline 
particles are visible. The shapes of these particles are irregular with rough and fragmented 
surfaces (Figure 2.4) which is consistent with the observations of (Price and Young, 2005). 
The 15 min and 30 min milled sample showed the particle that range in size from few 
microns to 70 µm and they have irregular and damaged surface. On milling, beyond 30 min, 
the size of particles is further reduced (it is 2 -15 µm in 45 min and 90 min sample) and they 
appear to have ‘soft’/‘fluffy’ surfaces (see Figure 2.4) with an underlying ‘hard’ crystalline 
particle. At the 180 and 270 min milling time points, the clusters of uniform nano-sized 
particles are observed which aggregate together forming clusters of ~500- 1000 nm as 
speculated in particle size results. In these samples there are hardly (if any) large particle.  
Note: Appendix I show some more micrographs of milled samples of lactose monohydrate at 
different magnifications. 
The SEM results have indicated the size reduction on ball milling (initial rapid reduction 
followed by relative slower decrease), which is almost consistent with the particle size 
results by laser diffraction. However the presence of larger particle (equal to or larger than 
the size of un-milled particles) in milled samples as speculated in particle size results (Section 
2.3.1) are not observed in SEM. Instead the clusters of smaller particles are seen in longer 
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milled samples. At this point, there is need for a technique that can measure the exact 
contribution of milling to the size reduction or increase in surface area.  
   
   
   
Figure 2.4: SEM images of un-milled and milled lactose monohydrate for different time intervals. Milling 
times and magnification have been indicated in boxes on each micrograph. 
2.3.3 BET Surface Area Results 
The surface area measurement by the nitrogen adsorption technique involves the partial 
pressure of adsorptive gas which is gradually increased to form a monolayer on the surface 
of adsorbent. The plot of partial pressure of gas against quantity adsorbed gives the 
adsorption isotherm. If this relationship is linear (which usually occur for p/p0 range of 0.05 - 
0.30) the adsorbed amount can be calculated by applying Brunauer-Emmett-Teller (BET) gas 
adsorption relation (Equation 2.1). 
𝐩
𝐧𝐚.(𝐩𝟎−𝐩)
=  
𝟏
𝐧𝐦.𝐂
+
(𝐂−𝟏)
𝐧𝐦 .𝐂
 .
𝐩
𝐩𝟎
   Equation 2.1 
Un-milled X 75 
15min milled X 10000 
90min milled X 10000 
45min milled X 10000 30min milled X 10000 
180min milled X 10000 
Un-milled X 1000 Un-milled X 10000 
270min milled X 10000 
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Where ‘na‘ is the amount adsorbed at the relative pressure p/p0, nm is the monolayer 
capacity and ‘C’ is BET constant related exponentially to enthalpy of adsorption to first layer. 
The value of ‘C’ < 10 indicates that the sample is non-porous and all surface area is external. 
The plots of quantity adsorbed against relative pressure of gas for un-milled and milled LMH 
are linear, indicating the uniform surface adsorption in all the samples. In milled samples of 
LMH, these plots not only shift upwards indicating the increase in the quantity adsorbed but 
also the gradient of these plots increases indicating the increase in the surfaces available for 
adsorption of the gas (Figure 2.5). This trend continues with milling time till 45 min and 
reverts again in long milled sample (i.e. 90 min). 
 
  
Figure 2.5: Nitrogen adsorption isotherm of un-milled and milled sample of lactose monohydrate. The arrow 
heads are showing increase or decrease in quantity adsorbed with increasing the milling time. 
BET surface area is calculated from the quantity adsorbed at monolayer coverage by 
applying the BET relation (Equation 2.2). 
𝐀𝐬(𝐁𝐄𝐓) =  𝐧𝐦
𝐚  . 𝐋 . 𝐚𝐦  Equation 2.2 
Specific surface area of un-milled lactose, as determined from BET is 0.26 m2g-1 (Table 2.2), 
which is not consistent with the particle size results (as from the average size of ~160 µm the 
specific surface area is lower than this value). Also this value of surface area is higher than 
that of the anhydrous sugar (sucrose, 0.035 m2g-1) but lower than the dihydrate sugar, 
trehalose (i.e. 1.43 m2g-1) with almost the same particle size. The main reason for high 
surface area of hydrated sugars is likely to be that, during pre-treatment (exposure to 60 °C 
overnight) water of hydration is desorbed from the crystals, leaving some pores that 
0.0
0.2
0.4
0.6
0.8
1.0
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35
Q
ty
. A
d
so
rb
e
d
 (
cm
³g
-1
) 
Relative Pressure (P/Po) 
Un-milled LMH
5min milled
15min milled
45min milled
90min milled
37 
 
 
contribute to the total surface area. Another reason is the presence of pits/fissure on the 
surface of these particles in comparison with the smooth surfaces of the anhydrous one. This 
is evidenced from the SEM micrographs of sucrose (Appendix II) and trehalose dihydrate 
(Appendix III). 
The value of BET constant ‘C’ for un-milled LMH is greater than 10, indicating the porous 
surfaces that probably have been created by the evaporation of water during the pre-
treatment. 
Table 2.2: BET surface area parameters of un-milled and milled lactose monohydrate determined from the 
nitrogen adsorption isotherms. 
 
Un-milled 
LMH 
5min milled 15min milled 45min milled 90min milled 
BET Surface Area 
(m²g
-1
) 
0.26 ± 0.0028 0.57 ± 0.0019 2.32 ± 0.0062 3.15 ± 0.0062 1.82 ± 0.0065 
Slope (g cm
-
³) 15.5 ± 0.1737 7.4 ± 0.0241 1.8 ± 0.0048 1.4 ± 0.0026 2.4 ± 0.0084 
Y-Intercept (g cm
-
³) 1.01 ± 0.0364 0.16 ± 0.0050 0.02 ± 0.0009 
0.015 ± 
0.0004 
0.038 ± 0.0016 
C 16.32 48.78 71.24 91.51 62.25 
Qm (cm³g
-1
) 0.06 0.13 0.53 0.72 0.42 
Correlation Coeff. 0.999 0.999 0.999 0.999 0.999 
Molecular cross-
Sectional area (nm²) 
0.162 0.162 0.162 0.162 0.162 
Specific surface area of milled lactose monohydrate increases gradually with milling time till 
45 min, and then it decreases in the 90 min milled sample (Table 2.2). These results 
(apparently in agreement with SEM and particle size results) show that there is a notable 
increase in the specific surface area particularly during early minutes of milling (i.e. 0.26 m2 
g-1 of un-milled to 2.32 m2 g-1 of 15 min milled sample; ~10 times increase). This is followed 
by a small increase where the value of specific surface area is 3.15 m2g-1 in case of 45 min 
milled sample and then decrease (1.82 m2 g-1) in 90 min milled sample. However these 
findings are not consistent with the particle size results (section 2.3.2) as the 10 times 
reduction in particle (that occurs in first 15 min of milling) would be expected to increase the 
surface area by the square of the size reduction factor (i.e. ~100 times). This observation is 
probably a result of the high contribution from internal surfaces that have been created 
through the loss of water in the pre-treatment process of elevated temperature and high 
vacuum. 
Also between 15 min to 45 min milling, where the particle size increases slightly (Table 2.1) 
due the formation of aggregates as visible in SEM images (Figure 2.4), the surface area 
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continues to increase (Table 2.2), which indicates the area of surfaces which are in effect 
internal to the agglomerates are accessible to the nitrogen gas probe. 
On milling beyond 45 min, where particle clusters are more frequent, and amorphous 
content of the sample also high (as discussed in Chapter 3, Section 3.3.3.9) the specific 
surface area appears to decrease (although the magnitude of this decrease is not consistent 
with particle size results). The reasons for this decrease might include; i) the amorphous 
content entering the interior of cluster that re-crystallizes owing to the high water content 
and high temperature of the mill, making the clusters non-accessible to the nitrogen probe 
(Figure 2.6), ii) the decrease in surface free energy in long milled samples after an initial 
increase in short milled one (see IGC results, Section 2.3.6.1). 
 
Figure 2.6: An illustration of the changes in surface area on milling and desorption of water of hydration 
(that is facilitated by milling). The clusters of particles are lose till 45min milling but are compact when 
amorphous content increase on long milling.  
It can be concluded that the surface to volume ratio increases on milling, however on long 
milling particles get aggregated decreasing the specific surface area (Figure 2.6). The present 
techniques measure the different scale lengths; where laser diffraction measures the scale 
length of particles, SEM visualizes the surfaces and the BET measures the surfaces accessible 
to nitrogen probe. Provided that the milled hydrated material like lactose monohydrate is a 
complex system containing a range of crystallites and different levels of amorphous (Chapter 
3) and moisture content (Section 2.3.4). The uncertainties about the contribution of each 
phase would exist and the complete characterization of such material is not reliable from 
these techniques. Therefore, we explored the application of dielectric spectroscopy. 
2.3.4 Thermogravimetric Analysis Results 
The desorption profiles of un-milled and milled lactose monohydrate are considered in 
terms of the release of both surface (physi-sorbed) and bound (chemi-sorbed) water and the 
impact that the defected crystalline structure of milled samples are likely to exert on the 
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onset temperatures for desorption of water. The TGA curves (Figure 2.7) show that 
desorption of water from the milled samples of lactose monohydrate is not straightforward, 
rather it occurs over a number of temperature ranges representing the presence of different 
assemblies of water. 
TGA curve of un-milled lactose monohydrate (top curve in Figure 2.7) has shown that the 
weight of sample remains almost constant until a small step of weight loss at ~120 °C 
followed by the desorption of the water of crystallization at ~144 °C. The initial small weight 
loss (~0.4%) is assumed to be desorption of physi-sorbed water. However, it seems 
improbable that the surface water would be released at such an elevated temperature. It is 
more likely that this apparent increase in the TGA thermogram (that probably occur because 
of uptake of moisture from environment as the analysis is carried in open pans) is in fact 
masking the analysis of the surface water loss, which is otherwise observed from 30 -70 °C. 
 
Figure 2.7: TGA thermograms of un-milled and milled lactose monohydrate, the onset temperature for 
desorption of crystallization water is indicated by vertical dotted line. The horizontal dotted line represents 
the plateau in weight. The arrow heads are showing the onset temperature for the release of surface water 
in milled and un-milled samples. 
In contrast, the desorption of surface water from the milled samples of LMH has a more 
realistic, early onset temperature of approximately 30 °C which continues until ~110 °C from 
where the desorption of the water of crystallization starts. Taking 0.4% as the value for the 
un-milled sample, it would then appear that the surface water increase almost linearly with 
milling time, with the 15 and 45 min milled samples containing 1.69% and 1.25% surface 
water respectively (Table 2.3). This proportion increase further in long milled samples (90 
and 180 min milled), where the percentages surface water are 2.20 and 1.60%, respectively. 
The other principle difference between the TGA curves for the un-milled and milled LMH is 
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the onset temperature of desorption of water of crystallization. It is ~144 °C in the un-milled 
LMH (comparable to an endothermic peak of water desorption in the DSC curve, Figure 3.4 
in Chapter 3), this temperature is ~110 °C in the milled samples. 
The factors that might be responsible for 35 - 40 °C decrease in the onset temperature for 
desorption of the crystallization water in the milled LMH (from ~144 °C of un-milled sample 
to ~105 °C in the 90 min milled one) are; the development of new pathways for dehydration 
in a structurally compromised crystalline phase, (Garnier et al., 2008) and the decrease in 
particle size (Shariare et al., 2011). 
Table 2.3: Values of un-bound and bound water in un-milled and milled lactose monohydrate as calculated 
from the weight changes in TGA thermograms. 
 
Un-bound/Surface water Bound/Crystallization water 
Milling time 
Start wt. 
(%) 
End wt. 
(%) 
Weight 
loss (%) 
Onset 
temp. (°C) 
Start wt. 
(%) 
End wt. 
(%) 
Weight 
loss (%) 
0 100.1 99.8 0.40 144 99.8 96.6 5.0 
10 100 98.24 1.76 106 98.24 94.4 3.84 
15 100 98.31 1.69 112 98.27 94.7 3.57 
30 100 97.28 2.72 102 97.8 94.35 3.45 
45 100 98.75 1.25 107 98.7 94.75 3.95 
90 100 97.8 2.20 106 98 94.8 3.2 
180 100 98.4 1.60 106 98.4 94.8 3.6 
*from the stoichiometric ratio of water in lactose monohydrate 
It is important to note that in case of un-milled LMH, the change in the gradient beyond 160 
°C (after the release of ~2.5% water) remains incomplete may be due to the fact that it is 
increasingly harder to remove the water as the drying front recedes into the crystals. The tail 
of desorption process then merges with the melting onset at approximately 210 °C, so the 
experiment is stopped. Given that the heating rate is relatively high i.e. 20 °C min-1, there is 
not sufficient time for the release of all the water of crystallization before the material starts 
to decompose. It follows that the estimation of percentage concentration of water of 
crystallization (bound water) is not realized by this technique. Therefore, we assume that the 
bound water concentration is that calculated from the stoichiometric ratio of lactose to 
water in lactose monohydrate (i.e. ~5% w/w). In milled samples where the weight loss 
reaches the plateau at ~165 °C with release of 3.5 to 4.5% (w/w) of water in 10 min to 180 
min milled samples (Table 2.3). 
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From these observations of the increase in surface water in the milled materials might be 
due to, in part, the water of crystallization that is released from the crystals which then 
becomes adsorbed onto the surface of the new fragments of the original particles. However, 
the increase in surface water in the milled material cannot be due to the water of 
crystallization alone, it must also include a proportion of water adsorbed from the 
environment because +1% of surface water can’t be ‘found’ from a ~0.5% loss in the water 
of crystallization (in 45 min milled sample). The other 0.5% must have come from the 
atmosphere as a direct result of the increased surface area of the milled material. 
A further consideration is the characteristics of new surfaces generated on milling. As the 
particle size decreases with increased milling time, there is an increase in the surface area of 
particles with ‘hard crystalline’ surfaces, i.e. those surfaces which result from the cleavage of 
the parent particle. However, some particles may not fracture on impact but rather the 
energy is absorbed by the particle, causing an increase in the local temperature which 
results in the formation of an amorphous surface domain. This new amorphous phase will 
also adsorb the moisture. 
Note: the un-bound/surface moisture of lactose with particles size (45, 60, 80, 100, 150 and 
200 mesh) was also determined and it lies in the range of 0.3 to 0.4%. Therefore it was 
considered that the starting moisture is almost negligible and is not dependent on the 
particle size of un-milled material. 
2.3.5 Dynamic Vapour Sorption Results 
DVS studies are conducted to estimate the surface domain of amorphous phase that is 
produced on milling which can influence the moisture uptake and dissolution rate of the 
milled materials. The results of DVS are usually expressed as vapour sorption plots that 
represent the percent change in mass of a material (based on dry mass) versus time at 
various humidity levels. The vapour sorption plots of 15 min and 90 min milled LMH are 
shown in Figures 2.8a and 2.8b, respectively. The continuous line plotted on the left y-axis 
shows the % change in mass (based on dry mass). The dotted line, plotted on the right y-axis, 
represents the target % partial pressure of water vapour in the DVS as a function of time. 
These results have indicated that both the samples began to lose mass around 50% RH and 
showed a unique pattern of gain and loss of water steps. This is most likely due to the 
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crystallization of the amorphous phase present in these milled samples. This transition 
continues with each humidity step until the samples reaches around 90% RH. 
  
a b 
Figure 2.8: DVS mass change response with different humidity steps for a) 15 min milled and b) 90 min milled 
(b) lactose monohydrate. Note that the Y-axis scale in Figure ‘a’ is 0-3, while in Figure ‘b’ is 0-5. 
The water vapour sorption isotherms are obtained by plotting mass increment (endpoint at 
equilibrium) against each humidity level. These plots for cycle 1 and 2 of 15 min and 90 min 
milled samples have been shown in Figures 2.9a and 2.9b respectively.  
  
a b 
Figure 2.9: DVS isotherm plots for a) 15min milled and b) 90min milled lactose monohydrate for cycle-1 
(filled marker) and cycle-2 (open marker). 
The cycle 1 shows a clear difference between the total vapours up taken up and desorbed, 
as indicated by a wide hysteresis gap across the humidity range which narrows down during 
cycle-2. This indicates that both the milled samples contain amorphous content, most of 
which recrystallize to hydrated lactose after sorption in cycle 1. Hence, there is hardly any 
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change in mass during the cycle-2. The early sharp rise in mass followed by a slow increase 
after 40% humidity indicates that the sorption of water vapours occurs in two steps; 
probably because of the presence of particles of different size that sorb water at different 
rates. 
It is also worth to note that these samples still hold some water (0.433% in 15 min milled 
and 1.195% in 90 min milled sample) even after desorption in cycle1 is complete. This might 
represent the weight used in forming the hydrated crystals during re-crystallization. The 
weight retained by each sample at the end of desorption cycle can be used to calculate the 
amorphous content in these milled samples (Burnett et al., 2004). Based on the assumption 
that the 100% amorphous lactose if re-crystallized completely: would retain 5.26% water (18 
g H2O/342 g of anhydrous lactose to form 1 mole of stoichiometric monohydrate). 
Therefore, the 15 min and 90 min milled sample contains 8.23% (0.433/5.26) and 22.72% 
(1.195/5.26) amorphous content, respectively. 
Another way to estimate the amorphous content from DVS results is to consider the water 
uptake by the test sample at a particular level of relative humidity and comparing it to 100 % 
amorphous of that material. At 55% RH the water uptake by 15 min milled LMH was ~1.08% 
while it is ~2.24 % for 90 min milled sample. By comparing these values to the DVS isotherm 
of 100% amorphous lactose i.e. ~11% (Burnett et al., 2006), the amorphous content in these 
milled samples was calculated. The amorphous content in 15 min and 90 min milled sample 
was 9.84% (1.08/11) and 20.33% (2.24/11), respectively. 
2.3.6 Inverse Gas Chromatography Results 
2.3.6.1 Dispersive and Specific (Acid-base) Surface Energies 
Dispersive (S
D), specific or acid-base (S
AB) and total surface energy (S
T) profiles of 15 min 
and 90 min milled LMH are obtained directly from the IGC SEA (Figures 2.10a-c). These 
profiles are energetically heterogeneous; as the surface energy changes with surface 
coverage. In addition, it can be observed that the dispersive component contributes a major 
part of the surface energy in both milled samples. 
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a b 
 
 
c  
Figure 2.10: The plots of a) dispersive surface energy b), specific energy and c) total surface energy of both 15 
min and 90 min milled lactose monohydrate samples. 
The value of dispersive energy at zero coverage (corresponding to the infinite dilution) of 15 
min and 90 min milled samples were 51 and 47 mJm-2 respectively (Table 2.4). These values 
are in agreement with (Thielmann et al., 2007), and higher than the dispersive energy of un-
milled lactose monohydrate i.e. 31.2 mJ m-2 which is taken from literature (Newell et al., 
2001). The increase in surface energies of LMH is expected as the milling increase in surface 
area and surface domain of amorphous content as shown by BET and DVS analysis, 
respectively. It is interesting to note that the total surface energy of longer milled (90 min) 
sample is less than the short milled (15 min) one, indicating that the surfaces which were 
active with more surface free energy on short milling become less active on long milling. This 
was in agreement with the results of SEM and BET where the aggregation of particles and 
decrease in surface area was observed in comparison with the previous milling time point 
i.e. 15 and 45 min. 
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Table 2.4: Dispersive (S
D
), specific (S
AB
) and total (S
T
) surface energy distribution of milled lactose 
monohydrate. 
 
Dispersive (S
D
) energy 
(mJ m
-2
) 
Specific (S
AB
) energy  
(mJ m
-2
) 
Total surface energy (S
T
) 
(mJ m
-2
) 
 Min Average Max Min Average Max Min Average Max 
Un-milled LMH - 31.2* - - - - - - - 
Milled LMH 
15min 
44.04 45.38 51.20 5.34 5.73 7.47 49.46 51.18 58.64 
Milled LMH 
90min 
41.15 42.27 47.17 3.58 4.12 6.47 44.85 46.49 53.63 
* Values taken from literature (Newel, 2001) 
2.3.7 Broadband Dielectric Spectroscopy Results 
2.3.7.1 Percolation Phenomenon 
The dielectric response of un-milled lactose monohydrate is presented as 3D spectra 
constructed between imaginary permittivity (ε″) against frequency and temperature (Figure 
2.11a) and shows a simple response surface with a single peak at 5 °C. This peak is due to the 
water, as evidenced by decrease (~50%) in peak height on drying (Figure 2.11b) as the same 
sample is measured during the back run of the experiment. Therefore this peak is assigned 
as percolation and occurs because of water (proton) hopping over the hard crystalline 
surfaces of the un-milled particles of LMH (Smith G., 2007). The shape of percolation peak 
also appears to have changed in the dried sample; it is now broader, less symmetrical and 
extends to lower temperatures (i.e. the peak starts at -50 °C as compared to -30 °C in case of 
original sample). 
  
a b 
Figure 2.11: 3D dielectric spectra of un-milled lactose monohydrate before and after drying (a & b 
respectively), showing the plots of imaginary permittivity (ε”) vs temperature and frequency. 
ε″ ε″ 
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2.3.7.2 Effect of Particle Size on Percolation  
The 3D dielectric spectra of large particles (45 through to 100 mesh) of lactose monohydrate 
shows only one percolation peak between 0 °C and 5 °C (shown by arrow heads in Figure 
2.12a-d). This peak became broader as the particles size decrease from 45 mesh to 60 and 
85 mesh. In samples with further smaller particles (100 mesh), this peak becomes again 
sharp with the appearance of shoulders on the sides of main peak as highlighted by dotted 
circle in Figure 2.12d. 
   
a b c 
   
d e f 
Figure 2.12: 3D dielectric spectra of lactose monohydrate samples having different particle size distribution 
a) 45mesh, b) 60mesh, c) 80mesh, d) 100mesh, e) 150mesh and f) 200mesh. The arrow heads indicate the 
position of percolation peak while the dotted circles highlight the change in shape of spectra around the 
percolation. 
In the samples with relatively smaller particles (150 and 200 mesh), the dielectric spectra 
apparently contain two to three peaks (as shown by dotted circle in Figure 2.12e & f) and 
these occur at much lower temperatures (between -20 to 10 °C) than the percolation peak in 
the larger size range particles. It seems more probable that the shoulders around percolation 
that started in 100 mesh particles become sharper in 150 and 200 mesh particles and the 
ε″ 
ε″ ε″ ε″ 
ε″ ε″ 
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shape of spectra (particularly of 150 mesh) looks like a horse shoe with the percolation peak 
present in the middle. 
The appearance of percolation peak in different mesh size samples of LMH at almost the 
same temperature (0 - 5 °C) is contrary to our previous results i.e. Tp is proportional to 1/d2 
(Smith G., 2007). However, the results of 150 and 200 mesh suggest that although the 
particle size affects the percolation process, it is the path length available for proton hopping 
that defines the percolation temperature. The path length is influenced by other factors 
including: i) moisture content, ii) aggregation and iii) surface energies of the particles. 
2.3.7.3 Effect of Ball Milling on the Percolation of Lactose Monohydrate 
The dielectric spectrum of the short milled lactose monohydrate (i.e. 15 min milled) showed 
that the percolation splits into two peaks, both having a huge magnitude as compared to the 
un-milled sample (Figure 2.13a). The first percolation peak (indicated as PP1 in Figure 2.13a) 
is sharp while the second percolation peak (PP2) is relatively broad and occurs towards the 
higher temperature side.  
On the other hand, in long milled samples (≥ 45 min) where the magnitude of process drops 
again, a change in the dielectric spectra occurs; i.e., the shoulders appear on both sides of 
the percolation peak (Figure 2.13b). These shoulders gradually grow in height as milling 
progresses (Figure 2.13c) and the spectrum takes the saddle-shape (this shape resemble 
horse shoe) in 180 min milled sample (Figure 2.13d), with the percolation present in the 
centre. On further milling beyond 180 min the shoulders of this process decrease in 270 min 
milled sample (Figure 2.13e) and the percolation again becomes conspicuous at 360 min 
milled sample with the disappearance of saddle shape (Figure 2.13f). Appearance of such 
saddle shape in the dielectric spectrum was previously ascribed to the water confined in the 
porous glasses or to the complex materials (Ryabov et al., 2001, Feldman et al., 2002). This 
will be discussed in detail in Section 2.3.7.5, here we return to some more description of 
percolation phenomenon. 
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a b c 
   
d e f 
Figure 2.13: 3D dielectric spectra of various samples of lactose monohydrate a) 15min, b) 45min, c) 90min, d) 
180min, e) 270min and f) 360min. PP1 & PP2 represent first and second percolation peaks in short milled 
samples. The saddle-shape develops in long milled samples that disappear on further milling. The dotted 
circles highlight the low temperature window where the processes linked with amorphous phase (γ and β 
processes) are not prominent. 
The percolation phenomenon in different milled samples of LMH is analysed i) qualitatively 
(by measuring its temperature change with milling time), ii) quantitatively (by measuring the 
amplitude of this process) and iii) by expressing this process in time domain to determine 
the dipole correlation function that may be helpful in defining the fractal dimension of the 
milled samples. 
Percolation Temperature: The temperature slices from the dielectric loss spectra of milled 
samples of LMH at 0.1 Hz are given in Figure 2.14, while at four different frequencies (Figure 
2.15) has shown that the single percolation peak of un-milled sample splits into two peaks in 
15min milled sample (Figure 2.15a). The first percolation peak (PP1) occurs at 5 °C, similar to 
the un-milled sample, while the second peak (PP2) occurs at 30 °C. The temperature of both 
percolation peaks shifts towards higher side with milling time till 90 min and then decreases 
Saddle shape 
process 
Percolation 
Shoulders appear around the 
percolation peak PP2 PP1 
ε″ ε″ ε″ 
ε″ ε″ ε″ 
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on further milling (Figure 2.15c & f). The 360 min milled sample has the percolation again at 
5 °C. These values have been summarised in Table 2.5. 
 
Figure 2.14: Temperature slices at 0.1Hz frequency from the dielectric spectra of a) un-milled and 45min, 
90min and 180min milled of lactose monohydrate. 
 
Table 2.5: Values of temperature of first and second percolation peaks (PP1 & PP2) for the milled samples of 
lactose monohydrate. 
Milling time 
(min) 
Percolation 
temperature (°C) 
 1
st
 2
nd
 
0 5 - 
15 5 30 
45 20 45 
90 35 55 
180 20 30 
360 5 - 
Amplitude of Percolation: In short milled sample of LMH (15 min milled), the amplitude of 
both percolation peaks (PP1 & PP2) is enormously higher than that in the un-milled one 
(Figure 2.15a & b). However, in longer milled samples (45 and 90 min milled), the amplitude 
of percolation drops but it is still higher than that of the un-milled one (Figure 2.15c & d). In 
180 min milled sample the percolation decreases to less than that in un-milled one but 
increases again in 360 min sample (Figure 2.15e & f). 
The milling of LMH results in the release of water along with the size reduction. This water 
then adsorbs onto the lactose particles or small fragments (which still have a ‘hard surface’), 
hence results in the continued observation of the first percolation peak– though now much 
bigger) while the appearance of second percolation peak represent the presence of 
internalized surfaces. May be the exact mechanism depends on surface water coverage (i.e. 
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the concentration per unit area). However, it is a complex phenomenon which seems to be 
dependent on many factors simultaneously. 
At the same time, the size reduction and amorphization promote the packing of powder bed 
which therefore requires more energy for the percolation of charges through it (this is a 
different argument to scale length being linked to particle size). Hence the temperature of 
percolation increases in the milled samples. However, in 360 min milled sample where the 
small particle aggregate (SEM micrographs, Appendix I) and the amorphous phase re-
crystallizes (residual crystallinity start increasing at 90 min milling, thus the powder bed is 
less compact and results in the occurrence of percolation at lower temperature. The regain 
of hard crystalline surfaces at this milling point also results in the increase in amplitude of 
percolation. 
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a b 
  
c d 
  
e f 
Figure 2.15: Temperature slices (plots of imaginary permittivity (ʺ) vs temperature) at various frequencies 
from the dielectric spectra of a) un-milled and b) 15min, c) 45min, d) 90min, e) 180min and f) 360min milled 
of lactose monohydrate. The vertical dotted lines show the temperature of first and second percolation 
peaks respectively. 
The enormous increase in amplitude of percolation in short milled sample is presumably 
because of the following reasons  
i. At the start of milling the creation of surface cracks and fragmentation of particles 
results in generation of a large number of new surfaces (as evident from laser 
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diffraction, SEM and BET results, Section 2.3.1, 2.3.2 and 2.3.3, respectively) that 
are available for percolation as the surfaces were still crystalline and leads to the 
reduction of percolation path for proton diffusion. 
ii. Increased moisture in milled sample which is released on disrupting the 
monohydrate crystals adsorbs onto the surfaces of particles (TGA results have 
shown higher water content in milled samples). 
However, on milling beyond 15 min, the amplitude of percolation peak abruptly drops, 
although the surface area is still high (the particle size of 45 min milled sample is smaller 
than 15 min one). The one reason might be the less proportion of water which is driven off 
by the raised temperature of the mill. Another reason to explain the decrease in peak height 
in long milled samples is the presence of amorphous surfaces. The intimate interaction 
between water and the multi-hydrogen bonding opportunities provided by the amorphous 
phase (basically the defects within it) would reduce the frequency of proton exchange/slow 
the proton flux through the material. 
Therefore, the height of the peak is dependent on the water percolating on the hard 
crystalline surfaces while the shift in percolation temperature would be associated with 
changes in surface area available for the diffusion of water. Basically, there is a change in the 
diffusion path length that might be either path 1 or path 2 (Figure 2.16 a-b) or combination 
of these. 
 
 
a b 
Figure 2.16: Proposed paths 1 and 2 (a & b) for the hopping of protons that are responsible for percolation 
peaks in the dielectric spectra of milled lactose monohydrate. 
The percolation processes so observed for hard crystalline materials has led to the partial 
development of a method for characterizing the amorphous external surface with hard 
internal surface of micronized particles. In particular the observation of a second percolation 
process in milled lactose and the observation of a saddle shaped process appear to suggest 
that clusters of water appear in the material on extended milling. We speculate in general 
that the observation of these processes might be indicative of the internalized surfaces, i.e. 
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surfaces inside the particles that are associated with defects in the crystal structure and that 
these might provide additional routes for water to penetrate the crystal resulting in an 
increased dissolution rate. 
The milling of anhydrous sugar clearly show the evidences of the amorphous phase in 
dielectric spectra (Chapter 4), while in case the hydrated materials the signatures of 
amorphous phase are not prominent rather a complex behaviour was observed that is 
dictated by the presence of water released from the wreaked hydrated crystals. A 
comparison of dielectric properties around the percolation of this monohydrate sugar with 
that of anhydrous (sucrose) and dihydrate (trehalose) is given in Appendix IV. 
2.3.7.4 Changes in Fractal Dimensions and Porosity on Milling  
The dielectric results at percolation have indicated that the milled sugars behave like porous 
material that provides a network of interconnected channels through which the electric 
excitation travels across the material. This transfer of excitation can be  described by using 
the dipole correlation function (DCF) (Puzenko et al., 1999). The DCF is obtained by 
expressing the dielectric relaxation spectrum at the percolation temperature in the time 
domain (i.e. by Fourier transform (FT) of the frequency domain data obtained from the 
dielectric analyser). 
This is accomplished by the plotting the frequency slices at percolation temperature of the 
dielectric spectra of each milled sample (Figure 2.17 a & b). One can see immediately that 
the strength of the process increases dramatically after 15 min of milling and appears to shift 
to higher frequencies. After selecting the appropriate frequency range (0.1-10 Hz) the time 
domain data are obtained by IFT. 
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a b 
Figure 2.17: Screen shots showing the frequency slices at percolation temperature from the dielectric spectra 
of a) un-milled b) 15min milled. The frequency range selected for IFT have been shown by dots on these 
plots. 
The frequency slices on the imaginary permittivity plots of un-milled and short milled (i.e. 15 
min) sample shows a single relaxation process. Based on these observations, it can be 
concluded that only the short milled samples show Debye relation and therefore DCF can be 
used to describe the fractal dimension for this sample. Whereas in long milled samples 
where the particle start aggregating (as evidenced by BET and SEM results, 2.3.1 and 2.3.2, 
respectively) and the amorphous content also increase (DVS results, Section 2.3.5), the 
fractal dimension cannot be estimated from the DCF. 
As the DCF displays complex non-exponential time behaviour (non-Debye), a stretched 
exponent function of Kohlrausch-Williams-Watts (KWW) given in Equation 2.3 is used to fit 
the data in Datafit-9 software (Oakdale Engineering). 
𝐘 = 𝐚 ∗ 𝐞𝐱𝐩(−(𝐱/𝛕)^𝛎) + 𝐱 ∗ 𝐝 + 𝐞  Equation 2.3 
Where ‘Y’ is diploe correlation function, ‘a’ and ‘d’ are the intercept and slope of fit line 
respectively, ‘τ’ is relaxation time and ‘’ is stretching exponent while ‘e’ is a constant. The 
plot of DCF vs time for un-milled and milled LMH (Figure 2.18) has shown that this 5-
parameter function fits well to the data. 
Un-milled lactose monohydrate 15min milled lactose monohydrate 
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Figure 2.18: Time domain plots of the dielectric spectra of un-milled and milled lactose monohydrate 
showing plot of dipole correlation function (DCF) against time at percolation temperature. The solid lines 
represent the fit function. 
Now using the values of this stretched exponent (), the fractal dimension (Df) of un-milled 
and milled LMH are obtained by using the Equation 2.4. These values are summarized in 
Table 2.6. 
𝐃𝐟 = 𝟑𝛎   Equation 2.4 
The value of fractal dimension for un-milled LMH is approximately equal to unity, indicating 
the propagation of the excitation occurs along a linear path with lot of hydration centres as 
present with each molecule of un-milled LMH. However, in the dried sample of un-milled 
LMH the value of fractal dimension is between 1 and 2 may imply that the excitation now 
occurs through the hydration centre present on the inner pore surface (which is developed 
by the evaporation of water from the sample). In the short (15 min) milled sample, the value 
of Df calculated from both percolation peaks is between 2 and 3, which indicates a more 
three dimensional path, possibly due to the presence of ultra-small porous structure 
(cracks/fissures) produced within the milled material. The huge increase in the magnitude of 
the percolation process at this milling point is likely to be a consequence of the water of 
hydration being dislocated (released) from the crystal lattice which may now propagate 
through fault lines (defects) within the lattice to provide for extensive 3-dimensional 
percolation paths for protons (Gutina et al., 2003). The fractal dimension of this sample is 
approximately equivalent to that of rough pore surface i.e. 2.5 (Agamalian et al., 1997). 
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Table 2.6: Values of stretched exponent obtained from the fitting of dielectric data at percolation 
temperature of un-milled and milled samples of lactose monohydrate and the fractal dimension calculated 
from it. 
Material 
Stretched 
exponent () 
Fractal 
dimension (Df) 
Un-milled lactose 0.36 1.06 
Un-milled lactose (dried) 0.57 1.70 
15min milled (1
st
 peak) 0.79 2.36 
15min milled (2
nd
 peak) 0.95 2.84 
In summary, the dielectric excitation linked with percolation gives the useful information on 
the fractal geometry of milled hydrated material. This is important in explaining the 
presence of internalized surfaces present in the milled materials that contribute to the 
enhanced surface area available for dissolution or water sorption in such materials. 
2.3.7.5 Relaxation Processes in Dielectric Spectra of Milled Lactose Monohydrate 
An important observation about the dielctric spectra of milled LMH is that the low 
temperature ( and β) process characteristics of the amorphous phase (as discussed in 
chapter 4) are absent (the region is highlighted by dotted circles in Figure 2.13). Rather a 
small temperature dependent process with a typical saddle shape is observed in long milled 
samples of LMH (≥ 45 min milled). The changes in dielectric spectra around this process have 
been described in section 2.3.7.3, where it is shown that this process is most prominent in 
180 min milled sample, probably because of some or all of the following reasons: 
i. The particles size is uniform at 180 min milling point and it is close to that of the 150 
or 200 mesh samples (where this process was also present- Figure 2.12e & f). In 
both cases the nano-sized particles form clusters of 500 nm to 1000 nm. 
ii. The amorphous content sample is maximum in 180 min milled and there is no 
further reduction in crystallinity even after 90 min milling (as described in Chapter 
3). 
iii. This sample also has a reasonably high proportion of surface moisture, including 
both the moisture adsorbed from environment by the newly created soft surfaces 
and that which is released from the hydrated crystals on milling (as discussed in 
Section 2.3.4). 
The characteristics of this saddle shaped process are better understood by making frequency 
slices (f-slices, the plot of imaginary permittivity against frequency at different 
57 
 
 
temperatures) through the dielectric spectra of the 180 min milled sample. The plot shows 
that this process starts in the low frequency side of the experimental window at a 
temperature of -50 °C and shifts toward higher frequencies with increasing the temperature 
till 40 °C from where it again returns towards low frequencies indicating the temperature 
dependence nature of this process (Figure 2.19). 
 
Figure 2.19: Frequency slices (obtained by plotting the imaginary permittivity against log of frequency) from 
the dielectric spectrum of 180min milled lactose monohydrate. 
The plot of relaxation time against the inverse of temperature for this process of 180 min 
milled sample shows Arrhenius behaviour at low temperatures (-10 to +20 °C) but as the 
temperature increases above +20 °C, it shows deviation from this behaviour (Figure 2.20). 
 
Figure 2.20: Plot of natural log of relaxation time against inverse of temperature for 180min milled lactose 
monohydrate. The plot shows Arrhenius trend towards lower temperature but deviate from this behaviour 
towards higher temperatures. 
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The activation energy calculated from the linear part of this plot is ~240 KJmol-1, which is 
comparable with the activation energy of α-relaxation of sugars/monosaccharide i.e. 205 – 
450 KJmol-1 (Noel et al., 2000). From this behaviour one might surmise that the saddle 
shaped process is the structural relaxation of the amorphous phase. Looking for the other 
possibilities the dynamic glass transition temperature is calculated from the relaxation time 
(τ = 100sec) for this process. This value is -9 °C for 180 min milled sample, which is lower 
than one might expect for an amorphous disaccharide. However, the presence of water in 
such systems has changed the cooperative relaxation of the amorphous phase with the scale 
length close to the cooperative units and therefore one can expect the confinement 
dynamics. The confinement of the amorphous phase can decrease the glass transition 
temperature, which then has implications on the stability of such material (Kremer and 
Schönhals, 2003, Noel et al., 1996). 
Now there are two possibilities; 
i. Confinement of water molecules in nano-porous structure of disordered LMH OR 
ii. Amorphous phase confined within thin domain on the surface of milled particles. 
In order to test the second hypothesis; firstly, it is assumed that the amorphous phase is 
restricted to a thin uniform layer on the surface of milled spherical particle (Figure 2.21) and 
from the limiting size (~100 nm from SEM) the volumes of external (total) and internal 
(without amorphous layer) particles are calculated using the Equation of volume of sphere 
(Equation 2.5). 
𝐕 =  
𝟒
𝟑
 𝛑𝐫𝟑   Equation 2.5 
 
Figure 2.21: A hypothetical spherical particle having a thin surface layer of amorphous phase as indicated by 
red external circle. 
The scale length of amorphous phase is then obtained from the difference of radii of two 
spheres. The scale length for 180 min milled samples is ~3.9 that indicates the confinement 
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of the amorphous phase but whether confined or not depends on the scale length of the 
domain in relation to the scale of the minimum cooperative unit which is un-known for 
amorphous disaccharides. 
Secondly, the glass transition temperature of this phase is obtained from the amorphous 
content and the moisture present in the milled sample by applying Gordon-Taylor equation 
(Equation 2.6) as used by (Roos, 1995) and compared with the Tg of bulk amorphous phase 
i.e. from DSC results. 
𝐓𝐠 =  
𝐰𝟏𝐓𝐠𝟏+𝐊𝐰𝟐𝐓𝐠𝟐
𝐰𝟏+𝐊𝐰𝟐
  Equation 2.6 
The calculated value of Tg for 180 min milled lactose monohydrate is ~42 °C, that is very 
close to the measured value from DSC i.e. 47 °C. This suggests that the amorphous phase is 
not confined on the surfaces of particles as presumed; rather it is more likely concentrated 
within a few domains across the surface. In real state of the particle is probably someway in 
between the two extremes, A and B (Figure 2.22). 
           
Figure 2.22: Proposed location of amorphous phase (red colour) in supposed spherical particles. 
Therefore the saddle shape might be the confined structured water in the vicinity of defects 
of milled lactose. Given that the activation energy of this process is quite high than the bulk 
ice (Gutina et al., 2003), again there is difficulty to consider that the water alone is 
responsible for such response of the milled LMH. Therefore, it is assumed that the complex 
system with porous geometry developed in the milled LMH that consisted of amorphous, 
crystallites and water is responsible for the behaviour like the adsorbed water in porous 
glasses as already reported (Feldman et al., 2003). 
In summary, the changes brought about by milling with their mechanism and implication on 
the solubility and dissolution rate have been summarized in Table 2.7. 
A B 
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Table 2.7: Summary of changes brought about milling as measured by different techniques and their 
mechanistic effect on the solubility/dissolution rate of solid materials. 
Changes 
brought 
about by 
milling 
Analytical 
techniques  
Observation 
Key 
implication 
Mechanism 
Particle size 
reduction 
SEM 
 
 
BDS 
Actual change in particle size and 
surface topography (specific surface 
area) 
Shift in percolation peak to higher 
temperature 
Dissolution 
rate 
improvement  
Increase in surface to volume 
ratio 
 
Surface and 
internal 
cracks on 
particles  
BDS 
 
 
 
BET 
Internal surfaces provide routes for 
percolation within inside the particles 
resulting in the appearance of new, 
high temperature percolation peaks 
Increase in specific surface area 
Dissolution 
rate 
improvement  
Infiltration of water into the 
particles 
 
Partially 
damaged 
crystal 
lattice 
DSC 
(results 
discussed in 
Chapter 3, 
Section 3.3.2.1) 
For crystal hydrates a shift in 
desorption peak to lower 
temperature. 
Shift in melting peak and reduction in 
enthalpy of melting. 
Solubility 
enhancement 
Increased ease by which water 
leaves the crystal structure 
(through a reduction in the 
crystal hydrates energy) may also 
support the opposite effect of 
increased ease by which water 
penetrates the crystal during the 
process of dissolution 
Amorphous 
phase 
generation 
TGA 
 
DSC 
 
BDS 
 
DVS 
Decrease in bound water loss peak 
Shift in desorption peak to lower 
temperature  
Shift in melting peak and reduction in 
enthalpy of fusion 
A process of dielectric relaxation in 
typical horse shoe shape 
DVS isotherm show hysteresis gap 
between sorption and desorption 
curve 
Solubility 
enhancement 
Changes in thermal analysis 
indicate the change in phase 
(generation of phase with 
compromised crystalline 
structure or with totally 
disordered structure i.e. 
amorphous phase). 
Change in 
moisture 
content of 
powder 
TGA 
Shift in onset of desorption peak to 
lower temperature  
Increase in surface water loss in 
milled material. 
Solubility 
enhancement 
Increased water has plasticizing 
effect on the powder that might 
increase its solvation. 
Change in 
surface 
energy 
IGC 
Increase in dispersive and specific 
surface energy 
Solubility 
enhancement 
Higher surface energy makes the 
solution faster 
2.4 Conclusion 
Ball milling can produce nano-structured systems in the milled hydrated material (lactose 
monohydrate). These systems consisted of water, damaged crystals along with amorphous 
phase. The nitrogen adsorption technique has shown an increase in surface area (linked with 
the smaller particle in milled material). However the dielectric spectroscopy has revealed the 
presence of cracks and fissures thus expose the more surfaces present in the milled 
materials. The increase in surface energies on long milling causes the clustering of particles 
and they develop the fractal geometry of porous structures. These observations may be 
important in explaining the enhancement of dissolution in materials that are milled for a 
short period (before any amorphous phase is generated). The presence of surface domain of 
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amorphous phase although show the bulk characteristics in DSC but the characteristic 
dielectric behaviour indicated that the amorphous phase, rather exist as a complex system in 
milled hydrated material and its characteristic might be different. 
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3 Quantification of Crystallinity/Amorphicity of Ball Milled 
Pharmaceuticals (lactose and ibuprofen) using Thermo-
Analytical Techniques and Terahertz Pulsed Spectroscopy 
3.1 Background/Context 
The generation of amorphous phase from crystalline is the objective of many studies that 
intend to enhance the solubility and dissolution rate of poorly soluble drugs, milling is one of 
such techniques (detailed in Chapter 1). However, unless the residual crystalline material or 
newly generated amorphous phase is quantified, the contribution of milling (in terms of 
milling times and ball-oscillation frequencies) towards the solubility and dissolution rate 
enhancement cannot be explained. This quantification is also important in order to control 
the milling process as well as explaining the impact of milling on the stability of these 
materials during storage. 
The quantification of the residual crystalline/amorphous content in milled materials is 
challenging because these materials are complex and contain a range of disordered entities 
from partially defected crystalline particles to wholly amorphous phases (Caron et al., 2011).  
These states within a milled material, particularly the presence of crystalline seeds and the 
extensive surface area of the amorphous phase, make them very sensitive to temperature 
and moisture. It is therefore necessary to develop an appropriate technique which can 
quantify the degree of residual crystallinity which can then be used to assess the stability of 
these materials. 
The techniques commonly employed for quantification of the crystalline material include 
dynamic vapour sorption (DVS), isothermal micro-calorimetry, differential scanning 
calorimetry (DSC), hyper-DSC, near infra-red (NIR), Raman spectroscopy and powder X-ray 
diffraction (PXRD). Some of these are based on the analysis of the crystalline phase (PXRD, 
NIR) whereas others (Hyper-DSC, DVS and Microcalorimetry) are based on the analysis of the 
amorphous phase, while DSC can determine both the crystalline and amorphous phases.  
DVS is based on water vapour sorption and may give misleading results for materials in 
which the crystals also sorb water, alongside the amorphous phase under scrutiny. Organic 
vapour sorption is a possible alternative method (Young et al., 2007) but this technique is 
not universal in its application. Isothermal micro-calorimetry detects the heat associated 
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with the sorption of water by the amorphous phase but it requires the crystallization of the 
amorphous to be favoured kinetically (Dilworth et al., 2004). 
PXRD might be considered as gold standard for measuring crystallinity but the results are 
inconsistent as it requires the preferred orientation of crystals in the path of X-ray beam, 
therefore whole pattern fitting is required for the complete characterization of a powder 
(Shah et al., 2006). Also it can give wrong results if the sample is not prepared adequately 
particularly the particle size, distribution and pre-treatment are critical (Buhrke et al., 1998). 
Measurement of crystallinity by Raman spectroscopy can induce photochemical reaction in 
the materials. In NIR, amorphization is inferred from a shift in the baseline of the spectral 
region rather than any changes in the specific absorption peaks (Buckton et al., 1988), 
therefore the first or second derivative of spectra are taken for quantification of amorphicity 
(Bai et al., 2004). In addition, the NIR measurements are influenced by moisture (Shah et al., 
2006). Although both these vibrational techniques (Raman and NIR) are sensitive and quick, 
each requires a complex multivariate calibration curve to be constructed from known 
crystalline and amorphous mixtures (Buckton and Darcy, 1999). 
TGA measures the weight change associated with loss of adsorbed water (if any) and the 
water of crystallization, in the case of a hydrated material. From the weight of the latter, the 
changes in crystallinity in milled hydrated materials may be estimated (Buckton et al., 1998, 
Chidavaenzi et al., 1997). In order to use the TGA technique, one has to assume that the 
water of hydration in the residual crystalline material (within the milled material) provides 
an opportunity to quantify the proportion of un-damaged crystalline material remaining. 
However, there is always the possibility that the hydration water of the partially 
compromised crystalline particles will behave differently than the material in its native state, 
resulting in some uncertainty in the estimates of crystallinity so derived.  
DSC is routinely used for the analysis of crystalline/amorphous materials. The crystallinity 
may be determined from the analysis of either the crystalline form or the amorphous state. 
The endothermic event associated with the melting of the crystalline phase that remains 
post milling may be used to determine the change in crystallinity on milling. However, the 
presence of an amorphous phase in a milled material may also manifest in the thermogram 
as a step in the baseline (indicating a glass transition) and/or exothermic peak in the 
thermogram (indicating a de-vitrification event). This de-vitrified amorphous phase will then 
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contribute to the enthalpy of melting. Therefore one must subtract this contribution from 
the enthalpy of crystallization, in order to calculate the crystalline content of the milled 
material prior to analysing the DSC data. 
Terahertz pulsed spectroscopy (TPS) is a relatively new technique that has been used for the 
characterization (Strachan et al., 2004) and quantification (Strachan et al., 2005) of the 
crystallinity of APIs. TPS produces pulses in the femtosecond time scale and therefore has 
the ability to probe crystal lattice and hydrogen bonding vibrations, which occur at 
frequencies in the low terahertz region (0.1 – 4 THz). The intensity of the specific absorption 
peaks can be used to quantify the degree of crystallinity in a mixed phase system. This 
technique has also been employed to differentiate hydrous and anhydrous forms (Liu et al., 
2007) and for studying dehydration process in various pharmaceuticals (Zeitler et al., 2007). 
This technique has been used recently for the measurement of crystallinity in amino acids 
(Darkwah et al., 2013) and freeze dried sugars (Ermolina et al., 2014). 
In this chapter, TPS was used for the determination of residual crystallinity in milled 
pharmaceuticals; the results were compared to that of the thermal methods (DSC and TGA) 
in an attempt to highlight the issues with the latter techniques for quantification of residual 
crystallinity. 
Two types of lactose (monohydrate and anhydrous) were used in this study to demonstrate 
the effect of milling on hydrated and anhydrous crystals in term of changes in crystallinity or 
anomeric composition. The lactose monohydrate and anhydrous lactose studied in this work 
were taken from commercial sources and therefore there is inevitably a proportion of the 
sample which is in other i.e. alpha or beta lactose (Raymond C Rowe, 2003). The residual 
crystallinities quoted throughout this chapter are therefore stated as a relative measure of 
the change in crystallinity from the original starting material. To that end the term relative 
residual crystallinity (RRC) has been adopted. 
Ibuprofen is also used in this study. Milling of this drug at room temperature has not been 
studied yet because of its low melting temperature (i.e. ~80 °C). However, the short time 
milling that reduces its particle size and damages the crystals may be useful for imparting a 
positive effect on the dissolution rate of this drug. The estimation of extent of damage to the 
crystalline structure of this drug on milling is the focus of this study. 
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3.2 Materials and Methods 
Lactose monohydrate (as described in Section 2.2) was used in this study. Anhydrous 
lactose was also used in this study for the comparison with its hydrated counterpart. It 
was purchased from Fluka, UK and used as received from the supplier. It was a fine 
crystalline powder and contained mainly beta lactose with a small proportion of alpha 
lactose. It is commercially produced by roller drying a solution of lactose above 93.58°C. 
The resulting product is then milled and sieved and contains 70–80% -lactose and 20–
30% α-lactose (Raymond C Rowe, 2003). 
Note: The lactose monohydrate used in this study is alpha lactose monohydrate and 
abbreviated as LMH or α-LMH, while the anhydrous lactose is beta lactose and 
abbreviated as β-LA. 
Ibuprofen was purchased from Fagron, UK and used as received from the supplier. It was a 
white crystalline powder with characteristic odour. The ibuprofen exists as acicular 
crystals in SEM having the approximate particle size between 10 to 60 µm.  
3.2.1 Ball Milling 
Milling of both types of lactose was performed as per method described in Section 2.2.1 
using milling speed of 18 Hz and time till 60 min. However in case of ibuprofen, the speed of 
15 Hz and time interval of 30 min was used to avoid the risk of vitrification of this drug. 
3.2.2 Thermogravimetric analysis (TGA) 
TGA of un-milled and milled materials was carried out according to the method already 
described in Section 2.2.4. 
3.2.3 Differential Scanning Calorimetry (DSC) 
DSC experiments were performed according to the method described in literature (Hurtta et 
al., 2004) using a Jade DSC (Perkin Elmer, US). The heating rate and heat flow were 
calibrated at 20 °C min-1 using indium and zinc standard. Approximately 7 mg sample was 
taken in 50 µL aluminium pans, sealed non-hermetically with perforated lids to allow the 
evaporation of water and then loaded in the analyser by the auto-sampler. All samples were 
analysed over the temperature range 25 °C to 250 °C (in case of ibuprofen the range was 25 
to 110 °C) at the heat flow rate of 20 °C min-1, applying the calibration of 20 °C min-1. The 
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crystallization temperature was reported as the onset of exothermic peak while melting 
temperatures was taken as the midpoints of endothermic peaks. The residual crystalline 
content was calculated from the enthalpy of melting and/or crystallization. 
3.2.4 Terahertz Pulsed Spectroscopy (TPS) 
3.2.4.1 Sample Preparation 
The samples for THz measurement were prepared by manually mixing polyethylene (PE) 
powder with spatula (at room temperature and humidity conditions, 23 °C and 40%, 
respectively) with un-milled lactose monohydrate (at concentrations of 4%, 6%, 8%, 10% and 
12% w/w) or milled LMH (10% w/w). PE powder was provided by Teraview, UK and used as 
the THz blank. The geometrically mixed samples were pressed to the disc shaped pellets 
using Gamlen Tablet Press (CT5, Gamlen Tableting Nottingham, UK- shown in Figure 3.1) 
with a compaction force of 500 Kg. The weight of each pellet was of ~400 mg and thickness 
of 3.80 ± 0.08 mm. The same weight pellets containing 100% PE were also prepared to act as 
a reference. 
 
Figure 3.1: Gamlen tablet press CT5 used for the preparation of pellets for THz measurement, photograph 
taken from our lab. 
3.2.4.2 Terahertz Measurement 
The experimental setup and principles of terahertz pulsed spectroscopy (TPS) have been 
documented well in the literature (Beard et al., 2002, Dorney et al., 2001, Yamamoto et al., 
2005, Taday et al., 2003, Strachan et al., 2005). 
Terahertz spectra were acquired in transmission mode by TPS spectra 3000 (Teraview 
Limited, UK – shown in Figure 3.2a). Each terahertz waveform was obtained by averaging 
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900 scans applying the frequency of 30 scans per second and spectral resolution of 1.2 cm-1. 
The reference pellet (PE alone) and all samples were individually placed in a 13 mm 
(diameter) sample holder, which helps to focus the terahertz beam onto the centre of the 
pellet (Dorney et al., 2001). The sample is placed into a compartment (Figure 3.2b) which is 
dried by purging with nitrogen gas for 10 min prior to and during each measurement. All 
samples were prepared in triplicate and the THz spectrum of each pellet was measured at 
three different points across its diameter and mean was taken of the resultant 9 
measurements (n = 9). 
 
 
 
a b 
Figure 3.2: Photograph of a) THz spectroscopy unit (TeraView 3000) and b) sample holder unit and assembly, 
taken from google images of Teraview webpage. 
3.2.4.3 Principal of operation of THz Pulsed Spectroscopy 
A schematic operation of THz spectroscopy has been shown in Figure 3.3. THz spectrometer 
contains cryogen cooled heat detectors (bolometer) that acts as photoconductive switch. A 
laser beam of femtosecond pulses (Titanium sapphire NIR laser, 800 nm) splits into two by 
the splitter placed in its way, one of which after attenuated to 25% is focused on 
semiconductor material with switch open. This generates the electron hole pairs that are 
accelerated by the applied field through substrate generating the THz radiations. A parabolic 
mirror is used to collimate and reflect the beam of radiation into the test material. Another 
set of mirrors is used to collimate and reflect the transmitted radiations on to the detector. 
The second laser reflected from the beam splitter (attenuated by 75%) is combined with the 
transmitted beam from the test material and focussed on the detector. A photo-diode 
detector is applied to detects and monitor the changes in probe beam. The output signal is 
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amplified and recorded as change in electrical field as a function of time which is then 
converted to frequency domain spectra by inverse Fourier transform (Storey and Ymen, 
2011). 
 
Figure 3.3: Flow diagram showing of Terahertz operation (Taday, 2004). 
3.3 Results and Discussion 
3.3.1 Thermogravimetric Analysis Results 
The TGA results of un-milled and milled lactose monohydrate have been described in 
Chapter 2, Section 2.3.4. Using those results, the relative residual crystallinity (%RRC) in the 
milled samples was calculated from the weight loss linked with desorption of the water of 
crystallization (Table 3.1), having assumed that the starting material of crystalline lactose 
monohydrate contains 5% water of crystallization (Dilworth et al., 2004). 
Table 3.1: The values of weight changes corresponding to desorption of water of crystallization of un-milled 
and milled lactose monohydrate and the relative residual crystallinity (%RRC) calculated from these values. 
Milling 
time 
Onset temp 
of desorption 
(°C) 
Weight loss of 
crystallization 
water (%) 
Residual 
Crystallinity 
(%) 
0 144.0 5.0* 100.0 
10 106.0 3.8 76.8 
15 112.0 3.6 71.4 
30 102.0 3.4 69.0 
45 107.0 3.9 79.0 
*from the stoichiometric ratio of water in lactose monohydrate 
The results have shown that the estimates for residual crystallinity decreases erratically with 
milling time(Table 3.1), with the most significant decrease in crystallinity occurring over the 
first 10 min where there is ~25% loss in crystallinity. There is an approximate ± 10% variation 
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in estimates of crystallinity in all milled samples of LMH (between 65%  to 75%) thus, it is not 
clear as to whether there is a progressive decrease in crystallinity as the milling time 
increases beyond 10 min. 
3.3.2 Differential Scanning Calorimetry Results 
3.3.2.1 DSC Curves of Un-milled Lactose (Monohydrate and Anhydrous)  
The DSC curve of un-milled lactose monohydrate (Figure 3.4a) shows one endothermic peak 
with an onset temperature of 144 °C corresponding to the release of water of crystallization 
(as evident from TGA results in Figure 3.4a), followed by one melting endotherm at 222 °C 
associated with the melting of α-lactose. Such DSC results of LMH are in agreement with the 
data reported by (Gombas et al., 2002, Moolchandani et al., 2014) but contrary to the 
observations in these studies, whereas they have shown two melting peaks (corresponding 
to the alpha and beta forms of lactose), we observe only one melting endotherm. 
DSC results of anhydrous lactose are described in Chapter 4, Section 4.3.1, here only the DSC 
curve (Figure 3.4b) is given for the purpose of comparison with monohydrate. 
  
a b 
Figure 3.4: a) DSC curve of un-milled lactose monohydrate overlaid by its TGA curve showing the onset 
temperature for desorption of water of crystallization ~ 144°C as indicated by the dotted line, b) DSC curve of 
un-milled anhydrous lactose showing melting endotherm at 238°C, the inset highlights the endotherm of 
desorption at 140°C and melting endotherm of α-lactose at 210°C. 
3.3.2.2 DSC Curves of Milled Lactose (Monohydrate and Anhydrous) 
The DSC curves of milled LMH (Figure 3.5a) have shown that the desorption event splits into 
two peaks, first broad peak between 116 °C and 143 °C followed by a relatively sharp peak 
between 131 °C and 157 °C. The melting peak also splits into two peaks; the first occur from 
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210 °C to 222 °C while the second occur from 227 °C to 236 °C. These peaks represent the 
melting of α and  forms of lactose, respectively (Garnier et al., 2008). 
  
a b 
Figure 3.5: a) DSC curves of milled lactose monohydrate (a) and anhydrous lactose (b). The milling time 
intervals have been indicated against each curve. The dotted lines represent the change alpha form to beta 
or vice versa. The downward and upward arrows indicated exotherm and endotherm respectively. (Tc = 
temperature of crystallization; Tm alpha = melting temperature of alpha lactose; Tm beta = melting temperature 
of beta lactose; Tdh = temperature of desorption of water of crystallization). 
In samples milled for 15 min or higher, an exothermic process is also observed between 52 
°C and 73 °C that represents the de-vitrification of amorphous lactose. This event was 
previously reported at ~170 °C in fully amorphous (spray dried) or in short milled lactose 
(Gombas et al., 2002, Shariare et al., 2011) but in collapsed amorphous (produced by 
exposure of high relative humidity) it was reported at 70 °C (Darcy and Buckton, 1997). 
Therefore it was inferred that the milling reduces the glass transition temperature due to 
plasticization effect of water (released from hydrated crystals during milling). This inference 
is supported by the fact that the onset temperature for water desorption decrease and the 
percentage of un-bound water increase in the milled samples. When this milled material is 
exposed to heat in DSC it undergoes structural collapse at a reduced Tg and gives a low 
temperature re-crystallization peak. This structural collapse was complete as we did not 
observe the high temperature crystallization peak (Darcy and Buckton, 1997). 
Mutarotation of lactose monohydrate (i.e. conversion of α-form of lactose to the beta form 
or vice versa) is observed in the milled samples which is induced by heat and the presence of 
water during the DSC run (Garnier et al., 2002a, Garnier et al., 2002b). The area of the de-
vitrification peak and the ratio of the melting peak for beta lactose (as compared to alpha 
peak) increases as the milling time increases up to 60 min. This suggests that as the damage 
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to the crystals increases, there is a greater proportion of amorphous lactose and a greater 
propensity to produce beta lactose. Therefore, it was inferred that the de-vitrified 
amorphous lactose forms β-lactose either at the de-vitrification temperature or it first re-
crystallizes to the α-form (McIntosh et al., 2013), which subsequently undergoes 
mutarotation on heating to produce the beta form. Therefore, the greater the amorphous 
content, the greater is the structural collapse and the greater will be the β-anomer content 
in the lactose sample (Gombas et al., 2002, Shariare et al., 2011, Buckton, 1997). 
DSC results of milled anhydrous lactose are described in Chapter 4, Section 4.3.1, here only 
the DSC curves (Figure 3.5b) are given for the purpose of comparison with monohydrate. 
The DSC curve of milled samples of anhydrous lactose have revealed the transfer from beta 
to alpha form of lactose particularly at 60 min milling point (Figure 3.5b), where the largest 
de-vitrification peak is observed among all the milled samples. This indicates that the 
amorphous phase de-vitrified to alpha form that gives the melting endotherm at ~217 °C. 
The results of TPS do not confirm this transfer as there is no peak related to of alpha lactose 
in milled samples of β-LA (see THz results, Figure 3.8b). This is contrary to the reports of the 
early 1990s (Otsuka et al., 1991), that there occur ~20% mutarotation of lactose on milling. 
Instead we suggest that mutarotation is merely an artefact occurred during DSC experiment 
and not a real transition due to milling (Willart et al., 2004). However the featureless THz 
spectrum of 60 min milled sample confirmed the DSC results that this sample has the highest 
amorphous content. The overlaid DSC curves of lactose monohydrate and anhydrous lactose 
have been given in Appendix V for a comparison of the changes that occur on milling. 
3.3.2.3 DSC Curves of Un-milled and Milled Ibuprofen  
The DSC curve of un-milled Ibuprofen (Figure 3.6a) showed a single endothermic peak at 
79.9 °C representing the melting of ibuprofen with the value of enthalpy of melting as 
116.46 Jg-1. The temperature of melting peak is in agreement, while the value of enthalpy is 
less than that already reported in literature (Madhuri Newa and Bong Kyu Yoo, 2008). The 
DSC curves of milled ibuprofen at the milling times of 2.5 to 30 min heated from the room 
temperature have shown only a single melting peak with the melting temperature almost 
similar in all milled samples (indicated by dotted line in Figure 3.6b). However, the milled 
sample annealed and heated from negative temperature (-60 °C) have shown a de-
vitrification peak with onset temperature at ~25 °C similar to that observed in amorphous 
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(quenched cooled) ibuprofen (event ‘B’ in Figure 3.6a). However, it does not show Tg step in 
contrary to quenched sample (event ‘A’ in Figure 3.6a). 
  
a b 
Figure 3.6: a) DSC curves of un-milled; 15min milled and quenched ibuprofen. The dotted circle ‘A’ shows the 
Tg step as present only in quenched ibuprofen and the circle ‘B’ highlights the de-vitrification peak as a mark 
of amorphous phase present in quenched and milled sample. b) DSC curves of milled ibuprofen for different 
times, when heated from room temperature single only melting peak is observed. 
3.3.2.4 Estimation of Relative Residual Crystallinity from DSC Data 
The relative residual crystalline (%RRC) content in milled samples (i.e. that proportion of the 
original starting material which has retained its native state and has not undergone a 
transformation to either another crystalline state, a partially damaged state, or a wholly 
amorphous state) was calculated from DSC data by following two methods. 
DSC Analysis Method 1 is based on the approach taken from the literature (Phillips, 1997). 
This method takes the enthalpy of melting peak and divides it by the melting enthalpy of the 
100% crystalline material to provide the assessment of the remaining crystalline phase 
(Equation 3.1). 
𝐗𝐜(%) =
𝚫𝐇𝐦,
𝚫𝐇𝐦,(𝟏𝟎𝟎% 𝐜𝐫𝐲𝐬𝐭𝐚𝐥𝐥𝐢𝐧𝐞)
 × 𝟏𝟎𝟎 Equation 3.1 
where Xc is the estimate for residual crystallinity, ΔHm, is melting endotherm (Jg
-1).  
This method is used only for lactose monohydrate where the assumptions is that, the second 
melting endotherm from the anhydrous β-form is merely an artefact of the DSC method, as 
it is generated from the de-vitrification of the amorphous phase and therefore is not used in 
the calculation. 
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For anhydrous lactose and ibuprofen where amorphous phase re-crystallizes, the calculation 
of residual crystallinity is based on the approach taken from literature (Van den Mooter, 
2012). This involves the subtraction of enthalpies of crystallization and melting, which yields 
the enthalpy due to the initial crystallinity of different milled samples; and then dividing it by 
the enthalpy of fusion of the pure crystalline sample (Equation 3.2). 
𝐗𝐜(%) =
𝚫𝐇𝐦− 𝚫𝐇𝐜
𝚫𝐇𝐦(𝟏𝟎𝟎% 𝐜𝐫𝐲𝐬𝐭𝐚𝐥𝐥𝐢𝐧𝐞)
 × 𝟏𝟎𝟎 Equation 3.2 
here ΔHc is enthalpy of crystallization of the amorphous phase of lactose or ibuprofen. 
Given that there is significant variation in the enthalpies of melting of alpha lactose as 
reported in literature (Table 3.2) it was not possible to select any one value that could satisfy 
the criteria of a reference value (Drapier-Beche et al., 1999).  
Table 3.2: Literature values of enthalpy of melting (∆Hm) of alpha (both anhydrous and monohydrated) and 
beta (anhydrous) lactose. 
Reference Material used ∆Hm(Jg
-1
) 
Drapier. et. al, 1999  
α-lactose monohydrate (used as received from 
Sigma, Germany) 
134 
Ticehurst et. al, 1996  
α-lactose monohydrate (Four different batches 
used as received from Lactochem, Netherland) 
125 
101 
87 
92 
Dilwarth et al, 2004  
α-lactose monohydrate (used as received from 
Borculo Whey Product U.K.) 
169 
Caron et. al.2011  
Anhydrous α-lactose (Dehydration of lactose 
monohydrate from Sigma) 
151 
Drapier. et. Al, 1999  
Anhydrous α-lactose (Dehydration of lactose 
monohydrate from Sigma) 
122 
Drapier. et. Al, 1999  
Anhydrous β-lactose (treatment of lactose 
monohydrate from Sigma) 
198 
 Dilwarth et al, 2004  
Anhydrous β-lactose (treatment of lactose 
monohydrate from Borculo Whey Product U.K.) 
197 
Therefore in our study, the molar heat of fusion for the un-milled lactose monohydrate and 
anhydrous lactose of ΔHm as 115.2 Jg
-1 and 173 Jg-1, respectively were taken as reference 
values, and the residual crystallinity in milled samples represented as the percent relative 
residual crystallinity (%RRC) of the starting material. Similarly for ibuprofen 116.5 Jg-1 was 
taken as reference value. 
DSC Analysis Method 2 is used for both types of lactose (monohydrate and anhydrous). This 
method is based on the approach taken from (Lehto et al., 2006), whereby the amorphous 
content ‘Xa’ is first estimated from the enthalpy of de-vitrification of the milled material 
divided by the enthalpy of de-vitrification of a 100% amorphous material using Equation 3.3. 
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𝐗𝐚(%) =
𝚫𝐇𝐜
𝚫𝐇𝐜(𝟏𝟎𝟎% 𝐀𝐦𝐨𝐫𝐩𝐡𝐨𝐮𝐬)
 × 𝟏𝟎𝟎  Equation 3.3 
The ‘ΔHc’ value (105 Jg
-1) of 100% amorphous (spray dried) lactose was taken for calculations 
(Lehto et al., 2006). The crystalline content was then determined by applying Equation 3.4. 
𝐗𝐜(%) = 𝟏𝟎𝟎 −  𝐗𝐚(%)  Equation 3.4 
3.3.2.5 Results of Residual Crystallinity from DSC Data 
Milled lactose monohydrate: The results of residual crystallinity of milled LMH by DSC 
method 1, are in contrast to methods 2; in that there is monotonous decrease in %RRC with 
milling time up to 60 min where it reaches ~25% (Table 3.3). The DSC analysis method 2, 
shows the monotonic trend in %RRC with milling time similar to method 1, but it produces 
higher estimates for %RRC compared to the method 1 (i.e. ~75% at 60 min milling which is 
~25% in method 1). 
Table 3.3: Values of enthalpies of de-vitrification (ΔHc) and melting (alpha form) (ΔHm) of milled lactose 
monohydrate sample and the estimates of relative residual crystallinity based on these enthalpies. 
Milling 
time (min) 
∆Hc 
(Jg
-1
) 
∆Hm (α) 
(Jg
-1
) 
Residual 
Crystallinity (%) 
(DSC Method 1) 
Residual 
Crystallinity (%) 
(DSC Method 2) 
0 - 115.2 100.0 100 
5 - 100.2 86.9 100 
15 13.6 67.2 58.3 87.0 
30 16.6 49.9 43.4 84.1 
45 26.6 35.3 30.6 74.7 
60 26.6 29.8 25.9 74.6 
Milled anhydrous lactose: DSC method 1 has indicated that there is a monotonic decrease in 
crystallinity, where there is a 50% loss of %RRC in first 15 min of milling. Afterward the loss is 
gradual after 30 min of milling (Table 3.4). The 60 min milled sample has shown a ~70% loss 
of residual crystallinity.  
DSC method 2, shows a similar monotonic trend in the loss of crystallinity with milling time 
but it over estimates the amount of residual crystallinity compared to method 1, probably 
because this method is based on the de-vitrification process. At the scan rate of 20 °C min-1 
there may be insufficient time for complete de-vitrification to occur. Moreover, there is loss 
of sensitivity at early time points where the amorphous content is too low to observe the de-
vitrification peak. 
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Table 3.4: Values of enthalpies of de-vitrification (ΔHc) and melting (alpha forms) (ΔHm) of milled anhydrous 
lactose and the estimates of residual crystallinity based on these enthalpies. 
Milling 
time (min) 
∆Hc 
(Jg
-1
) 
∆Hm 
(Jg
-1
) 
Residual 
Crystallinity (%) 
(DSC method 1) 
Residual 
Crystallinity (%) 
(DSC method 2) 
0 Nil 173.2 100 100 
5 Nil 125.9 72.7 100 
10 20.8 119.5 57.0 80.2 
15 26.1 113.9 50.7 75.1 
30 37.6 97.8 34.8 64.2 
45 42.9 105.3 36.0 59.1 
60 41.8 96.9 31.9 60.2 
Milled ibuprofen: The estimates of residual crystallinity from the only method applied to 
DSC data of milled ibuprofen (method 1) decreases gradually with the milling time. However 
this reduction is very small as compared to the both types of lactose there is only ~15% loss 
in 30 min of milling (Table 3.5). 
Table 3.5: The values of enthalpies of de-vitrification (ΔHc) and melting (ΔHm) for milled ibuprofen and 
percentage crystallinity calculated from these values. 
Milling time ΔHc (Jg
-1
) ΔHm (Jg
-1
) 
Residual 
Crystallinity (%) 
0 - 116.5 100.0 
2.5 - 115.2 98.9 
5 - 111.5 95.8 
10 5.6 110.9 90.4 
15 7.9 108.9 86.7 
30 8.7 107.1 84.6 
3.3.3 Terahertz Pulsed Spectroscopy Results 
3.3.3.1 THz Spectrum of Un-milled Lactose Monohydrate  
THz time domain signals are attenuated by the presence of lactose in the path of beam 
indicating the absorbance of THz waves, while the other small deflections are due to the 
complex permittivity of this molecule. The solid state THz spectrum of un-milled lactose 
monohydrate in transmission mode has shown four absorption peaks at 0.52, 1.18, 1.37 and 
1.80 THz corresponding to 17.3, 39.2, 45.2 and 60.1 cm-1 (as indicated by letters A-D on 
Figure 3.7a). Also there is another peak near 82 cm-1, and the spectra become noisy in this 
region particularly in the samples with higher concentrations of LMH in the pellet (Figure 
3.7b). 
The first and third peaks (Peak ‘A’ and ‘B’ at 0.52 and 1.37 THz, respectively in Figure 3.7a) 
are considered as the signatures of LMH (Brown et al., 2007) and these peaks are assigned to 
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the intermolecular vibrations of hydrogen bonded crystalline structure (Euna Jung and Kiwon 
Moon, 2008) or more specifically the peak at ~0.52 THz to a hindered rotational mode of a 
particular axis of its crystals (Allis et al., 2007). The peaks at 1.18 and 1.80 THz (Peak ‘C’ and 
‘D’, respectively in Figure 3.7a) are because of the beta lactose present in the samples of 
lactose monohydrate. This is supported by the comparison of THz spectrum of α-lactose 
monohydrate to that of the beta lactose (commercial source) by highlighting the peaks by 
dotted lines in Figure 3.7a and 3.7c.  
The THz spectrum of anhydrous lactose (Figure 3.7c) has shown three peaks at 39, 45 and 61 
cm-1 indicated as peak B, C and D, respectively. The peak at 45cm-1 (peak B) represents the 
presence of a small amount of the alpha lactose in the sample of anhydrous beta lactose (its 
signature is also present in the THz spectrum of the alpha lactose monohydrate – Figure 3.7a 
and DSC results- Figure 3.4b). The other two peaks (C and D in Figure 3.7a) are typical to the 
anhydrous beta lactose (Strachan et al., 2005).  
Another feature of the THz spectra of un-milled lactose was the manifestation of Mie 
scattering. This is the phenomenon, of increased absorbance towards higher frequencies as 
a consequence of the mean particle size of sample reaches the wavelength of the incidence 
radiation (Shen et al., 2008). Mie scattering was especially prominent in the lactose 
monohydrate due to the presence of large particles of approximately 150 µm in diameter (as 
described in Chapter 2, Section 2.3.1) and it increases as the concentration of material 
increases in the pellet (Figure 3.6b). While in β-LA, where the particles are relatively smaller 
(100 µm) this scattering is lower (Figure 3.7). In the milled samples of both types of lactose 
this effect is diminished (Figure 3.7 a & b) indicating the particle size reduction. 
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a b 
  
c d 
Figure 3.7: THz absorption spectra of a) un-milled lactose monohydrate and b) its different concentartions, 
c), un-milled anhydrous lactose and d) its different concentration. THz peaks in both types of lactose are 
marked as A, B, C and D. Peaks A & B represents the characteristic peaks of lactose monohydrate while peaks 
(C & D) represents anhydrous lactose as shown by the dashed lines dropping on the spectra of anhydrous 
lactose.  
Note: The plots showing the time domain signals and sample spectra each of lactose 
monohydrate, anhydrous lactose and ibuprofen are given in Appendix VI. 
3.3.3.2 THz Spectrum of Milled Lactose Monohydrate  
The THz spectra of milled lactose monohydrate (Figure 3.8a) are similar to that of the un-
milled LMH in terms of the position of characteristic absorption peaks. However, the 
intensities of the major peaks (A and B in Figure 3.7a) decrease with milling time, indicating a 
progressive damage to the crystalline structure. The 2nd peak (near 45 cm-1) is more 
prominent in the short milled samples (< 10 min) but diminishes on further milling (> 10 
min). The spectra of the long milled (45 min and 60 min) samples show only two peaks with 
a diminished shoulder of the 2nd peak and an almost flat and featureless spectrum toward 
longer wavenumbers, which is rather typical of an amorphous material (Strachan et al., 
2005). 
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It is important to note that the spectral peaks of β-lactose (i.e. at ~39 and ~60 cm-1) 
diminishes with milling time as shown by dotted lines in Figure 3.8a, so that the milled 
samples (> 30 min) contain only the traces of the beta lactose. Therefore, THz results 
indicate that the milling does not cause any promising mutarotation as previously reported 
by (Willart et al., 2004) but it is contrary to the reports of (Otsuka et al., 1991) that milling 
caused ~20% mutarotation. 
  
a b 
Figure 3.8: THz spectra of a) milled lactose monohydrate and b) milled anhydrous lactose for various time 
intervals as indicated against each curve. The dotted lines show the changes in peak heights of contaminant 
anomer of lactose with the milling time. 
3.3.3.3 THz Spectrum of Milled Anhydrous Lactose 
The spectra of the milled anhydrous lactose (Figure 3.8b) are almost similar to the un-milled 
one in shape but the area of major peaks (C and D in Figure 3.7c) decrease with the milling 
time. The small peak at 45 cm-1 representative of the α-LMH, which was present in un-milled 
samples, was also observed in short milled samples (5 and 10 min). However it disappeared 
in sample milled for 15 min or beyond as highlighted by dotted line in Figure 3.8b. The 
spectrum of 60 min milled sample is almost flat, with very small peaks at position as with the 
un-milled sample.  
Note: The overlaid THz spectra of different milled samples of both types lactose have been 
given in Appendix VII to show the actual scattering and other changes in the THz absorption 
peaks. 
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3.3.3.4 THz Spectrum of Un-milled Ibuprofen  
The THz spectrum of ibuprofen (Figure 3.9a) has shown only a single absorption peak at 
1.035 THz corresponding to ~34.5 cm-1 and a noisy spectral region near 60 cm-1. The 
phenomenon of Mie scattering (as described in case of lactose) is also observed in case of 
ibuprofen. 
  
a b 
Figure 3.9: a) THz spectrum of un-milled ibuprofen showing the single prominent peak as highlighted by 
arrow head and increase in absorption towards higher wavenumbers (Mie scattering), b) THz spectra of 
milled ibuprofen for various time intervals showing the decrease in area of absorption peak as the milling 
time increases and the diminishing of Mie scattering in milled samples >5min. 
3.3.3.5 THz Spectra of Milled Ibuprofen  
The THz spectra of the milled ibuprofen for different times have indicated that the overall 
shape of spectra was almost the same as the un-milled one (Figure 3.9b). The notable 
changes are i) the intensity (measured as area) of the only absorption peak decreases as the 
milling time increases, ii) The raised spectra of un-milled and 5 min milled ibuprofen towards 
higher wavelength that represents the Mie scattering of larger particle, now trodden in 
milled samples. 
3.3.3.6 Estimation of Residual Crystallinity from THz Data  
The THz spectral region for quantitative analysis of each material was selected based on the 
largest spectral difference between its spectrum and that of the polyethylene. This region 
contains one representative peak in case of ibuprofen (at ~35 cm-1), while two peaks for 
each of lactose monohydrate (first at ~17 cm-1 and the second ~45 cm-1) and anhydrous 
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lactose (first at ~39 cm-1 and the second ~61 cm-1). The other peaks are either not true 
representative or least prominent, therefore were ignored for quantitative analysis. 
3.3.3.7 Peak Selection of Lactose for Quantitative Analysis 
Among the two THz peaks of alpha lactose monohydrate (as described in Section 3.3.3.1), 
the first peak is sharp, has well defined start and end points and has an approximately linear 
baseline in both un-milled and milled samples (Figure 3.10a & b). 
The second peak shows more scattering (shift of baseline in term of its gradient or offset) 
and presents difficulties in clearly defining the baseline, particularly in the milled samples 
(Figure 3.10c-f) which could lead to an under or overestimate of the residual crystallinity in 
milled samples. Therefore peak 1 was selected for the quantitative analysis of lactose 
monohydrate. The same region of THz spectrum was used previously for studying the 
crystallization process in amophous lactose monohydrate (McIntosh et al., 2013). Similarly, 
in case of anhydrous lactose peak 1 was selected for the quantitative analysis. 
3.3.3.8 Methods of Quantitative Analysis  
The THz spectra of un-milled and milled materials were analysed by a conventional method, 
based on estimation of area under absorption peak, as well as by multivariate method. It 
was recognized that accuracy of the former method, which does not account for the 
equipment noise and other external variables, is therefore dependent on the estimation of 
baseline of the peak. The multivariate analysis applied was based on partial least square 
(PLS) regression. Unlike the univariate peak area analysis approach, this method identifies a 
number of prediction variables, and scores each as a different principal component. The 
component with the highest score is the factor that contributes most to the observations. 
Multivariate chemo-metric analysis has been used previously for calculation of crystallinity 
of from NIR data (Nørgaard et al., 2005) and THz data (Darkwah et al., 2013). 
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a b 
  
c d 
  
e f 
Figure 3.10: Baseline characteristics from THz absorption data of lactose monohydrate. Peak 1 shows linear 
baseline in un-milled and milled samples (a, b) while peak 2 shows a non-linear baseline in milled samples (c-
f) in terms of shifts in gradient and offset with milling time. 
A) Area Under the Peak Method  
The THz absorption spectra of different concentrations (i.e. 4 to 12% w/w) in case of lactose 
or 6 to 20 %w/w ibuprofen were measured in the frequency range of 0 to 100 cm-1.The area 
under the absorption peak was then calculated by a trapezoidal method, following 
subtraction of the linear baseline between the start and end points of the peak (Figure 
3.11a, c & e) and used to construct a calibration curves. This gives straight lines with a R2 
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close to unity as described on each graph (Figure 3.11b, d & f). The linear function 
parameters of these calibration curves were then used to calculate the concentration of 
crystalline material remaining in each milled material. 
  
a b 
  
c d 
  
e f 
Figure 3.11: Baseline subtraction from THz absorption peaks (a, c, e) for lactose monohydrate, anhydrous 
lactose and ibuprofen, respectively and their calibration curves (b, d, f) from area under peak method in the 
same order. The error bars represent the standard deviation of 9 measurements (n=9). 
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B) Partial Least Square Method  
The multivariate calibration model was constructed using the un-processed THz absorption 
data of the selected region at different concentrations (4%, 6%, 8%, 10% and 12% w/w) of 
the un-milled lactose or 6 to 20 w/w % ibuprofen. A PLS algorithm was applied on the 
response (THz absorbance) and input (i.e. concentrations) using the Matlab software 
(R2010a) and a model with 4 latent variables was selected. The applied model demonstrated 
good agreement (constant of proportionality ~1) between the predicted and the actual 
concentrations for each of lactose monohydrate, anhydrous lactose and ibuprofen (Figure 
3.12a, b & c, respectively). The PLS regression coefficients (‘Beta’ coefficients) were then 
calculate and used to estimate the % (w/w) relative crystallinity remaining in the milled 
samples from the measured THz spectra. 
  
a b 
 
 
c  
Figure 3.12: Calibration models based on partial least square (PLS) applied to THz data of un-milled a) lactose 
monohydrate b) anhydrous lactose and c) ibuprofen. All these showing a good agreement between the 
predicted concentrations against calculated from this model. The error bars represent the standard deviation 
(SD) of the measurements (n=9). 
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The limit of detection (LOD) and the limit of quantification (LOQ) for each material are 
calculated using Equations 3.5 to 3.6, and the output values (Table 3.6) are used to compare 
the quality of each model. 
𝐋𝐎𝐃 =  𝟑. 𝟑 ∗ 𝐑𝐌𝐒𝐄  Equation 3.5 
𝐋𝐎𝐐 =  𝟏𝟎 ∗ 𝐑𝐌𝐒𝐄  Equation 3.6 
RMSE is root mean square error calculated from AUC data or PLS regression. 
Table 3.6: The LOD and LOQ values of lactose monohydrate, anhydrous lactose and ibuprofen as calculated 
from the both THz methods (AUC and PLS). 
 Area of peak method Partial least square 
 RMSE 
LOD 
(w/w %) 
LOQ 
(w/w %) 
RMSE 
LOD 
(w/w%) 
LOQ 
(w/w %) 
Lactose monohydrate 
(Peak 1) 
0.23 0.77 2.35 0.24 0.78 2.37 
Anhydrous Lactose 
(Peak 1) 
0.14 0.48 1.45 0.23 0.74 2.26 
Ibuprofen 
 
0.42 1.39 4.22 0.50 1.65 5.0 
3.3.3.9 Results of Residual Crystallinity of Milled Lactose Monohydrate from THz Data 
In the milled samples of lactose monohydrate, both area under the peak data and the PLS 
data show a monotonic decrease in crystallinity with the milling time (Figure 3.13). The most 
intensive/sharp reduction of crystallinity occurs at the beginning of milling where the %RRC 
reaches ~25% after 30 min of milling. Beyond this time point there is relatively slow loss of 
further 5% to 15% crystallinity during next 30 min and %RRC is ~15% in the 60 min milled 
sample. 
 
Figure 3.13: Comparison of relative residual crystallinity (%RRC) on milling of lactose monohydrate as 
calculated by area under peak method and PLS methods applied to THz data. The error bars represent the 
standard deviation (SD) of the measurements (n=9). 
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3.3.3.10 Results of Residual Crystallinity of Milled Anhydrous Lactose from THz Data 
For the milled anhydrous lactose, both the area under the peak data and the PLS data show 
a rapid reduction in crystallinity at the beginning of milling where the %RRC reaches ~70% 
after 10 min of milling (Figure 3.14). Beyond this time point there is a net increase of 15% 
crystallinity with the next 45 min followed by a sharp reduction in crystallinity until it reaches 
~35% in the 60 min milled sample. 
 
Figure 3.14: Comparison of relative residual crystallinity (%RRC) on milling of anhydrous lactose as calculated 
by area under peak method and PLS methods applied to THz data. The error bars represent the standard 
deviation (SD) of the measurements (n=9). 
3.3.3.11 Results of Residual Crystallinity of Milled Ibuprofen from THz Data 
The method based on area under the peak, shows an intensive reduction of crystallinity of 
ibuprofen at the beginning of milling where the %RRC reaches ~50% after 10 min of milling. 
Beyond this time point there is relatively slow loss of further 15% crystallinity in next 20 min 
of milling (Figure 3.15). While the PLS method show that the residual crystallinity decreases 
erratically with milling time, with the most remarkable decrease in the crystallinity occurring 
over the first 5 min. There is an approximate ± 10% variation in the estimates of crystallinity 
in all milled samples of ibuprofen  (between 42% to 52%) meaning that it is not clear as to 
whether there is a progressive decrease in crystallinity as the milling time increases beyond 
10 min. 
20
40
60
80
100
0 10 20 30 40 50 60
R
e
la
ti
ve
 R
e
si
d
u
al
 C
ry
st
al
in
it
y 
(%
) 
Milling Time (min) 
AUC method
PLS method
Anhydrous Lactose 
86 
 
 
 
Figure 3.15: Comparison of relative residual crystallinity (%RRC) on milling of ibuprofen as calculated by area 
under peak method and PLS methods applied to THz data. The error bars represent the standard deviation 
(SD) of the measurements (n=9). 
3.4 Discussion 
It is expected that ball milled materials will contain a number of phases from the partially 
damaged (i.e. compromised) crystalline material to the fully amorphous phases, as a 
consequence of the high energy collisions of the particles. Results from the various 
techniques and methods of data analysis provide a range of estimates for the residual 
crystallinity, with all techniques generally showing similar behavior, i.e. a generalised 
decrease in the proprtion of the crystalline part with the milling time. This outcome may be 
considered somewhat inevitable given that each approach is based on the analysis of a 
different facet of the collection of milled particles. The discussion will focuss on the 
exploration of these differences between approaches used in this study (i.e. TGA, DSC and 
THz) for the determination of residual crystallinity. 
3.4.1 Comparison of DSC and TGA of Lactose Monohydrate 
One feature of the estimates for %RRC, as determined by TGA, is that they are generally 
much higher than the estimates obtained from the DSC method 1 (Figure 3.16).  
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Figure 3.16: Comparison of relative residual crystallinity (%RRC) of lactose monohydrate as calculated by TGA 
and DSC (method 1 & 2).  
The disparity between TGA and DSC was probably due to the fact that; in case of TGA, the 
assessment was based on the weight loss linked to the release of water of crystallization. 
Therefore, while the estimate of crystallinity may actually represent that part of the 
(crystalline) material which is largely un-changed during milling process, it may also include 
that part which is partially damaged during milling but still retains some form of the 
entrapped water (which may in fact be considered as some form of water of crystallization). 
This would lead to a higher estimate of crystallinity in the milled material than a method 
which is based on the assessment of the melting enthorm of lactose monohydrate (i.e. DSC 
method 1). Another fact is that the percentage loss of crystallinity as determined by TGA is 
based on the assumption that the starting material comprises only alpha lactose 
monohydrate, with a water content of 5%. Inevitably this is added to the over estimate of 
the residual crystalline content. 
Another feature of the estimates for %RRC from TGA is the undulation of data over time, 
which could result from the variation in the characteristics of the material taken as a sample 
from the ball mill. It is possible that a material in which crystals are weakened on milling, 
may allow water to leach out before analysis, and this would reflect less %RRC than the 
sample in which water of crystallization is relatively stable. Such effects would be 
exacerbated from a lack of uniformity across the milled material. 
DSC method 2 also gives a higher estimate of crystallinity than DSC method 1. The 
descrepancy in DSC method 2 is because of its reliance on the process of de-vitrification and 
the presumption that this process is completed within the time frame of the DSC analysis. 
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However, at the scan rate of 20 °C min-1 there may be insufficient time to allow for complete 
de-vitrification. Moreover, this process would be impacted by the amount of water in each 
sample, therefore introducing a further degree of variability in the assessment of 
crystallinity. Also there is loss of sensitivity at early time points where the amorphous 
content is too low to observe the de-vitrification peak. The minimum sensitivity is ~ 13% of 
amorphous in order to detect and make a reliable estimate of %RRC by this method; so it 
follows that the estimates for %RRC are likely to be higher than one could expect. 
Based on the discussion above we might pre-suppose that the broad agreement between 
TGA, and DSC method 2 implies that these estimates for the %RRC provide a more realistic 
assessment of the damage induced by milling. However, it is recognised that the TGA is likely 
to include, in its estimates the proportions of material that have been structurally 
compromised in some way. In the case of DSC method 1, the assessment of %RRC is based 
on the melting endotherm of -lactose monohydrate and is more realistic. Any amorphous 
form which de-vitrifies on heating within the DSC experiment is presumed to crystallise out 
exclusively as the beta form (and not the alpha form as discussed in Section 3.3.2.2) and 
therefore does not contribute to the metling endotherm of α -lactose monohydrate. 
3.4.2 Comparison of DSC (method 1) and THz Results 
For lactose monohydrate: The assumption that the de-vitrification of a proportion of the 
amorphous form to the beta form, on heating within the DSC experiment, is borne out by 
the THz data which demonstrates the absence of any increase in the beta form, post milling. 
Therefore the calculation (method 1) of residual crystalline content in milled samples may be 
based entirely on the melting enthalpy of α-anomer.  
For the THz analysis, the estimates for %RRC from both methods of analysis (area under 
peak and PLS) seemed similar, therefore the average of their estimates were taken and 
compared with DSC method 1. It represents that both estimates were the closest to one 
another, in that the rate of decrease of crystallinity followed a similar trend (Figure 3.17). 
However, the DSC estimates were generally higher than that from the THz analysis. This 
might suggest that the aforementioned exclusive de-vitrification of the amorphous form into 
the beta form, may not be strictly true and that de-vitrification may also re-introduce a 
proportion of the -form. 
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Figure 3.17: Comparison of residual crystallinity (%RRC) for the milled lactose monohydrate as calculated by 
DSC method 1 and THz methods (average of two THz methods). 
In Summary, the THz estimates of residual crystallinity are more promising and consistent. It 
is futher emphasized that this technique is non-invasive and directly measures the 
crystallinity by probing the lattice of solid material. In contrast, the thermo-analytical 
methods are all indirect methods based on the assessment of transitions between different 
physical states of material, which are dependent on the temperature rate and values that 
can be applied for the specific enthalpy of melting of each crystalline state. 
For anhydrous lactose: The averages of both THz estimates (determined from AUC and PLS 
methods) provide higher estimates of residual crystallinity, compared to both DSC methods, 
for all milling time points up to 45min (Figure 3.18). While at the 60 min point, the estimates 
from both DSC method 1 and THz were almost the same as one another. 
The difference in the estimates of residual crystallinity as determined from THz spectroscopy 
and DSC are probably because the opportunity for de-vitrification of the amorphous phase 
during sample preparation for the THz measurement at room conditions, given that there 
are inevitably lot of seeds for de-vitrification in milled samples (Caron et al., 2011). 
Moreover, the process of de-vitrification may in fact be triggered by the hydrophobic 
surfaces of PE coupled to the compression force applied during pellet preparation. This may 
explain why estimates for the residual crystallinity were higher for THz analysis up to the 45 
min time point. During this early phase of milling, the amorphous content was small and 
therefore sufficient seeds remained for the de-vitrification of this amorphous phase. 
However, at extended milling times (60 min), where the amorphous content is large and 
there are insufficient seeds to promote the re-crystallization of the amorphous phase, then 
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the material is more stable and the estimates for %RRC are almost the same as that 
determined by DSC. 
 
 
Figure 3.18: Comparison of residual crystallinity (%RRC) for the milled anhydrous lactose as calculated by DSC 
method 1 and THz methods (average of two THz methods). 
In summary, DSC method 1 (based on the melting and de-vitrification enthalpies) is relatively 
reliable method for the estimation of residual crystallinity in milled anhydrous lactose 
among the all DSC methods and THz. In contrast to our observations for the lactose 
monohydrate; where it is established that the THz measurements are relatively more 
reliable for the estimation of relative residual crystallinity on milling. Therefore, the best 
methods for each were taken for comparison of residual crystallinity of lactose monohydrate 
and anhydrous lactose after ball milling (Section 3.4.3). 
For milled ibuprofen: The appearance of melting peaks of all milled samples of ibuprofen at 
almost same temperature as the un-milled one (Figure 3.6b), has indicated that either the 
crystalline structure of ibuprofen was not damaged, particularly in short milled samples or 
there was some regain in crystallinity in samples milled for longer than 15 min. However, the 
signature of amorphous phase (the de-vitrification peak) in long milled sample >15 min 
(Figure 3.6a) indicates the crystalline damage. 
The quantitative analysis (by both DSC and THz) of residual crystallinity in milled samples of 
ibuprofen as compared to the initial crystalline material has revealed that there is a 
monotonic loss of crystallinity with milling times (Figure 3.19). However, the estimates of 
%RRC from DSC results are higher than that from the THz results. This is probably due to the 
thermal induced de-vitrification of amorphous phase generated on milling (Figure 3.6a), 
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which has been started even inside the jar of mill (as the temperature is close or higher that 
the de-vitrification temperature of ibuprofen i.e. ~35 °C). 
 
 
Figure 3.19: Comparison of residual crystallinity for the milled anhydrous lactose as calculated by DSC 
method 1 and THz methods (average of two THz methods). 
Therefore DSC results could not represent true change in crystallinity in ibuprofen on milling. 
On the other hand, the THz results look promising and reveal a rapid loss of residual 
crystallinity in first 15 min followed by a plateau afterwards. 
3.4.3 Comparison of residual crystallinity of milled lactose monohydrate and anhydrous  
A comparison of the residual crystallinity of ball milled lactose monohydrate (from THz data) 
and anhydrous lactose (from DSC data) shows that there is an initial, steep decline in the 
residual crystallinity in the first 15 min, followed by a more gradual reduction in crystallinity 
over the subsequent 45 min (Figure 3.20). After 5 min milling the two profiles reveal a 
systematic difference ~10% at each milling time point. 
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Figure 3.20: Changes in relative residual crystallinity of lactose monohydrate and anhydrous lactose as 
calculated from THz (for LMH) and DSC (for LA). 
The higher estimate of the residual crystallinity in case of anhydrous lactose (DSC method 1) 
as compared to the lactose monohydrate (THz method) is probably due to the fact that α-
LMH is more brittle than β-LA. The mechanical parameters such as tensile strength and 
Young’s modulus of α-LMH promotes its cleavage while the likelihood of cleavage is less in 
the case of anhydrous β-lactose (Busignies et al., 2004). The brittleness of LMH is also 
related to particle size. Previously it was shown that particles with the size > 45 µm are more 
brittle than fine powder particles (Peters, 2009). The size of particles for both materials 
under investigation is different. The α-LMH which was used in this study consisted of coarse 
particles of 150-180 µm; as compared to the particles of β-LA which were relatively fine (< 
100 µm). Another explanation might be due to the fact that the coarse particles (of α-LMH) 
have good flow behaviour and are therefore more mobile within the milling jar. As a 
consequence, they may experience a greater number of collisions with the moving ball and 
more shearing events against the side walls (Shariare et al., 2011) i.e. leading to greater 
attrition of the powder. On the other hand the fine powder of β-LA having poor flow, 
probably sticks to the walls of the milling jars and therefore only experiences the compaction 
force of ball against the wall of mill jar. 
3.5 Conclusion 
The results of residual crystallinity estimates for the milled lactose monohydrate has shown 
that both DSC method 1 and the THz methods yield almost similar results indicating that 
there is a limit of ~ 80% loss of starting crystalline content which occurs after 60 min milling. 
While TGA appears to show higher estimates of crystallinity because the estimation is based 
on the weight of crystallization water without any consideration of the structural damage to 
the crystal or the presence of an amorphous phase. Therefore it can be concluded that; TGA 
is un-reliable for the estimation of crystallinity,  DSC works but requires more steps in the 
calculation (to account for the induced de-vitrification and mutarotation of LMH during 
analysis by DSC) and therefore more assumptions and expected sources of error may 
associate with the method, while THz measures the material in its native state and is based 
on simple absorption spectra, requiring fewer assumptions and therefore standard 
computational techniques are satisfactory. In addition, a principle advantage of THz over 
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DSC might be that the technique could be adapted for on-line measurements and process 
control. 
On the other hand, for anhydrous lactose; DSC is more reliable method than THz, for 
measuring the crystallinity of materials after milling because of the de-vitrification of 
amorphous phase during sample preparation is more probable than for milled α-lactose 
monohydrate.  
In case of ibuprofen, where thermal analysis can induce partial de-vitrification of the 
amorphous phase, again THz spectroscopy is more reliable technique for the determination 
of loss of crystallinity in respect of the staring material. 
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4 Study of Molecular Dynamics of Amorphous Phase in Milled 
Sugars (Lactose and Sucrose) by Dielectric Relaxation 
Spectroscopy 
4.1 Background/Context 
The amorphous phase has the advantage of increasing the solubility and dissolution rate of 
poor soluble drug substances (Dudognon et al., 2006). At the same time, this phase is 
metastable (owing to the high surface free energy) and may ultimately revert back (i.e. de-
vitrify) to its original form, or even a different crystalline form, thus compromising the 
stability of the product during its shelf life. This instability is often associated with the 
sorption of moisture, which has the effect of reducing the glass transition and increasing the 
mobility of the constituent molecules (Zhang et al., 2006). 
The methods commonly used for the generation of amorphous phase include quench 
cooling of melts (Angell, 1995), freeze drying (Yu, 2001), spray drying (Gharsallaoui et al., 
2007), precipitation from solution (Li et al., 2000), vapour condensation (Kearns et al., 2007) 
and milling (Willart et al., 2004). Among these, milling is often considered to be the simplest 
and versatile method used in pharmaceutical industry. The applications and other benefits 
of milling have been detailed in Chapter 1. The amorphous phase obtained by milling is 
probably the most unstable because of the presence of residual crystallites, that act as nuclei 
for de-vitrification (Crowley and Zografi, 2002). Therefore the benefits of milling could only 
be achieved if the post-milling de-vitrification is prevented, for example by co-milling with an 
agent that stabilizes the amorphous phase. At the first stage, it is necessary to study the 
molecular dynamics of this phase then it may be possible to determine the extent to which a 
system containing an amorphous phase could be stabilized. 
There are a range of techniques available for studying the molecular dynamics and thus 
stability of the amorphous phase. Parameters such as the structural relaxation time, 
enthalpy relaxation and/or fragility index (obtained from DSC or isothermal micro-
calorimetry techniques) have been used to provide certain measures of molecular mobility 
(Pokharkar et al., 2006, Graeser et al., 2009, Liu et al., 2002). More recently, studies by 
dielectric spectroscopy have shown that the structural relaxation (in terms of the 
characteristics of the α-relaxation) reflects a level of molecular mobility that appears to 
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underpin the de-vitrification (and hence instability) of system containing amorphous phase 
(Kolodziejczyk et al., 2013, Rodrigues et al., 2013)  
However, it is worth noting that the amorphous phase studied in majority of these studies 
was usually produced by quench cooling of the melt; a procedure which is not commonly 
applied in pharmaceutical industry as it may degrade the material. Moreover, it produces a 
compact, non-porous material that dissolves slowly, a feature of a pharmaceutical product 
which is invariably undesirable. It is also relevant to recognize that the moisture is excluded 
from these systems during the quenching, which is not the real situation when amorphous 
phase is prepared in industry. 
Cryo-milling is an alternate method of producing amorphous state without thermal 
degradation of the material (Wojnarowska et al., 2010), however, it is important to 
remember that the method by which the amorphous phase is generated has itself an 
influence on the molecular dynamics characterizing the product (Kaminski et al., 2012). Thus, 
there is a need to study the specific molecular dynamics of amorphous phases, as they are 
generated by the more routinely used industrial processes (i.e. milling) in order to predict 
the stability of such materials after milling. 
Another important aspect of milling studies is to consider the fact that; the amorphous 
phase inevitably contains some quantity of the moisture (either generated from within the 
material in case of hydrated ones or adsorbed from the environment). A recent study on the 
ball milled indapamide (Wojnarowska et al., 2013) has suggested the presence of water 
relaxation peak rather than the typical relaxation processes of amorphous phase. The 
distribution and the impact of this water on the dynamics of the amorphous phase are 
important in defining the stability of this phase. Therefore the cooperative molecular 
dynamics of this amorphous phase, as modulated by the ‘plasticization’ effect of water may 
be of greater relevance to the stability of amorphous form than experiments taken on 
quench cooled systems. 
The objective of this study is the analysis of the dielectric relaxation processes in milled 
disaccharides (sucrose and lactose) at different milling times in order to understand the 
impact of milling on the dynamic behaviour of these widely used pharmaceutical excipients. 
This is an important aspect to investigate the dielectric properties of milled materials and 
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may help to establish the approaches for the prediction of the stability of milled 
pharmaceuticals. 
4.2 Materials and Methods 
Anhydrous lactose (as described in Chapter 3, Section 3.2) and sucrose used in this study 
were purchased from Fluka, U.K. and used as received from the supplier. Lactose occurs as a 
white crystalline powder with finely divided particles while the sucrose was a coarse 
crystalline material. 
4.2.1 Ball Milling 
Milling of both lactose and sucrose was performed as per method described in Section 2.2.1 
using the milling speed of 18 Hz for 60 min. 
4.2.2 Thermogravimetric analysis (TGA) 
TGA of un-milled and milled materials was carried out according to the method described in 
Section 2.2.4. 
4.2.3 Differential Scanning Calorimetry (DSC) 
DSC experiments of un-milled and milled materials were carried out according to the 
method described in Section 3.2.3. 
4.2.4 Broadband Dielectric Spectroscopy (Novocontrol) 
The dielectric measurements were performed at ambient pressure according to the method 
used by (Kaminski et al., 2008b) in BDS Novocontrol Alpha Analyser (Novocontrol, GMBH 
Germany- shown in Figure 4.1a). The powder sample was placed in the form of a thin film 
between two gold plated electrodes of a sample cell (Figure 4.1b). The diameter of the 
sample was taken from the cell i.e. 20 mm and the thickness of sample layer was ~1.0 mm. 
The cell was then mounted in the sample holder (Figure 4.1c) where it was supplied with 
liquid nitrogen. The measurements were carried out applying the frequencies between 0.1 
Hz and 10 MHz and temperature from −120 to +100 °C with 5 °C increments. The 
temperature was controlled (with stability of ± 0.1 °C) by Novocontrol Quattro system 
attached with the cryostat containing liquid nitrogen. The data were analysed by Data-View 
and Z-view software. 
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a b c 
Figure 4.1: Novocontrol dielectric spectrometer showing a) frequency response NVC alpha analyser unit 
connected with cryostat Dewar for temperature control during the measurements, b) sample cell containing 
an outer gold plated sample holder and two small gold plated electrodes mounted in Teflon assembly and c) 
sample holder assembly. 
4.3 Results and Discussion 
4.3.1 DSC Results of Anhydrous Lactose  
The DSC curve of un-milled lactose has shown a small endotherm at ~140 °C (peak ‘A’ in 
Figure 4.2a) followed by a shoulder at ~210 °C (indicated as ‘B’ in Figure 4.2a), and a large 
endotherm at ~238 °C (peak ‘C’ in Figure 4.2a). The first endotherm is desorption of the 
water of crystallization (as observed in case of lactose monohydrate (LMH) in Section 
3.3.2.1), indicating the presence of small quantity LMH in the sample of anhydrous beta 
lactose (β-LA). The second endotherm (i.e. peak ‘B’) represents the melting of anhydrous α-
lactose (α-LA) while the major endotherm (peak ‘C’) represents the melting of anhydrous 
beta lactose (Listiohadi et al., 2009). 
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a b 
  
c d 
Figure 4.2: DSC curves of a) un-milled anhydrous lactose (showing the two small endotherms ‘A’ and ‘B’ 
shown in the inset and a melting endotherm ‘C’), b) milled lactose for various time intervals c) segment from 
DSC curves of 30 & 60 milled lactose (showing Tg indicated as event ‘D’, de-vitrification (peak ‘E’) and water 
loss peak ‘F’) d) change in moisture content of anhydrous lactose from TGA (trend line shows the biphasic 
response. 
DSC curves of milled (for different times) anhydrous lactose (Figure 4.2b) have shown that 
the desorption endotherms of the water of crystallization is present in majority of the milled 
samples (although its enthalpy changes, see Table 4.1), while the melting endotherm of α-LA 
is not observed in any of the milled samples. The major melting peak (indicated as C’ in 
Figure 4.2b) shifts towards lower temperatures with milling time; from ~238 °C for the un-
milled lactose to ~222 °C for the 60 min milled sample. 
The signs of an amorphous phase, including a glass transition step (peak ‘D’ in Figure 4.2c) a 
de-vitrification (peak ‘E’ in Figure 4.2c) is also observed in the milled lactose. The onset 
temperature for de-vitrification (Tcr) does not have any regular pattern (Figure 4.2b) and 
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occurred between 45 and 90 °C. Another event in the DSC curves of milled samples at ~ 95 
°C (event ‘F’ in Figure 4.2c) probably represents the loss of surface water. 
The change in enthalpies of devitrification and melting on milling (Table 4.1), indicates the 
loss in crystallinity of anhydrous lactose (described in Chapter 3, Section 3.3.3.10), while the 
changes in melting temperature represent the thermally induced mutarotation, which may 
be considered as an artefact of the DSC analysis (Shariare et al., 2011) and the beta lactose is 
not sufficiently present in the native milled samples (prior to DSC measurement) as 
evidenced by the non-thermal technique i.e. THz (Chapter 3, Section 3.3.3.4). The 
observation of a glass transition indicates the presence of a real glassy state within the 
samples of lactose that had been milled for extended time period (45 – 60 min), as opposed 
to what has been described previously as a non-crystalline state by (Willart et al., 2004), i.e. 
one which is intermediate between a purely ‘intact’ crystalline state and the wholly 
amorphous state. 
Table 4.1: Values of crystallization temperature (Tc), enthalpy of crystallization (ΔHc), enthalpy of 
dehydration (ΔHdh), melting temperature (Tm) and enthalpy of melting (ΔHm) for milled anhydrous lactose.  
Milling 
time (min) 
Tc (°C) ΔHc (Jg
-1
) ΔHdh (Jg
-1
) Tm (°C) ΔHm (Jg
-1
) 
0 - - 10.1 238.1 173.2 
5 - - 14.8 234.0 125.9 
10 63.1 20.8 15.9 231.6 119.5 
15 48.0 26.1 20.1 230.1 113.9 
30 85.3 37.6 5.7 226.5 97.8 
45 57.9 42.9 14.0 226.2 105.3 
60 88.2 41.8 2.1 222.1 96.9 
4.3.2 Change in Moisture Content of Milled Lactose from TGA 
The moisture content of milled samples of anhydrous lactose (Figure 4.2d) show a biphasic 
response, with an initial increase at short milling times (from ~ 1.1% in un-milled lactose to 
1.7% in the 15 min milled), probably because of the water of hydration released form the 
material, followed by a reduction in moisture (1.25% in the 60 min milled sample) 
presumably as a consequence of drying as the temperature of the mill increases to ~ 40 °C in 
60 min milled sample as compared to ~30 °C in 15 min milled sample. 
4.3.3 DSC Results of Sucrose 
The DSC curve of un-milled sucrose (Figure 4.3a) has shown a single endotherm at ~192 °C, 
corresponding to melting of this sugar (Beckett et al., 2006). In milled samples (5 to 60 min 
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milling times) the melting temperature remains almost constant (within 192 ± 4 °C, Figure 
4.3b) and, the de-vitrification peak appears in the samples milled for 10 min or greater. The 
onset temperature for the de-vitrification decreases initially in the 15 min milled sample and 
afterwards increases gradually with milling time. For the samples exceeding 30 min milling 
time the glass transition step (event ‘A’ in Figure 4.3c) occur preceding the de-vitrification 
(peak ‘B’ in Figure 4.3c), which is followed by surface water loss (peak ‘C’ in Figure 4.3c) 
similar to those observed for lactose (Figure 4.2c). 
Again, the milled samples show a decrease in the enthalpy of the melting (from ~125 to ~110 
Jg-1) and increase in the enthalpy of de-vitrification ( from ~20 to ~40 Jg-1) as the milling time 
increases from 5 min to 60 min (Table 4.2), indicating the amorphization of sucrose. 
Table 4.2: Values of Crystallization temperature (Tc), enthalpy of crystallization (ΔHc), melting temperature 
(Tm) and enthalpy of melting (ΔHm) for milled sucrose. 
 Tc (°C) ΔHc (J g
-1
) Tm (°C) ΔHm (J g
-1
) 
0 - - 193.4 125.7 
5 - - 194.4 113.3 
10 48.7 18.4 193.7 115.3 
15 42.0 18.5 195.0 120.2 
30 44.4 28.6 195.7 116.0 
45 49.0 33.2 195.0 119.3 
60 56.6 40.4 191.5 110.7 
4.3.4 Change in Moisture Content of Milled Sucrose from TGA 
TGA results for the un-milled sucrose shows no change in weight with temperature, 
indicating the absence of any moisture in the sample. While the milled sucrose samples 
showed an increase in surface moisture with milling time. It was 0.8% in 15 min milled 
sample and 1.6% in 45 min milled sucrose and afterward decreased slightly; i.e. 1.4% in 60 
min milled sucrose (Figure 4.3d). 
The change in enthalpy of de-vitrification and melting of both sugars in DSC data indicates 
that the amorphous content increases with milling time (Font et al., 1997).and then de-
vitrifies with temperature. The amorphous phase of anhydrous lactose initially (when water 
released from hydrated crystals is high) de-vitrifies to α-monohydrate as evidenced from the 
increase in enthalpy of desorption peak (Table 4.1). Beyond 15 min of milling the de-vitrified 
form also contains β- lactose as the water is driven off by the raised temperature of the mill. 
The onset temperature for the de-vitrification was variable in milled lactose, in spite of the 
increase in the amorphous content with milling time. This was probably because of the 
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change in moisture content that goes up and down with milling time (Figure 4.2d). Therefore 
the moisture plays a key role in the dynamics of amorphous phase in the milled lactose. 
  
a b 
  
c d 
Figure 4.3: DSC curve of a) un-milled sucrose b) milled sucrose for different milling times (dotted lines ‘A’ and 
‘B’ indicate the shifts of de-vitrification and melting endotherms respectively), c) Segments of DSC curves of 
30 & 45min milled sucrose (showing Tg indicated as event ‘A’, de-vitrification (peak ‘B’) and water loss peak 
‘C’), d) change in moisture content of sucrose with milling time as determined by TGA. 
In milled sucrose, the shift of onset temperature for de-vitrification towards higher 
temperature with milling time indicates that the crystallization seeds were probably reduced 
with the increase in amorphous content and the onset for de-vitrification was delayed with 
each milling time and the adsorbed moisture has played a little role in de-vitrification onset. 
4.3.5 Dielectric Relaxation Processes in Un-milled Sugars 
The 3D dielectric loss spectra of un-milled samples of both lactose and sucrose are almost 
flat in the low temperature window (Figure 4.4a & b) indicating the absence of any low 
temperature process, however, in lactose there is a small process in this region as shown by 
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the dotted circle in Figure 4.4a. In the higher temperature window there is a large process in 
both sugars (shown by the arrow heads in Figure 4.4a & b), probably representing the 
percolation of protonic charges through the water present on the hard crystalline surface of 
these un-milled sugars. This is followed by dc conductivity in both sugars as the temperature 
is increased further again indicated by the arrow heads in Figure 4.4a & b. 
 
  
a b 
Figure 4.4: 3D dielectric loss spectra of a) un-milled anhydrous lactose and b) sucrose, showing the plot of 
imaginary permittivity against temperature and frequency. The spectrum of lactose shows a low 
temperature process highlighted by dotted circle. 
The dielectric spectra of each lactose and sucrose are expressed in term of temperature and 
frequency slices (t-slices and f-slices, respectively) for their detailed analysis. 
The t-slices (plot of imaginary permittivity against temperature at specific frequencies) 
through the dielectric spectra of un-milled lactose (Figure 4.5a & b) show that the 
percolation process starts near -20 °C at low frequency (indicated by line ‘A’ in Figure 4.5a) 
and move gradually towards the higher temperatures, as the frequency increases.  
Un-milled lactose Un-milled Sucrose 
Percolation peak 
Conductivity wing 
ε″ ε″ 
ε″ 
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a b 
Figure 4.5: t-slices from the dielectric spectra of a) anhydrous lactose and b) sucrose, showing the plot of 
imaginary permittivity against temperature. The dotted line ‘A’ & ‘D’ indicates the start, ‘B’ & ‘E’ plateau of 
percolation and ‘C’ the start of conductivity. 
The magnitude of the process (as indicated by the plateau region- line ‘B’ in Figure 4.5a) also 
decreases with increasing frequency. The temperature at which the conductivity wing (line 
‘C’ in Figure 4.5a) appears also increases with frequency from 60 °C at low frequency and 85 
°C at high frequency (Figure 4.5a). 
The comparison of dielectric behaviour of both un-milled sugars show that, the onset of the 
percolation process of sucrose is similar to that of lactose (i.e. -20 °C, line ‘D’ in Figure 4.5b) 
however the plateau is shifted to higher temperatures (line ‘E’ in Figure 4.5b), suggesting a 
broader process. One of the noticeable differences is that the onset of the conductivity wing 
is only evident for the low frequency spectrum of sucrose and cannot be seen in the higher 
frequency spectra. Both observations suggest that the percolation pathways between the 
lactose particles are more connected than in sucrose, a likely consequence of the differences 
in particle size and the associated moisture content (TGA results Figure 4.2d & 4.3d) at the 
surface of the particles. In sucrose the particle size is 425 - 500 µm, whereas the particle size 
of lactose is < 100 µm.  
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a b 
  
c d 
Figure 4.6: f-slices from the dielectric spectra of, a & c) un-milled anhydrous lactose and b & d) sucrose, 
showing the plot of imaginary permittivity (a & b) or real permittivity (c & d) against frequency. The arrow 
heads show the increase in both components toward low frequencies. 
The f-slices of both sugars (Figure 4.6), show that both the imaginary and real components of 
dielectric permittivity continues to increase towards lower frequencies, indicating that the 
low frequency process (observed at high temperatures) is not simply a dc conductivity 
phenomenon but is instead associated with yet another process in the material, which were 
presume to be due to the percolation of charge within the particles of the solid, through 
possible electronic charge transfer. The fact that both lactose and sucrose are the small 
organic molecules having covalent bonds, the conduction through these involves the 
mobility of delocalized electrons linked with the conjugated covalent bonds on applying the 
electric field. The conduction through these molecules occurs by tunnelling (as illustrated in 
Figure 4.7) rather than by propagation due to the formation of conductive pathway and this 
conduction is therefore sensitive to the relative orientation of the rings and the bonding 
between them (Samanta et al., 1996). 
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Figure 4.7: An illustration showing the (supposed) conduction through the solid particles. 
4.3.6 Dielectric Relaxation Processes in Milled Sugars  
In contrast to the un-milled sugars, the dielectric spectra for the milled samples (60 min 
milled) of these sugars display two secondary relaxation processes in the low temperature 
window (< 0 °C) represented as relaxation process 1 (RP1) and relaxation process 2 (RP2) by 
arrows on Figure 4.8 a & b respectively. In the high temperature window (> 0 °C), there are 
two processes in case of sucrose, RP3 which appears as a shoulder in the narrow 
temperature range followed by huge and sharp spike (RP4), while in case of lactose these a 
single process represented as RP3/4. 
  
a b 
Figure 4.8: 3D dielectric spectra showing the plot of imaginary permittivity against temperature and 
frequency of a) 60min milled anhydrous lactose and b) 60 min milled sucrose. Both plots show four 
relaxation processes (RP) as highlighted by arrow heads. RP1 and RP2 are well separated in both milled 
sugars, RP3 and RP4 are also well separated in case of milled sucrose but appear as a merged single huge 
wing in case of milled lactose. 
The low temperature processes (RP1 and RP2) of both milled sugars are secondary 
relaxations;  and β processes, respectively, which are typical of the amorphous phase 
(Kaminski et al., 2011). These are discussed in more detail in the later section of this chapter 
(Section 4.3.7). 
RP1 RP1 
RP 4 
RP2 
RP3 RP3/4 
RP2 
ε″ ε″ 
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Note: The 3D dielectric loss spectra of different samples (un-milled to 60min milled) of 
anhydrous lactose and sucrose have been given in Appendix VIII and Appendix IX 
respectively. 
4.3.6.1 High Temperature Processes in Dielectric Spectra of Milled Sugars 
The high temperature processes (RP3 and RP4) represent the structural relaxation (visible as 
a shoulder in a narrow temperature range) and the dielectric loss/conductivity (occur as 
sharp spikes in dielectric loss), respectively in the milled sucrose (Figure 4.9). The likely 
explanation for the spike is that, the material has passed through the glass transition (i.e. the 
structural relaxation phase) and now with enhanced mobility in the system, there is an 
opportunity for de-vitrification and/or collapse (liquefaction) in sucrose. Given that we 
observed the material at the end of the measurement cycle and that it appears, to all intents 
and purposes, as a structurally ‘intact’ matrix then we presume this conductivity spike is 
more than likely to be associated with de-vitrification (rather than collapse; a process which 
is observed in case of hydrated sugar, Section 3.3.2.2). In contrast, the single high 
temperature process of lactose, which appears as a large wing towards low frequency, as 
opposed to the two separate processes for sucrose, probably represents a merged structural 
relaxation and conductivity as already reported in case of freeze dried lactose (Ermolina and 
Smith, 2011). 
The characteristics of high temperature wing in dielectric spectra of milled sugars are more 
easily recognized and possibly understood by analysing the temperature slices at specific 
frequencies (Figure 4.9). 
The t-slices of milled lactose, at low frequency (0.1Hz) show that the structural relaxation 
(not distinguishable from conductivity and appear as a merged process- Figure 4.9a) starts at 
almost the same temperature as the percolation in case of un-milled lactose i.e. at -20 °C 
(indicated as line ‘A’ in Figure 4.9a) and shift towards higher temperature in high frequency 
windows (Figure 4.9c & e). The height of structural relaxation (as indicated by plateau) also 
decreases with increasing the frequency followed by the appearance of conductivity towards 
high temperatures (line ‘B’ in Figure 4.9a). 
Provided that the relative strength of this high temperature wing in milled lactose is almost 
100 times the strength of secondary relaxation processes (Figure 4.9a) which is contrary to 
107 
 
 
the observations of Kaminski, that the fully amorphous sugar has similar strength of 
structural and secondary relaxation processes (Kaminski et al., 2008a).  
  
a b 
  
c d 
  
e f 
Figure 4.9: Temperature slices (plots of imaginary permittivity against temperature) at 0.1 Hz, 10 Hz and 1K 
Hz frequencies from dielectric spectra of milled anhydrous lactose (left column) and milled sucrose (right 
column). The four processes have been labelled as , β, structural relaxation and conductivity. The vertical 
dotted lines indicated the peaks of both  & β processes of all milled samples processes lie on the same 
position but shift towards higher temperature by increasing frequency as indicated by the horizontal arrow 
heads. The inset in Figure ‘d’ indicates the change in height of  and β processes with milling time in sucrose. 
The downward arrow heads indicate the disappearance of structural relaxation signals in sucrose. 
This implies that the higher temperature wing in milled lactose cannot be the only structural 
relaxation of amorphous phase but also it has certain contribution from the percolation 
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since the milled samples contain particles with hard crystalline surface. The decrease in the 
strength of this process after an initial increase represents the decrease in percolation 
component as the hard crystalline surfaces recede with milling time. 
The height of this process is higher in short milled sample (10 min milled), then decreases 
gradually till 45 min and increase again in 60 min milled sample (Figure 4.9a). The probable 
reasons for this change include; in early few minutes of milling as the particle size gets 
smaller the size of dipole decreases, percolation path length decreases and dipole strength 
increases. On further milling, as the amorphous content increases the hard crystalline 
surfaces decrease so the height of this process. Although the amorphous content does not 
increase after 30 min (as indicated by DSC and THz results in Chapter 3, Section 3.4.2), the 60 
min milled sample is more conductive because of the aggregation of particles in such long 
milled samples (evidenced by SEM and BET results in Chapter 2, Section 2.3.2 and 2.3.3, 
respectively). 
The point where the high temperature wing takes the plateau of dielectric signals in low 
frequency window (i.e. 0.1 Hz) occurs at high temperature in the short milled samples and at 
the lower temperature in long milled samples (as indicated by dotted line ‘A’ in Figure 4.9a); 
probably represents de-vitrification. In short in milled lactose, as the amorphous content is 
low, de-vitrification is small and it occurs at higher temperature while in long milled samples 
where there is a high proportion of amorphous content the plateau in dielectric signals 
occurs even at relatively lower temperature. It is also worth to note that, this event occurs 
between 30 °C to 80 °C which is close to the de-vitrification peak temperature in DSC (50 to 
90 °C, Figure 4.2b). The small differences in de-vitrification temperature from both 
techniques might be due to i) the variation in the rate of heating and ii) different geometry 
of samples in both techniques (Megarry et al., 2014). 
Unlike lactose where it is masked under conductivity, the structural relaxation in milled 
sucrose (0.1 Hz frequency window) is observed as a shoulder in all milled samples in the 
temperature range of -10 °C to 45 °C (Figure 4.9b). In the intermediate frequency window 
(10 Hz), the range of structural relaxation signals narrows down and its strength drops in 
longer milled samples (i.e. ≥ 30 min milled) (Figure 4.9d). While at higher frequency window 
(1 KHz) the structural relaxation disappears in all milled samples ≤ 45 min (Figure 4.9f), and 
appears again in 60 min milled sample (these changes have been indicated by downward 
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arrows in Figure 4.9 d & f). This is followed by the appearance of huge and sharp peaks that 
start at ~50 °C and shift towards higher temperature with milling time.(Figure 4.9b) These 
spikes occur between 50 °C to 70 °C and represent the onset for de-vitrification with 
temperature very much similar to that observed in DSC results (see Figure 4.3b). 
4.3.6.2 Low Temperature Processes in Dielectric Spectra of Milled Sugars 
The gamma and beta processes are now discussed in term of temperature and frequency 
slices of dielectric spectra in order to provide in depth commentary on the dynamics of the 
amorphous phases produced by milling. 
The t-slices from low temperature window (< 0 °C) of milled lactose for various time 
intervals at three different frequencies 0.1 Hz, 10 Hz and 1 KHz (Figure 4.9 a, c & e 
respectively) show that the  and β relaxation processes shift toward higher temperatures as 
the frequency increases (indicated by arrow heads in Figure 4.9e). 
The t-slices of milled sucrose at same frequency windows again show two ( and β) 
relaxation processes (Figure 4.9 b, d & f) in low and intermediate frequency windows. These 
processes move toward higher temperature in high frequency windows (Figure 4.9 b & d) 
similar to the anhydrous lactose. However, in high frequency window (1 KHz) there is only 
one broad process instead of two typical low temperature processes in samples milled for 10 
min to 45 min milled; thereafter again two processes are observed in 60 min milled sample 
(Figure 4.9f) which are again shifted towards lower temperature. 
Across the experimental frequency range highlighted in the temperature slices of Figure 4.9 
(i.e. 0.1 to 1 KHz) the temperature range for the peak of the -process, for milled lactose, lies 
in the range -110 °C to -60 °C while the β process extends from -50 °C to +20 °C. For the 
sucrose the peak of the -process lies in the range -110 °C to -40 °C while the β process 
extends from -35 °C to -10 °C. The higher the temperature of each process the less mobile 
one might consider the matrix, it follows that the molecular dynamics in the amorphous 
phase of lactose are less restricted than in sucrose. This observation is explored further 
when the frequency slices are analysed using Arrhenius plots (Figure 4.14). 
The f-slices from the dielectric spectra 60 min milled samples of both lactose and sucrose at 
from -100 °C to +100 °C (with increment of 20 °C) are shown in lower (< 0 °C) and higher (> 0 
°C) temperature windows in (as shown by arrow heads in Figure 4.10a-d). There is only a 
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single broad process (gamma) towards lower temperature (in the experimental window), the 
height of this process increases and it narrows down along with shifting towards the higher 
frequencies as going towards higher temperature (Figure 4.10a & b). The second process 
(beta) appears at ~-75 °C as a small process and is more prominent near -20 °C, therefore the 
f-slices are taken at -20 °C to show both gamma and beta processes in different time milled 
samples of the both sugars. 
In higher temperature window, the beta process which is only present in temperature range 
≤ 50 °C continues shifting towards higher frequencies where it is followed by the huge 
conductivity wings that shifts towards lower frequencies as the temperature increases (as 
shown by the arrow heads in Figure 4.10c & d). 
  
a b 
  
c d 
Figure 4.10: The frequency slices (plots of imaginary permittivity against frequency) at low (a & b) and high (c 
& d) temperatures from dielectric spectra of 60 min milled anhydrous lactose (left column) and 60 min milled 
sucrose (right column). The shift of relaxation processes with frequency is shown by arrow heads. 
The f-slices of the both milled sugars at different milling times at -20 °C have indicated that 
the position of both secondary relaxations does not move with milling time and these occur 
at same frequency in all milled samples (as indicated by lines ‘A’ and ‘B’ in Figure 4.11 a and 
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line ‘C’ and ‘D in Figure 4.11b). The -relaxation process of milled lactose shows a peak at 
relatively higher frequency i.e. ~10e5 Hz than milled sucrose that occurs between 10e2 and 
10e3 Hz. On the other hand the β-relaxation process occurs at relatively lower frequency i.e. 
between 100 and 101 Hz for milled lactose and at ~10e0 Hz for milled sucrose. The height of 
these processes is assessed for both sugars at different milling times. 
  
a b 
Figure 4.11: Frequency slices of different milled samples of a) lactose and b) sucrose showing β and  
processes from lower to higher frequencies respectively. The vertical dotted lines indicate the peak point for 
each process. The arrow head in Figure b show the shift of process towards higher frequencies. 
The amplitude of secondary relaxation processes for each of lactose and sucrose were 
estimated in term of imaginary permittivity (ε″) and plotted against the milling time (Figure 
4.12). The results for lactose show that the amplitude of both gamma and beta processes 
increases with milling time until 15 min afterward there is a only a slow increase/plateau in 
30 and 45 min and increase again in 60 min milled sample (Figure 4.12a). In case of sucrose 
the peak heights increase with milling time until 30 min, thereafter almost plateau is 
achieved in 45 and 60 min milled sample (Figure 4.12b). 
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a b 
Figure 4.12: The plot of imaginary permittivity of secondary relaxation (gamma and beta processes) against 
milling time for a) milled anhydrous lactose b) milled sucrose.  
The magnitude of gamma process of milled lactose is slightly higher than the milled sucrose 
contrary to beta process, which is higher in case of sucrose. 
  
a b 
  
c d 
Figure 4.13: Plots of permittivity loss against log frequency showing fit results for 60min milled lactose (a-b) 
and 60min sucrose (c-d). The figures in left column show -process and while the β-process in right column. 
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In order to determine the specific parameters representing the dynamics of amorphous 
phase of these milled sugars, both  and β-processes were fitted applying the Haviliak-
Negami function (Equation 4.1). Some examples of the fitting have been shown in Figure 
4.13 a-d. 
ε∗(ω) =  ε∞ +  
εs− ε∞
[1+ (iωτm)α]β
   Equation 4.1 
The plot of relaxation time against the reciprocal of temperature for both  and β-processes 
of milled lactose and sucrose has indicated that the temperature dependence in term of 
linear Arrhenius behaviour (Figure 4.14). The gradients of these plots for -process do not 
change on milling (Figure 4.14a & b), however these change for β-process (Figure 4.14c & d). 
This indicated that the β-process is more influenced by the milling of these sugars than the -
process. In order to investigate it further two parameters; activation energy (Ea) and 
relaxation time (tau/τ) are obtained for these processes. 
  
a b 
  
c d 
Figure 4.14: The plots of relaxation time against inverse of temperature (Arrhenius plots) for different milled 
samples of lactose and sucrose. Figure a & b) show the plots of gamma process while c & d show the beta 
process of both milled sugars respectively. 
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The activation energies of both  and β-processes are calculated from the gradient of these 
plots, by applying Arrhenius relation (Equation 4.2), while the ‘τ‘ is obtained from the fit 
results/peak frequency at -60 °C and -20 °C for the  and β-processes, respectively. The 
results for both are summarized in Table 4.3. 
𝐊 = 𝐀𝐞
−𝐄𝐚
𝐑𝐓⁄    Equation 4.2 
where ‘Ea’ represents the activation energy, ‘T’ is temperature in kelvin and ‘R’ is universal 
gas constant. The values of activation energy of -process of all milled lactose samples are 
~44 KJ mol-1, which is very close to the values reported for this process in freeze dried 
lactose (Ermolina and Smith, 2011). For milled samples of sucrose the activation energy is 
~50 KJ mol-1 which is in agreement with that in amorphous sucrose (Kaminski et al., 2008a). 
The activation energies of β-relaxation process of milled lactose samples  i.e. ~ 72 KJ mol-1 
are in agreement with that is freeze dried lactose and that of milled sucrose sample ~ 82 KJ 
mol-1 in agreement with that of amorphous sucrose, therefore the β-process is true Johari 
Goldstein process. Also, it is of worth to note that the activation energies for both secondary 
relaxations in milled sucrose are higher than that in the milled lactose (Table 4.3) which 
potentially indicates the higher stability or rigidity of sucrose as compared to lactose. 
Table 4.3: The values of activation energies as calculated for the milled lactose and sucrose. (Ea= energy of 
activation in KJ mol
-1
). 
milling 
time(min) 
Anhydrous lactose Sucrose 
 
Gamma process  
Ea ( KJmol
-1
) 
Beta process 
 Ea ( KJmol
-1
) 
Gamma process  
Ea ( KJmol
-1
) 
Beta process 
 Ea ( KJmol
-1
) 
15 44 ± 1.6 71 ± 3.8 51 ± 0.5 84 ± 8.4 
30 43 ± 1.1 71 ± 5.9 50 ± 0.5 83 ± 4.8 
45 43 ± 1.2 72 ± 5.7 50 ± 0.5 82 ± 7.0 
60 44 ± 1.0 79 ± 5.9 52 ± 0.7 79 ± 7.6 
4.4 Discussion 
The molecular dynamics of the amorphous phase in both milled lactose and sucrose were 
described in term of secondary relaxation processes. Among the two secondary relaxation 
processes; -process in sugars originates from the movement of pendant groups on the 
surface of the molecule (Ermolina and Smith, 2011). In the milled anhydrous lactose this 
process occurs at a relatively higher frequency and its amplitude is larger than that in the 
milled sucrose, which may indicate that the pendant groups of lactose are more hindered as 
compared to those of sucrose. 
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The amplitudes of this process increase with milling time up to 30 min in both sugars and till 
60 min milling in lactose only. This increase is greater in milled lactose than that in the milled 
sucrose. This indicates relatively higher mobility in milled lactose as compared to the milled 
sucrose. Although the -relaxation represents a local scale movement but its change with 
milling time indicates an increase in the fluidity of the molecules due to the crystal damage 
that facilitates the movement of pendant groups. However on longer milling (45 and 60 
min), the amplitude does not increase further that probably because of the lower moisture 
in long milled samples (TGA results, Figure 4.2d & 4.3d) that decreases the overall fluidity.  
The β-process shows somewhat more facilitative intramolecular movements with the scale 
length larger than that of the -relaxation. In the small molecules of disaccharides it involves 
the bending/twisting of the two constituent mono-saccharides around the glycosidic linkage 
(Ermolina and Smith, 2011). It is shows somewhat cooperativity therefore can be considered 
as the precursor of structural relaxation (Ngai and Capaccioli, 2004) . The β-process for both 
milled sugars occur at almost the same frequency, however the amplitude for sucrose is 
larger in short milled samples than for lactose which is affected more by milling (in the 
framework of experimental error), whereas both have almost the same amplitude at 60 min 
milling. This represents relatively more freedom/flexibility in lactose molecule and the 
higher rigidity of the sucrose as already stated (Kaminski et al., 2008a). The larger amplitude 
of lactose or its variation with milling is probably due to the fact that it absorbs more 
moisture than milled sucrose. 
The conformation of activation energies of both milled sugars with that from freeze dried 
and super cooled sugars represents that amorphous phase is almost the same regardless of 
processing methods. As the activation energy of sucrose is decreasing with milling time, it is 
counterintuitive to the results from DSC that the crystallization is delayed with milling time 
as the amorphous content increases particular. Therefore, Ea alone cannot be primitive 
factor in defining the stability of milled sucrose. 
4.5 Conclusion 
In this study we have presented the dynamics of amorphous phase produced by ball milling 
the two common sugars; lactose and sucrose. The molecular dynamics in terms of ‘’ and 
Johari-Goldstein β process at various milling time and de-vitrification kinetics indicate that 
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the lactose is more mobile and it has more propensities for de-vitrification than sucrose after 
milling. The study also indicates that both the gamma and beta processes are not affected by 
milling time, although the height increases with amount of amorphous phase but within 
each phase, the dynamics of amorphous phase remains unaffected by milling time. Also the 
moisture is found to play a key role in the onset for de-vitrification in milled lactose. 
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5 Study of Milling and Co-milling: Techniques for the Improvement 
of Solubility and Dissolution Rate of Poorly Soluble Drug – 
Ibuprofen 
5.1 Background/Context 
Milling and co-milling are well known techniques that have a positive influence on solubility 
and dissolution rate of sparingly soluble drugs (Jagadish et al., 2010, Bahl and Bogner, 2008). 
Co-milling is defined as milling in the presence of an excipient. It has been shown to be a 
simple, efficient and economical process that does not require any sophisticated 
instruments. It is also environment friendly as it does not involve the use of any organic 
solvent (Friedrich et al., 2005). A further detail of this phenomenon is given in Chapter 1, 
Section 1.6. 
Ibuprofen is one of the propionic acid derivatives that provide analgesia through the 
inhibition of the enzyme cyclooxygenase (COX). It is widely used in the treatment of 
rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and acute gouty arthritis (Brunton 
et al., 2006). Ibuprofen is practically insoluble in water or acidic medium (Saleh et al., 2008), 
resulting in poor bioavailability when administered as a conventional dosage form. 
The issue of poor solubility of ibuprofen has been addressed in the literature by applying 
different approaches e.g. milling (Plakkot et al., 2011), preparation of solid dispersions with 
PEG (Hasnain and Nayak, 2012) or poloxamer (Newa et al., 2008, Passerini et al., 2002), 
complexion with β-cyclodextrin (Chowdary and Susmitha, 2012, Salústio et al., 2011) and co-
milling (Mallick et al., 2008b, Mallick et al., 2008a, Han et al., 2011). 
In the majority of these studies, size reduction or dispersion of the drug in an amorphous 
matrix were the underlying mechanisms for the improvement of solubility and dissolution 
rate. It was noted that there was only a little improvement in dissolution rate with particle 
size reduction from milling ibuprofen alone. However, milling in the presence of inorganic 
salts (Kaolin, aluminium hydroxide) or hydrophilic substance (PVP) resulted in the 
amorphization, chemical interaction, de-aggregation and improved wettability of the drug, 
which in turn resulted in higher dissolution rates. 
Among the excipients used in co-milling with ibuprofen, neither would be expected to 
solubilise the drug. To that end, the recent work with soluplus (Thakral et al., 2012), on the 
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solubility enhancement by the way of hot melt extrusion, solid dispersion, electro-spinning, 
solvent evaporation, spray drying and freeze drying  (Shamma and Basha, 2013, Nagy et al., 
2012) has suggested that this excipient may be used to advantage when co-milled with 
drugs. In addition, there are many other potential candidate excipients which have not been 
investigated to date for their potential in enhancing the solubility and dissolution rate of 
ibuprofen. Nevertheless, these including HPMC, PVP, MCC and lactose are the widely used 
excipients for their hydrophilic and wettability enhancing properties (Garg et al., 2009, Vogt 
et al., 2008c, Vogt et al., 2008b). 
The objectives of this study are the potential enhancement of the solubility and dissolution 
rate of a poorly soluble drug, ibuprofen by co-milling (this will include the development of a 
UV-spectroscopic method for the determination of ibuprofen in unknown samples in the 
presence of interfering excipient) and to characterise the co-milled mixtures for changes in 
particle size, morphology, physicochemical interactions and the changes in 
crystallinity/amorphicity. 
The initial part of the work involving the solubility study was carried out in two phases; in the 
first phase; the excipient type and processing conditions (including the speed and time of 
milling) were selected on the basis of best outcomes in term of processing properties (like 
flowability) and solubility of the drug in water. In the second phase the selected parameters 
were applied to prepare co-milled mixtures and to determine their effect on solubility and 
dissolution rate (in phosphate buffer pH 7.4). In the last part of this study, the co-milled 
mixtures based on these selected excipients were characterized by various analytical 
techniques to establish the mechanism of solubility and dissolution rate enhancement. 
5.2 Materials and Methods 
Ibuprofen (Zafa Chemie, Lahore Pakistan), was obtained from Unexo lab, Lahore Pakistan. 
Soluplus® (a graft co-polymer of PEG) and Lutrol® F-68 (or Poloxamer is a block co-polymer 
non-ionic surfactant consisting of Poly-oxyethylene-(POE-) and Polyoxypropylene-(POP-) 
units) were obtained from BASF, UK. Polyvinyl pyrrolidone (PVP K30) (Jiaozou Fine Chemical, 
China), hydroxy-propylmethyl cellulose (HPMC-E5) (Ashland, US), micro-crystalline cellulose 
(MCC, avicel Ph-101) (Accent Microcell Pvt. Ltd. India), and PEG-6000 were obtained from 
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CCL Pharmaceuticals Pvt Ltd, Lahore Pakistan. All excipients were of pharmaceutical grade 
and were used as received from the suppliers. 
5.2.1 Co-milling of Ibuprofen with Different Excipients 
Ibuprofen was co-milled with different excipients: (Soluplus, HPMC, Lutrol, PVP, MCC, 
lactose and PEG-600 in screening phase while the first two in extended phase) in the 
vibratory ball mill according to the method described in Section 2.2.1. The mill was operated 
at frequency of 15 Hz for 15 min (this low speed was selected for ibuprofen and its mixtures 
to avoid the melting of this drug). The sample was collected into a glass vial and immediately 
used for solubility determination or stored in desiccator until used for the further analysis. 
Note: Based on the highest solubility of ibuprofen in their co-milled mixtures (see results in 
Figure 5.7); soluplus and HMPC were selected for the next phase of this study. In this phase, 
different drug to excipient ratios (i.e. 1:0.25, 1:0.5, 1:0.75 and 1:1) of selected excipients 
were used in order to determine the effect of excipient concentration. The physical and 
milled physical mixtures (abbreviated as PM and mPM, respectively) of Ibuprofen with these 
excipients were also prepared for the purpose of comparison with co-milled mixtures. The 
PM was prepared by simple mixing the both components with spatula in a weighing boat 
(Barzegar-Jalali et al., 2010) and  the milled physical mixtures were prepared by milling the 
ibuprofen and excipients separately in ball mill then mixing these in 1:1 ratio. 
5.2.2 Solubility Studies 
Shake flask method (Nandi et al., 2003) was used to determine the solubility of ibuprofen in 
distilled water and phosphate buffer pH 7.4. Excess quantity of ibuprofen or its co-milled 
mixtures (equivalent to 200 mg ibuprofen) with each of the excipients was added to a 100 ml 
conical flask containing 50 ml of the solvent. The flasks were capped and shaken at 100 rpm 
on a multi-flask shaker (Heidolph Unimax 2010, Germany) at room temperature (~25 °C). 
The samples were collected after 6, 12, 24 and 48 hours, filtered through 0.45 µm syringe 
filters (Millipore, US) and diluted adequately. The concentration of ibuprofen was 
determined by the UV spectrophotometry. 
Note: The standard solutions of known concentrations of ibuprofen in distilled water and 
phosphate buffer pH 7.4 were prepared and the calibration curves were constructed. These 
curves in adherence to Beer-Lambert law (i.e. A < 1) were linear in the range of 0.005 to 0.08 
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mg ml-1 in distilled water (Figure 5.1a) and 0.05 to 0.45 mg ml-1 in phosphate buffer (Figure 
5.1b) with value of correlation coefficient near unity and value of intercept on the ordinate, 
near to zero. 
  
a b 
Figure 5.1: Calibration of ibuprofen as prepared in distilled water (a) and phosphate buffer pH 7.4. 
5.2.3 Dissolution Studies 
Ibuprofen and its co-milled mixture with different excipients, equivalent to 200 mg 
ibuprofen, were filled in colourless hard gelatine capsule shells and subjected to dissolution 
studies in USP type-I (paddle) apparatus (DT-700, Erweka Germany). The phosphate buffer 
pH 7.4 was selected as the dissolution medium. The temperature of the medium was 
maintained at 37  0.4 °C with a paddle rotating speed of 50 rpm. Aliquots of 5 ml were 
withdrawn at intervals of 5, 10, 20, 30, 45, 60 and 90 min and replaced with the equal 
volume of the fresh dissolution medium. Each sample was filtered through a syringe filter 
(0.45 µm) and then diluted adequately (i.e. Amax < 1) for assay by the UV spectrophotometry. 
The release of ibuprofen from physical and co-milled mixtures was also expressed in term of 
dissolution parameters (calculated from the dissolution profile) including Q30 min (mean 
percentage of drug dissolved in the first 30 min), dissolution efficiency (area under the 
dissolution-time curve up to time ‘t’) and the mean dissolution time (average time for the 
drug dissolution). 
5.2.4 Determination of the Intrinsic Dissolution Rate (IDR) 
Sample preparation: The weighed quantity of ibuprofen or its co-milled mixtures were 
pressed into 13 mm circular compacts by hydraulic press (Perkin Elmer, US), at the pressure 
y = 1.7083x + 0.0237 
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of ~10 kPa. These compacts were weighed and placed in the centre of a cylindrical plastic die 
placed on glass sheet. The molten hard paraffin wax (temperature near 40 °C) was poured in 
the plastic die to cover the sample compacts completely (Figure 5.2a). These dies were 
cooled to avoid the overheating of ibuprofen and allowed to solidify. After solidification, the 
waxed compacts were removed from dies and cut to size of dissolution basket by sharply 
edged metal pipe. The compacts now have one surface available for exposure to the 
dissolution medium (Figure 5.2b). These plugs were inserted in baskets of dissolution 
apparatus facing downward. 
  
a b 
Figure 5.2: a) Formation of wax plugs around the compacts in the plastic moulds b) tablet embedded in wax 
plug. 
Dissolution study was carried out in phosphate buffer (pH 7.4) using a USP type II (basket) 
apparatus, applying the method as described in Section 5.2.3. 
5.2.5 Laser Diffraction for Particle Size Determination 
Particle size distribution (PSD) of un-milled Ibuprofen and its co-milled mixtures was 
determined with dry dispersion laser diffraction technique according to the method already 
described in Section 2.2.2. 
5.2.6 Scanning Electron Microscopy (SEM) 
The un-milled, milled and co-milled Ibuprofen samples were photographed according to the 
method described in Section 2.2.3. 
5.2.7 Differential Scanning Calorimetry (DSC) 
DSC experiments of un-milled ibuprofen and its co-milled mixtures with different excipients 
were performed according to method described in Section 3.2.3. The sample was analysed 
over the temperature range of 25 to 150 °C at a heat flow rate of 20 °C min-1. 
In order to compare results of milled ibuprofen with that of a 100% amorphous sample, the 
ibuprofen contained in non-hermetically sealed DSC pan was vitrified by heating in an oven 
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at 90 °C for 10 min then quenched by dipping it in the liquid nitrogen. This pan was loaded in 
a pre-cooled DSC furnace and heated from -60 °C to 110 °C at the rate of 10 °C min-1. 
5.2.8 Attenuated Total Reflectance (ATR) Spectroscopy  
The IR spectra of un-milled, milled and co-milled ibuprofen were recorded in Bruker Alpha –
FTIR Spectrophotometer (Bruker, Japan) fitted with a Smart Performer, platinum ATR 
accessory, according to the method described in (Singh et al., 2009). The data were analyzed 
by Alpha Opus Software. The instrument was configured with ATR sample cell containing a 
diamond crystal with scanning depth of 2 µm. Sample powder was placed on the surface of 
crystal and secured in place with clutch type lever. Each sample was scanned for 20 times 
against air between 4000 - 400 cm-1 at the resolution of 2 cm-1. 
5.2.9 Powder- X-ray Diffraction (PXRD) 
The samples for PXRD were mounted on the zero background silicon wafers and the 
measurements performed on a Bruker D4 diffractometer according to the method as 
described by (Dong et al., 2008) using Cu Kα radiation, and λ = 1.5418 A° . The samples were 
spun to improve the counting statistics. Each sample was exposed to X-rays for 0.12 seconds 
per 0.02° of 2θ increment (continuous scan mode) over the range 2° to 40° in theta-theta 
mode. 
5.2.10 Terahertz Pulsed Spectroscopy (TPS) 
THz measurements of un-milled and co-milled materials were carried out according to the 
method already described in Section 3.2.4. The pellets of polyethylene powder contained 
the co-milled mixture equivalent to 10% w/w of the ibuprofen. 
5.3 Results and Discussion 
5.3.1 Solubility of Un-milled and Milled Ibuprofen  
The solubility of un-milled ibuprofen in distilled water at room temperature (~25 °C) was 
~0.09 mg ml-1 (n=3). Unsurprisingly, milled Ibuprofen was found to have almost the same 
solubility. These values were comparable or slightly higher than the reported solubility 
values of Ibuprofen from the literature (viz. 0.056  0.004 (Kocbek et al., 2006), 0.09 mg ml-1 
(Milhem et al., 2000) and 0.081 mg ml-1 (Wikarsa et al., 2008). 
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5.3.2 UV Spectra of Ibuprofen and Excipients 
A 0.05% w/v solutions of the un-milled and milled ibuprofen in pH 7.4 phosphate buffer 
showed a well-defined, large peak at 221 nm (can be seen in the diluted samples) and two 
other peaks; one at 264 nm and second at 273 nm and a shoulder at 258 nm (Figure 5.3a). 
The overlaid spectra of solutions (0.05% w/v) of ibuprofen and four major excipients used in 
this study (Figure 5.3b) have shown that, 0.05% w/v Lutrol and 0.05% w/v HPMC in 
phosphate buffer have negligible absorbance over the entire UV range. In contrast, 0.05% 
w/v PVP and 0.05% w/v soluplus in phosphate buffer exhibit a high absorbance, with the 
former only at wavelengths below 230 nm while the later over the entire range of 
wavelengths (210 – 330 nm) (see Figure 5.3b). 
  
a b 
Figure 5.3: UV spectra of a) un-milled ibuprofen in  alkaline medium showing two peaks and a shoulder b) 
Overlaid UV spectra of 0.05% w/v solutions of ibuprofen and the excipients, Soluplus , PVP, HPMC, and 
Lutrol in phosphate buffer (pH 7.4). 
5.3.3 Selection of UV Absorbance Peak for the Ibuprofen Assay 
The fact that solutions of soluplus and PVP, in pH 7.4 phosphate buffer, exhibit large 
absorbance below 230 nm, precluded the use of the absorbance peak of ibuprofen at 221 
nm in the development of the UV-assay for these two excipients. For consistency this was 
also not used for the other excipients. In order to select the analytical wavelength, the 
absorbance of ibuprofen was determined at 258, 264 and 272.4 nm (Table 5.1a). The results 
indicated that Lutrol, HPMC and PVP have only 1-2% of the absorbance at the three 
potential analytical wavelengths for ibuprofen. Therefore, the wavelength of maximum 
absorbance (max) i.e. 264 nm, was selected for the assay of ibuprofen in the presence these 
0.0
0.5
1.0
1.5
220 245 270 295 320
A
b
so
rb
an
ce
 (a
.u
) 
Wavelength (nm) 
 Ibuprofen (0.05%) in alkaline medium 
264 
-0.1
0.1
0.3
0.5
0.7
0.9
1.1
1.3
210 230 250 270 290 310 330
A
b
so
rb
an
ce
 (a
.u
) 
Wavelength (nm) 
Ibuprofen
Soluplus
PVP
HPMC
Lutrol
Buffer
273 258 
124 
 
 
excipients. On the other hand, the UV spectrum soluplus solution has shown a significant 
absorbance over the entire wavelength range, which increases towards lower wavelengths 
(Figure 5.3b). This spectrum, when overlaid on the spectrum of same concentration of 
Ibuprofen it shows higher absorbance than ibuprofen solution towards higher wavelength 
(~285 nm), the point where the absorbance of ibuprofen start increasing which now 
obviously higher than the soluplus solution absorbance towards lower wavelengths. 
Therefore, two wavelengths were selected for the estimation of ibuprofen in the presence of 
soluplus; first 264 nm which is the max of ibuprofen and has the highest ratio of absorbance 
with soluplus among the three potential wavelengths (Table 5.1b), second, 287 nm which is 
the max for soluplus as the absorbance of soluplus to ibuprofen is maximum. 
Table 5.1: a) Relative absorbance of the excipients as compared to the absorbance of Ibuprofen at three 
potential wavelengths of ibuprofen b) ratio of absorbance of ibuprofen and soluplus at three potential 
wavelengths of ibuprofen. 
a) 
 
Relative absorbance (%) of 
excipients at three wavelengths  
of ibuprofen 
 
258 nm 264 nm 272.4 nm 
HPMC 1.4 1.1 1.2 
Lutrol 0.4 0.3 0.4 
PVP 2.1 1.5 1.5 
b) 
Ratio of absorbance of ibuprofen and soluplus  
258nm 264nm 272.4nm 
2.8 3.9 3.6 
5.3.4 Correction of the Interference (UV Absorbance) of Soluplus in the Quantitative 
Determination of Ibuprofen in the Mixture 
5.3.4.1 Two Wavelength Assay 
The two wavelength assay approach which is described as absorbance ratio method (Erk, 
2000) or simultaneous equation method (Patil et al., 2009, Nallasivan et al., 2010) in 
literature with slight modifications but generally involves the measurement of the 
absorbance of both drug and the interfering excipient (i.e. ibuprofen and soluplus in our 
case) at two different wavelengths; 1 and 2 (as described in Section 5.3.3). The calibration 
curves are constructed by plotting these absorbance values against concentrations of both 
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single component solutions of ibuprofen x(d) and soluplus x(e) respectively. From this 
calibration curve, the absorption of both drug and excipient at two wavelengths can be 
described by the following relation (Equations 5.1 to 5.4). 
𝐀(𝐝, 𝛌𝟏) = 𝐦(𝐝, 𝛌𝟏) . 𝐱 (𝐝)   Equation 5.1 
𝐀(𝐞, 𝛌𝟏) = 𝐦(𝐞, 𝛌𝟏) . 𝐱 (𝐞)   Equation 5.2 
Similarly at 2 
𝑨(𝒅, 𝝀𝟐) = 𝒎(𝒅, 𝝀𝟐) . 𝒙 (𝒅)   Equation 5.3 
𝑨(𝒆, 𝝀𝟐) = 𝒎(𝒆, 𝝀𝟐) . 𝒙 (𝒆)   Equation 5.4 
Where m(d, λ1), m(b, λ1) are the slope of curve drawn for the drug at 1 and 2; while, m(e, 
λ1), m(e, λ2) are the slope of excipient at 1 and 2 respectively. The total absorbance of the 
mixture of drug and excipient at both wavelengths is measured as A(T,λ1) and A(T,λ2) 
respectively. The individual contributions to the total absorbance at 1 and can be described 
by Equations 5.5 – 5.6. 
𝐀(𝐓, 𝛌𝟏) = 𝐀(𝐝, 𝛌𝟏) + 𝐀(𝐞, 𝟏)   Equation 5.5 
𝐀(𝐓, 𝛌𝟐) = 𝐀(𝐝, 𝛌𝟐) + 𝐀(𝐞, 𝟐)   Equation 5.6 
Now by substitution of the expressions for the individual absorbance of both components 
from equations 5.1 to 5.4 in Equations 5.5 and 5.6, gives the following expression for total 
absorption (Equation 5.7 and 5.8). 
𝐀(𝐓, 𝛌𝟏) = 𝐦(𝐞, 𝛌𝟏). 𝐱(𝐞) + 𝐦(𝐝, 𝟏). 𝐱(𝐝)   Equation 5.7 
𝐀(𝐓, 𝛌𝟐) = 𝐦(𝐞, 𝛌𝟐). 𝐱(𝐞) + 𝐦(𝐞, 𝟐). 𝐱(𝐝)   Equation 5.8 
The unknown concentration of drug x(d) in the mixture is determined by applying the 
following expression (Equation 5.9) obtained from re-arranging and substituting the above 
equations. 
𝐱(𝐝) = [
𝐀(𝐓,𝛌𝟐).  𝐦(𝐞,𝟏) −𝐀(𝐓,𝟏.𝐦(𝐞,𝟐)
𝐦(𝐝,𝛌𝟐).𝐦(𝐞,𝟏)−𝐦(𝐞,𝟐).𝐦(𝐝,𝟏)
 ]   Equation 5.9 
5.3.4.2 Multivariate Method  
While assaying the ibuprofen in the presence of soluplus by two wavelength method, it is 
realized that the UV spectrum of 1 to 1 mixture of solution of both ibuprofen and soluplus is 
expected to overlay exactly with the theoretical mixture (obtained by taking the sum of 
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individual spectra of both after division by two). However, the measured spectrum was 
higher than the theoretical one (Figure 5.4). This might be due to the light scattering effect 
of soluplus that has formed micelles in the solution. Therefore, the interference by the 
soluplus could not be corrected simply by two wavelength method. 
  
Figure 5.4: Overlaid UV spectra of 0.05% solution (in phosphate buffer pH 7.4) of both ibuprofen and soluplus 
and their 1 to 1 mixture. The theoretical spectrum is the mathematical sum of individual spectra of these 
components. 
The least-squares solution to calculate the concentrations from the mixture spectrum, using 
reference spectra of individual components may be given by the Equation 5.10. 
C = (S'S)
-1
S'y  Equation 5.10 
Where ‘C’ is the concentration factor, which represents the exact contribution of the 
individual components in the mixture of ibuprofen and soluplus and ‘y’ is the measured 
spectrum of the mixture of both components. For the application of this method, the 
reference spectra of both ibuprofen and soluplus after division by 2 (denoted by ‘s1’ and 
‘s2’) were collated into a single, two column matrix, called ‘S’ (Figure 5.5). 
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Figure 5.5: Screen shot from the excel spreadsheet showing the collation of individual spectra of ibuprofen 
and soluplus into single matrix ‘S’ as highlighted in blue columns. The inset shows the labelling of columns. 
The concentration factor is then calculated by applying the matrix multiplication function to 
the collated matrix ‘S’ (of individual spectra of ibuprofen and soluplus) and the spectrum of 
known mixture of both components as shown in Figure 5.6. 
 
Figure 5.6: The screen shot from the excel spreadsheet showing the calculation of concentration factor from 
the individual spectra of ibuprofen and soluplus and the spectrum of their mixture. 
The new spectrum is predicted from the matrix based on this concentration factor and 
overlaid on the measured spectrum (Figure 5.7a). It is noted that the spectrum predicted 
from this method did not exactly overlay the measured spectrum, however the same 
approach when applied to the derivatives of individual and measured spectra, both exactly 
overlaying (Figure 5.7b). Therefore the concentration factor ‘C’ from this predicted relation 
is used to calculate the concentration of drug in the unknown solution. 
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a b 
Figure 5.7: a) UV spectra of 1 to 1 mixture of 0.05% ibuprofen and soluplus in phosphate buffer (pH 7.4). The 
measured spectrum is directly obtained from the machine while the predicted spectrum is calculated by 
using concentration factors for both components. b) first derivatives approach to the same spectra. 
Having developed this assay for ibuprofen-soluplus mixtures (based on the use of derivative 
spectra) it was then possible to determine the solubility of ibuprofen in co-milled mixtures of 
the ibuprofen and soluplus. The solubilities of ibuprofen in all other excipient-drug 
combinations were determined by simply taking the absorbance at the analytical wavelength 
of 264 nm and equating that to ibuprofen via the calibration curve for pure ibuprofen in 
distilled water or phosphate buffer. 
5.3.5 Results of Screening Phase 
5.3.5.1 Effect of Excipient Type on the Solubility of Ibuprofen after Co-milling 
Figure 5.8 shows the comparison of solubilities of ibuprofen and its co-milled mixtures with 
different excipients. The results indicate that the solubility of ibuprofen in co-milled mixtures 
is higher than the un-milled drug alone. The highest effect is observed in co-milled mixtures 
with HPMC-E5, Lutrol and soluplus whereby the solubilities of ibuprofen in 1:1 CM mixtures 
with these excipients are 0.56 mg ml-1, 0.62 mg ml-1 and 1.96 mg ml-1, respectively. In 
contrast, the milling with lactose, PEG-6000, PVP-K10 and MCC-101 hardly increase the 
solubility of ibuprofen; the values are 0.14 mg ml-1, 0.19 mg ml-1, 0.22 mg ml-1, and 34 mg ml-
1, respectively. The statistical comparison of these values with that of un-milled ibuprofen 
have indicated that the co-milled mixtures with HPMC, Lutrol and soluplus have significant 
difference with the value of confidence interval <0.05, while all other mixtures have this 
value >0.05 so statistically non-significant. 
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Figure 5.8: Solubility values of Ibuprofen and its co-milled mixtures with 1:1 ratio of different excipient. (CM 
is co-milled). The error bars represents the standard deviation from repeats of the milling processes (n=3). 
Based on the highest solubility of ibuprofen of its co-milled mixture, soluplus is selected for 
the optimization of processing conditions (mill speed and time). 
5.3.5.2 Selection of Milling Speed 
The ibuprofen and soluplus were milled at three different speeds, i.e. 15, 18 and 25 Hz, for 
the time period of 15 min. The solubility of ibuprofen increased with the milling speed, 
however at the higher speed (> 20 Hz), the co-milled mixture became clammy and difficult to 
recover from the jar of the mill. Therefore, the speed of 18 Hz was used for the milling 
experiments. 
5.3.5.3 Selection of Milling Time 
Now at the constant mill speed (i.e. 18Hz), the ibuprofen was co-milled with soluplus for 5, 
10, 15 and 30 min at in two different ratios (1:0.25 and 1:0.5) and the solubility of drug in 
these co-milled mixtures was determined in distilled water. The solubilities with 1 to 0.25 
mixtures are 0.19, 0.19, 0.71 and 0.63 mg ml-1 with 5, 10, 15 and 30 min milling times 
respectively. While with drug to excipient ratio of 1:0.5 the solubility values are 0.31, 0.54, 
1.26 and 1.30 mg ml-1, respectively. This indicate that the solubility increase with increasing 
the milling time from 5 min to 30 min. However, the milling for long time (> 15 min) results 
in the clammy mixtures due to increased temperature in the milling jar. This mixture has 
0.09 
0.14 
0.19 0.22 
0.34 
0.56 
0.62 
1.96 
0.0
0.5
1.0
1.5
2.0
So
lu
b
ili
ty
 (
m
g 
m
l-1
) 
130 
 
 
poor flowability and is difficult to extract from the mill, therefore 15 min milling time is 
selected for the next phase of this study. 
5.3.6 Results of Extended phase 
5.3.6.1 Effect of Concentration of Excipients on the Solubility of Ibuprofen 
Solubility in distilled water: The co-milled mixtures of ibuprofen and HPMC with 1:0.25, 
1:0.5, 1:0.75 and 1:1 ratios, have the solubility values 0.41, 0.53, 0.57 and 0.56 mg ml-1, 
respectively (Figure 5.9a), while the physical mixture even with highest ratio i.e. 1:1 has the 
solubility 0.25 mg ml-1. On the other hand, the co-milled mixtures with same ratios of 
soluplus have the solubility values 0.71, 1.26, 1.42 and 1.96 mg ml-1 respectively and the 
physical mixture (1:1 ratio) has the solubility value of 0.93 mg ml-1 (Figure 5.9a). Thus the 
solubility of ibuprofen in co-milled mixtures with HPMC is 4 to 5 times higher as compared 
with the un-milled or milled drug and 10 to 20 times higher in the co-milled mixtures with 
soluplus. 
Solubility in phosphate buffer (pH 7.4): The solubility values of un-milled ibuprofen i.e. 
~2.40 mg ml-1 remains almost the same in the co-milled mixtures with HPMC; However the 
mixtures with soluplus results in slightly increase in the values of solubility of i.e. ~3.0 mg ml-
1 (Figure 5.9b). 
  
a b 
Figure 5.9: Solubility values of ibuprofen and its co-milled mixture in different ratios with HPMC and soluplus 
as measured in a) in distilled water b) in phosphate buffer pH 7.4. (PM is physical mixture, CM is co-milled 
mixture). The error bars represents the standard deviation of three values (n = 3). 
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5.3.6.2 Dissolution of Ibuprofen and its co-milled mixtures 
The in-vitro release profile of un-milled, milled and co-milled ibuprofen with soluplus in 
phosphate buffer (pH 7.4) has been illustrated in Figure 5.10a. The percentage of un-milled 
ibuprofen dissolved in first 15 min is ~40% and ~75% at 90 min, whereas the milled (15 min) 
ibuprofen exhibited a slightly higher profile with ~45% drug dissolving in first 15 min and 
~80% in 90 min. The co-milled mixtures with soluplus exhibited the greatest release of drug 
i.e. 60 to 85% in first 15 min and ~95% to ~100% after 90 min (Figure 5.10a) which increased 
with the proportion of soluplus in the mixture. The physical and milled physical mixtures of 
soluplus also have higher dissolution rate than the ibuprofen alone (both un-milled and 
milled).  
The co-milled mixtures with HPMC, in contrast, show a relatively slow release of drug that 
gradually increases as the amount of HPMC increases in the co-milled mixtures (Figure 
5.10b). The percentage release from 1:1 physical mixture was almost similar as from the un-
milled ibuprofen i.e. ~40% in 15 min time. The cumulative release increases by ~5% in milled 
physical mixture and further 10% in each co-milled mixture with increasing the HPMC ratio 
from 1:0.5 to 1:1. At the end of 90 min there is ~90% release from the co-milled mixture as 
compared to ~70% of physical mixture. 
The co-milled mixtures of ibuprofen with both HPMC and soluplus have shown better 
wettability and better release as compared to the drug alone. 
  
a b 
Figure 5.10: Dissolution profiles (in phosphate buffer pH 7.4) of un-milled, 15min milled ibuprofen and its 
physical and co-milled mixtures with a) soluplus, b) HPMC. The error bars represent standard deviation with 
n = 3. 
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The dissolution parameters (shown in Table 5.2) indicate that the values of Q30 min 
increases in the order of physical mixture < milled physical mixture < co-milled with HPMC < 
co-milled with soluplus. The DE of ibuprofen which is hardly affected by milling or in physical 
mixtures with HPMC; increases by ~40% in co-milled mixtures of both HPMC and soluplus 
and physical mixture with soluplus. The MDT is ~23 min in un-milled ibuprofen that increases 
slightly in milled sample representing the agglomeration on milling with overall decrease in 
effective surface area. While in the co-milled mixture it decreases by 2-3 folds indicating the 
increase in effective surface area for dissolution. 
Table 5.2: Dissolution parameters of ibuprofen and its physical and co-milled mixtures with Soluplus and 
HPMC. (Q30min = the percentage of drug released in 30min, DE = dissolution efficiency and MDT = median 
dissolution time). 
  Q30min (%) DE MDT (min) 
Un-milled Ibuprofen 48.9 0.56 23.3 
Milled Ibuprofen 15min 53.9 0.61 23.4 
PM with HPMC (1:1) 52.2 0.56 16.2 
Milled PM with HPMC (1:1) 44.3 0.57 19.1 
CM with HPMC (1:0.5) 68.9 0.64 13.4 
CM with HPMC(1:1) 79.0 0.78 15.1 
PM with Soluplus  (1:1) 70.2 0.75 21.8 
Milled PM with Soluplus  70.2 0.75 18.9 
CM with Soluplus (1:0.5) 76.9 0.72 7.65 
CM with Soluplus (1:1) 93.4 0.88 8.64 
5.3.6.3 Intrinsic Dissolution Rate of Ibuprofen and its Co-milled Mixtures 
The interference of the wax plugs in the IDR results of ibuprofen was first determined by 
incorporating a plug of same size (without ibuprofen compact) as used for embedding the 
ibuprofen compacts; in the dissolution medium (phosphate buffer, pH 7.4) and subjected to 
the conditions of IDR. The aliquots of the medium were drawn at different intervals till 90 
min and its absorbance was measured in UV spectrophotometer. The absorbance of all the 
samples was almost equal to the absorbance of blank indicated that the interference by wax 
was negligible. 
The changes in the surface of exposed part of the compacts were observed by stereo zoom 
microscope at 15 min, 30 min and 60 min during IDR (Figure 5.11). These indicated that the 
surfaces erode gradually and pits were developed on the entire surface. The compacts 
containing co-milled mixture with HPMC showed the highest degree of erosion while the co-
milled mixture with soluplus showed the least erosion and milled ibuprofen is in between. 
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 15 min 30min 60min 
Co-milled 
with 
soluplus 
   
Milled 
Ibuprofen 
   
Co-milled 
with 
HPMC 
   
Figure 5.11: Photographs of wax plugged compacts of 15min milled ibuprofen and the co-milled mixtures 
with soluplus and HPMC taken during different stages of dissolution test (stereo zoom microscope camera) 
IDR was calculated from the cumulative drug released over the period of 90 min and the 
area of exposed surface of the compact. The results indicated that the IDR of un-milled 
ibuprofen was 0.3 mg cm-2min-1 which is in agreement with (Viegas et al., 2001). The 15 min 
milled Ibuprofen has IDR of ~0.6 mg cm-2min-1 i.e. approximately twice higher than that of 
un-milled drug. 
The process of milling results in the increase of effective surface area exposed to the 
dissolution medium which is evident from the nitrogen adsorption results. The BET surface 
area of 15 min milled ibuprofen is 0.58 m2 g-1 that is almost thrice than that of un-milled one 
(0.20 m2 g-1). The co-milled mixtures of ibuprofen with HPMC seems to have higher IDR 
values (~0.7 mg cm-2min-1) than the milled drug (Figure 5.12a), while the co-milled mixture 
with soluplus has the IDR only slightly higher than un-milled drug (Figure 5.12b). There is the 
possibility of two opposing mechanisms in co-milled mixtures with HPMC, where the high 
concentration of HPMC forms gel after absorbing the water and hinders the drug release; 
the erosion and disruption on the other hand might increase the drug release. The higher 
values of IDR in co-milled mixtures with HPMC than with soluplus are probably due to the 
swelling property of HPMC that resulted in higher wettability and erosion of compacts and 
hence prevailing of second mechanism. This was evidenced from the observation of the 
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surfaces at different times during IDR experiments, the compacts of HPMC co-milled 
mixtures erode rapidly and pits are developed that leads to movement of dissolution 
medium inside the compact (Figure 5.11). On the other hand the compacts containing 
soluplus remained intact even at the end of 90 min; therefore the release occurs from the 
exposed surface only. 
  
a b 
Figure 5.12: IDR of ibuprofen and its co-milled mixtures with different ratios of a) HPMC and b) soluplus. (PM= 
physical mixture, CM=co-milled mixture). The error bars represent the standard deviation of three readings 
(n=3). 
5.3.7 Characterization of Co-milled Mixtures 
5.3.7.1 Changes in Particle Size Distribution on Co-Milling (Laser Diffraction Results) 
The cumulative particle size distribution plot of un-milled ibuprofen indicates that majority 
of the particle (~70%) have the size greater than 70 µm (as shown by the dotted lines in 
Figure 5.13a. The density distribution plot shows Gaussian distribution (size distribution 
range between 70 – 400 µm) with the peak at ~160 µm and a shoulder of peak towards 
smaller particle size (10 – 70 µm). 
The co-milled mixture with 10% soluplus has a bimodal size distribution (Figure 5.13b) with a 
broad peak (~8 µm) and a small peak at ~100 µm. This plot indicates that ~80% are less than 
50 µm and there is still a small percentage (~20% ) of particle that remains unchanged with 
respect to their size. Similarly the co-milled mixture with 10% HPMC has almost the same 
PSD curve as that of 10% CM with soluplus except the presence of an extra small peak with 
the particle size even greater than the original ones (Figure 5.13c). In the co-milled mixture 
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with 1:1 ratio with HPMC, there is only one peak towards smaller particle size (~10 µm) and 
a small shoulder toward large particle size(Figure 5.13d). 
  
a b 
  
c d 
Figure 5.13: Particle size distribution plots (density distribution and cumulative distribution) of a) un-milled 
Ibuprofen and its co-milled mixture with b) Soluplus and c-d) HPMC. 
The PSD parameters have indicated that the value of d50 (~120 µm for un-milled ibuprofen) 
was greatly reduced in all co-milled mixtures; it was 8.4 µm and 8.9 µm for co-milled mixture 
with 10% and 50% (i.e. 1:1) HPMC while 6.7 µm for co-milled mixture with 10% Soluplus, 
respectively (Table 5.3). 
Table 5.3: Values of d50 and d90 for un-milled ibuprofen and its co-milled mixtures with HPMC and Soluplus 
Sample d(v,0.5),µm d(v,0.9),µm 
Un-milled Ibuprofen 119.7 274.9 
CM with HPMC 1:10% 8.4 131.1 
CM with HPMC 1:1 8.9 49.2 
CM with Soluplus 1:10% 6.7 23.2 
The results of PSD have revealed that the co-milling with both soluplus and HPMC shifts the 
size distribution of ibuprofen towards lower values and increase in the density of the fines. It 
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is of worth to note that the density of fines was higher in co-milled mixture with 10% 
soluplus in comparison with the co-milled mixture of HPMC with all ratios. This reduction in 
the particle size has resulted in a greater increase in the surface area in co-milled mixtures of 
soluplus than that of HPMC resulting in higher dissolution rate of ibuprofen co-milled with 
the former. However the presence of large size particles (equivalent or greater than the 
original un-milled particle) in the co-milled mixtures indicates that either there is some 
proportion of particle that survive milling (milling time was small i.e. only 15min) or some 
particle are aggregated or may be some large excipient particles. There is another possibility 
i.e. the re-crystallization of the ibuprofen on milling (as discussed in Section 5.3.7.3). 
5.3.7.2 Changes in Size, Shape and Dispersibility of Ibuprofen on Co-milling/SEM Results 
The SEM images of ibuprofen have shown that the un-milled ibuprofen (Figure 5.14, upper 
panel) occurs as acicular shape crystals (80 to 160 µm in size) that are longer than width and 
have smooth surfaces (Han et al., 2011). On milling, the particles are fragmented and show 
lots of eruptions and cracking on the surface of particles (Figure 5.13, middle panel), which 
might have provided the enlarged surface for wicking of the solvent during dissolution 
experiment. 
The co-milled mixtures of ibuprofen with HPMC and soluplus (Figure 5.14, lower panels) 
show that the drug particles lose their geometric shape and adhere to the surface of 
excipients. This phenomenon prevents the aggregation of particles and therefore, enhances 
the dispersibility, leading to an increase in surface area exposed to the dissolution medium. 
This might be one of the reasons for enhanced dissolution of drug in these co-milled 
mixtures. The aggregation of drug particle in co-milled mixtures (as speculated in particle 
size results) is not confirmed from the SEM images. 
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Figure 5.14: SEM images of un-milled, 15min milled ibuprofen and its co-milled mixtures with Soluplus and 
HPMC at different magnifications. 
5.3.7.3 Changes in Crystallinity of Ibuprofen on Milling and Co-Milling/ DSC Results 
The DSC curve of un-milled Ibuprofen (Figure 5.15a) shows a single endothermic peak at ~ 
79.9 °C corresponding to the melting of ibuprofen (Madhuri Newa and Bong Kyu Yoo, 2008). 
In the milled ibuprofen, the melting temperature is almost the same but the enthalpy of 
melting slightly decreases from ~116 Jg-1 to ~107 Jg-1 after 15 min of milling. The glass 
transition step, the first signature of amorphous phase, is not observed in milled ibuprofen, 
however the de-vitrification peak is present at almost the same temperature as observed in 
case of fully amorphous (quenched) ibuprofen (Figure 5.15a). 
Un-milled Ibuprofen X 75 
Milled Ibuprofen X 75 
Un-milled Ibuprofen X 10000 Un-milled Ibuprofen X 500 
Milled Ibuprofen X 10000 Milled Ibuprofen X 500 
CM Ibu & Solu X 75 CM Ibu & Solu X 10000 CM Ibu & Solu X 500 
CM Ibu & HPMC X 75 CM Ibu & HPMC X 10000 CM Ibu & HPMC X 500 
138 
 
 
  
a b 
Figure 5.15: a) DSC curves of un-milled, 15min milled and amorphous (quenched) ibuprofen, the inset shows 
the Tg step near -40°C in quenched ibuprofen and de-vitrification peaks in quenched and milled ibuprofen 
near 25°C which were otherwise absent in un-milled ibuprofen. 
The DSC curves of co-milled mixtures of ibuprofen with HPMC and soluplus (Figure 5.15b) 
have shown that the melting peak of ibuprofen shifts toward lower temperature (Table 5.4) 
and the Tg appears near -35 °C indicating the presence of amorphous phase. However, the 
de-vitrification peak that is present in the milled ibuprofen near 30 °C is not observed in any 
of the co-milled sample. This indicated the stabilization of amorphous phase by the co-milled 
excipients (Pokharkar et al., 2006). 
Table 5.4: The values of melting temperature and enthalpy of melting for un-milled, 15min milled ibuprofen 
and its co-milled mixtures and the percentage crystallinity as calculated from the enthalpies of melting.  
Sample Melting 
peak (°C) 
Enthalpy of 
melting (Jg
-1
) 
Residual 
Crystallinity  
(%) 
Un-milled Ibuprofen 79.7 116.5 100 
15 min milled 79.7 108.9 86.7 
CM with HPMC 1:10% 78.4 102.2 87.8 
CM with HPMC 1:20% 78.0 93.1 80.0 
CM with HPMC 1:1 74.9 51.4 44.1 
CM with Soluplus 1:10% 77.5 93.8 80.6 
CM with Soluplus 1:20% 76.1 85.6 73.5 
CM with Soluplus 1:1 65.8 39.6 34.0 
The melting enthalpies also decrease gradually as the proportion of soluplus or HPMC 
increases in the co-milled mixtures (Table 5.4). The percentage residual crystallinity of 
ibuprofen in the co-milled mixtures is calculated from the changes in enthalpies by using the 
method already described in Chapter 3, Section 3.2.3. The un-milled ibuprofen was 
considered as 100% crystalline with ΔHm as 116.2 Jg
-1 (which is lower than the value given in 
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literature 129 Jg-1 (Madhuri Newa and Bong Kyu Yoo, 2008). The results of residual 
crystallinity have been summarized in Table 5.4. 
The loss of crystallinity/presence of amorphous phase of ibuprofen (in stabilized form) in co-
milled mixtures might be responsible for the increased solubilities and hence dissolution 
rates of as compared to drug alone. 
5.3.7.4 Change in Crystallinity of Ibuprofen on Milling and Co-milling/PXRD Results 
The PXRD pattern of un-milled ibuprofen (Figure 5.16a) show the characteristic peaks of 
ibuprofen at angles 2θ of 6.16°, 12.27°, 16.76°, 17.75°, 22.42° and 24.86°. The residual 
crystallinity of ibuprofen in the co-milled mixtures was estimated by peak intensity ratio 
method (Fix and Steffens, 2004). The results (Figure 5.16b) indicate that there is ~75% loss of 
crystallinity on 15 min milling. The PXRD pattern of co-milled mixture of ibuprofen with 
HPMC and soluplus also produce the characteristics peaks of ibuprofen but their intensities 
are reduced with the halo pattern observed in co-milled mixture with HPMC due to the 
amorphous nature of HPMC. This indicated that the crystalline nature of drug is not fully 
disappeared in these co-milled mixtures, however the loss in crystallinity occurs which is 
calculated to be ~75% in co-milled mixture with HPMC and 65% in co-milled mixture with 
soluplus. However, this high percentage of crystallinity loss may not be true and it require 
whole pattern fitting of PXRD data. 
  
a b 
Figure 5.16: a) Powder X-ray diffraction patterns of un-milled, 15min milled ibuprofen and its co-milled 
mixtures with HPMC and Soluplus b) percentage residual crystallinity as calculated from peak intensity ratios 
of these samples. 
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5.3.7.5 Change in Crystallinity of Ibuprofen on Milling and Co-Milling/THz results 
The THz spectrum of un-milled ibuprofen has the absorption peak at ~35 cm-1 while, the 
overall shape of the spectra of co-milled mixtures with HPMC and soluplus is almost the 
same (5.17a). The major changes in the spectra of co-milled mixtures are i) the decrease in 
area of the only absorption peak and ii) the increase in the intensity of absorption as the 
proportion of excipients is increased in the co-milled mixture (Figure 5.17a). The first effect 
is because of the milling while the second is the combined effect due to Mie scattering and 
effect of amorphous nature of HPMC and soluplus (Strachan et al., 2004). 
  
a b 
Figure 5.17: a) THz spectra of un-milled, 15min milled and co-milled ibuprofen with HPMC and soluplus b) 
Crystallinity of these samples as calculated from area under peak method. The error bars represent the 
standard deviation of 9 measurements (n=9). 
The residual crystallinity in co-milled mixtures is calculated from area under the absorption 
peak of THz data (as described in Chapter 3, Section 3.3.3.8) show that, there is ~60% loss in 
crystallinity when the drug is milled alone and co-milling with small proportion (10 or 20%) 
of excipients (HPMC or soluplus), reduces only 15-20% of crystallinity of the ibuprofen 
(Figure 5.17b). However, in the mixtures with equal proportion of excipients (i.e. 1:1 with 
drug), the loss of crystallinity is almost the same (as in case of HPMC) or greater (in case of 
soluplus) as compared to the milling the ibuprofen alone. This indicates that the co-milling 
with HPMC stabilize the amorphous phase while the soluplus facilitates the amorphization in 
co-milled mixture. The above mentioned changes have explained well the solubility 
enhancement of ibuprofen in co-milled mixtures. 
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5.3.7.6 Molecular Interaction of Ibuprofen with Co-milled Excipients/ATR Results 
The IR spectrum of un-milled ibuprofen (Figure 5.18a) has shown an intense and well-
defined peak at ~1704 cm-1 corresponding to the carbonyl-stretching of propionic acid 
group, a characteristic band from 800 to 1500 cm-1 due to hydrogen bonding as ibuprofen 
forms dimer and a spectral band between 2800 and 3000 cm-1 due to the stretching of -OH 
bond (Newa et al., 2008).  
The IR spectra of co-milled mixtures of ibuprofen with HPMC and soluplus (Figure 5.18a) are 
almost similar to that of un-milled ibuprofen, except that the spectral band near 3000 cm-1 
becomes less intense and the stretching vibration of carbonyl peak near 1700 cm-1 was still 
present indicating that the drug’s crystalline form was not completely lost during co-milling. 
The carbonyl stretching peak that is relatively broad in the un-milled ibuprofen becomes 
sharper and shifts towards higher wavenumbers on milling the drug alone and co-milling it 
particularly with soluplus (Figure 5.18b). This shift suggests that there is a change in the 
dimer structure and hydrogen bonding (Nokhodchi et al., 2010). This is probably due to the 
solubilization action of soluplus, where the vinyl-acetate and vinyl-caprolactam moieties of 
this surfactant surround the drug while the PEG backbone forms the backing as shown in 
Chapter 1, Section 1.10.3.2. 
  
a b 
Figure 5.18: a) IR spectra of un-milled, 15min milled ibuprofen and its co-milled mixtures with HPMC and 
Soluplus in 1:1 ratio b) a segment from IR spectra of these samples showing the shift in position of carbonyl 
peak is indicated by arrow heads. 
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5.4 Conclusion 
This study indicates that the co-milling with an excipient (polymer or surfactant) effectively 
enhances the solubility and dissolution rate of ibuprofen. This effect is a result of crystal 
damage as shown by the decrease in enthalpy of melting in DSC results and change of dimer 
structure as depicted by FTIR spectra of milled and co-milled samples of ibuprofen. 
Furthermore, the increased surface area, surface damage and decreased aggregation (from 
improved dispersibility) as observed in SEM images, along with the generation and of 
stabilization amorphous phase as observed in DSC results are responsible for the enhanced 
dissolution rate of the candidate drug. Additionally the improved of wettability as provided 
by milling with HPMC and solubilization action by soluplus further enhance the solubility and 
dissolution rate of ibuprofen. Although the size reduction and amorphization are generally 
accepted changes of milling, however the presence of HPMC and soluplus during milling of 
ibuprofen facilitates these changes. 
The study also presents a comparative analysis of various techniques e.g. DSC, PXRD and THz 
for measuring the crystalline/amorphous changes in co-milled mixtures of the candidate 
drug. The study shows THz pulsed spectroscopy can be a complementary technique for such 
measurements. 
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6 Conclusions from this Study  
It is well known that milling induces a complex series of events which compromise the 
structure of a crystalline material (from the creation of minor defects and fissures to the 
fragmentation of the particle and the partial conversation to a disordered crystalline state). 
Understanding of these events, in terms of the extent and distribution of the morphological 
changes that result and the achievement of the desired state (of increased solubility and 
dissolution rate) is inevitably a complex task; one which is made more difficult because of 
the short comings of a number of the techniques used to study such materials. The short 
comings of the techniques have been stressed throughout this work, while seeking out 
additional analytical technologies to study this important, industrial relevant process. 
It was pointed out that nitrogen adsorption studies cannot measure the internalized cracks 
of milled material due to an inability of the probe (i.e. nitrogen gas) to penetrate the micro 
scale pores; Nor can this method be used for crystal hydrates given the fact that the 
evacuation of the sample chamber results in the desorption of the water of crystallization 
and the creation of new surfaces that are then explored by the BET gas probe. In addition, 
SEM and laser diffraction techniques may over or under-estimate the particle size influence 
on the surface area of milled materials. This is because of the formation of particle clusters 
and the amorphous phase, and the subsequent re-crystallization of this phase, can impact 
the apparent size distribution. 
While these challenges remain, it was demonstrated in this thesis that dielectric relaxation 
spectroscopy may provide further insight into the generation of internalized surfaces in 
short milled samples, which may assist in our understanding of the contribution of these 
surfaces to the dissolution rate of milled materials (as described in Chapter 2). 
In the case of samples being milled for extended periods of time, where the amorphous 
content is high, the de-vitrification of this phase may be induced by the moisture (inherent 
as in hydrated materials or taken from the environment) or thermal by treatment during the 
analysis by DSC and TGA. Here, it was demonstrated that THz spectroscopy can measure the 
material in its native form, while being encased in a hydrophobic material (PFTE) that in 
effect stabilises the material to the ingress of further moisture. Therefore it is helpful for the 
quantification of residual crystallinity in milled material. 
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Another aspect that is often over-looked in studies of milled materials with significant 
amorphous content is the dynamics of the phase and the impact of moisture and crystallite 
seeds within in the phase on stability of the amorphous component. Once again, dielectric 
relaxation spectroscopy was shown to be a useful technique for studying the molecular 
dynamics of milled materials which might provide the understanding of relative stabilities of 
such materials. 
Finally, an analytical method for the estimation of a drug in the presence of an excipient that 
interferes with UV absorbance was developed. This part of thesis, demonstrated that the co-
milling with excipients can enhance the solubility and dissolution rate of poor soluble drug, 
ibuprofen. Moreover, it was shown that the methodologies developed for the analysis of 
milled material were also applicable for the characterization of co-milled mixture in 
explaining the mechanism of solubility and dissolution improvement. 
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7 Future Perspectives 
The dielectric spectroscopy of milled hydrated sugars, in this study, has shown a unique 
behaviour (saddle shaped process in permittivity loss spectrum) in milled lactose 
monohydrate which is characteristics of complex, micro-porous systems. If such behaviour is 
a feature of milled material, in the sense that it defines/under pins any beneficial effects on 
drug solubility and dissolution rate, then such studies are inevitably of interest to the 
assessment of the stability of nano-structured systems for drug delivery. 
In the approach to quantify the residual crystallinity in the milled pharmaceuticals, various 
concentrations of crystalline material in a matrix of PE were used to construct calibration 
graphs. As a possible improvement to this method, one might consider using combinations 
of amorphous and crystalline materials (prepared under controlled humidity conditions) to 
draw the calibration graphs. While this system may be more realistic of the structural 
properties of a mixed crystalline/amorphous phase, inevitably, the issues of amorphous 
phase stability may preclude the use of such mixtures. 
Another aspect of the methods that could be improved, relates to the assessment of 
changes in the crystallinity of lactose in respect of each anomeric form (alpha and beta). 
Some effort should have been devoted in transforming the minor component to the major 
component, e.g. the beta content to 100% alpha. Another enhancement would have been to 
have cryo-measurements to sharpen up the peaks of THz in an attempt to quantify the each 
component. 
From the study of dynamics of amorphous phase, it has been indicated that the instability of 
milled materials depends on many factors, particularly the presence of moisture (both 
inherent i.e. released from the hydrated crystals and sorbed from the atmosphere), 
temperature and length of milling process (this may leave the seeds for re-crystallization). 
The time domain THz measurements (THz-TDS) of the milled material at different 
temperatures and moisture conditions would demonstrate the effect the above 
experimental conditions, viz moisture, temperature and milling time on the post-milling 
storage of the milled and co-milled materials. These studies will also help to predict the 
stability of the milled materials during storage. 
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Dry milling of an API (ibuprofen) produced micro-particles along with some amorphization of 
the drug, when co-milled with soluplus and HPMC. It is envisioned that the application of 
wet milling using appropriate surfactants may produce the nano-size particles of drugs with 
different degrees of amorphization. Wet milling may also be suggested for the further 
enhancing the benefits of the co-milling and help to improve the solubility and dissolution of 
poorly soluble drugs, while producing materials of a desired size which can then be 
employed for absorption and the delivery of a drug to target sites. 
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9 Appendices 
Appendix I 
SEM micrographs of un- milled and various milled samples of lactose monohydrate. Each row shows the micrographs of same sample at different magnifications (the 
milling time and magnification is indicated on each micrograph). 
    
    
  
  
Un- milled x 75 
15min milled x 1000 
Un- milled x 1000 Un- milled x 10000 
15min milled x 500 15min milled x 5000 15min milled x 10000 
Un- milled x 500 
30min milled X 1000 30min milled X 5000 30min milled X 500 30min milled X 10000 
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90min milled x 5000 
f
 
 x 75 
90min milled X 500 90min milled X 1000 
180min milled X 1000 180min milled X 2500 
90min milled x 10000 
180min milled x 10000 180min milled x 50000 
45min milled X 1000 45min milled X 5000 45min milled X 500 45min milled X 10000 
167 
 
 
Appendix II 
SEM micrographs of un- milled and various milled samples of Sucrose. Each row shows the micrographs of same sample at different magnifications (the milling time 
and magnification is indicated on each micrograph). 
   
 
    
    
  
Un-milled x 75 
90min milled x 5000 
15min milled x 1000 
90min milled x 10000 
Un-milled x 500 Un-milled x 1000 
15min milled x 5000 
90min milled x 500 
15min milled x 10000 15min milled x 500 
90min milled x 1000 
168 
 
 
Appendix III 
SEM micrographs of un- milled and various milled samples of Trehalose dihydrate. Each row shows the micrographs of same sample at different magnifications (the 
milling time and magnification is indicated on each micrograph).  
    
    
    
 
90min milled x 10000 90min milled x 5000 
Un-milled x 75 
90min milled x 1000 
15min milled x 1000 
90min milled x 500 
 15min milled x 5000 
Un-milled x 1000 Un-milled x 5000 
 15min milled x 10000 
Un-milled x 10000 
15min milled x 500 
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Appendix IV 
Comparison of the dielectric properties of un-milled and milled samples of three sugars (sucrose, lactose 
monohydrate and trehalose dihydrate) around the percolation peak (measured by BDS Solartron 
instrument). The left Y-axis represents log frequency in Hz, while the unit of temperature is °C. 
Milling 
time 
Sucrose Lactose monohydrate Trehalose dihydrate 
0min 
   
 
Single broad PP  at 5°C 
No sub Tg process (crystalline) 
Single broad PP  at 5°C 
No sub Tg process (crystalline) 
Single broad PP  at 10°C 
No sub Tg process (crystalline) 
15min 
   
 
No percolation 
Low temp.RP 1 & 2 appear 
a sharp peak at 60°C 
Percolation splits into two 
peaks (at 5°C & at 30°C) 
Both have a huge amplitude 
Huge PP at 5°C 
itsmerges with conductivity  
RP 1 towards low temp. 
30min 
   
 
RP 1 & 2 more prominent 
sharp peak shifts at 65°C 
PP1 with Huge amplitude 
sharp and its shoulders grow 
On both sides 
PP merge with  conducttivity 
wing 
Another process  in low 
temperature region 
PP – Percolation peak, RP - Relaxation process; RP1 –  process, RP2 -  process, structural relaxation α 
process 
  
PP1 
RP2 
RP1 
PP2 
PP1 
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Milling 
time 
Sucrose Lactose monohydrate Trehalose dihydrate 
45min 
   
 
RP 1 & 2 more prominent 
sharp peak persists at 65°C 
Shoulders around percolation 
more prominent, with low 
magnitude 
Merged PP & conducttivity wing 
Low temp. process again 
present 
90min 
   
 
RP 1 & 2 more prominent 
Relatively broad peak at 65°C 
Percolation becomes broad and 
shoulders continue to grow 
PP at 30-45°C (recrystallization) 
RP 1 & 2 appaer as merged 
broad process 
180min 
   
 
RP 1 & 2 prominent 
peak at 70°C again becomes 
sharp 
Spectrum takes the Saddle 
shape with PP present in the 
centre 
PP & conducttivity wing again 
start merging 
PP – Percolation peak, RP - Relaxation process; RP1 –  process, RP2 -  process, structural relaxation α 
process 
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Appendix V 
Overlaid DSC curves of un-milled and milled samples of lactose monohydrate and anhydrous lactose showing 
the peaks of de-vitrification, desorption of water and melting from left to right of the curves in sequence.  
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Appendix VI 
THz Time domain signals and THz spectra of un-milled samples of lactose monohydrate, anhydrous lactose 
and Ibuprofen. The arrow heads show the characteristic peaks. 
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Appendix VII 
Overlaid THz spectra of un-milled and milled samples of lactose monohydrate, anhydrous lactose and 
ibuprofen showing the changes in scattering and heights of the principal peaks with milling time. 
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Appendix VIII 
3D dielectric loss spectra of a) un-milled and b) 5min, c) 10min, d) 15min, e) 30min, f) 45min and g) 60min 
milled samples of anhydrous lactose showing the plots of imaginary permittivity against temperature and 
frequency.(measured by BDS Novocontrol Alpha-Analyser). The left Y-axis represents log frequency in Hz, 
while the unit of temperature is °C. 
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Un-milled lactose 
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10min milled 5min milled 
60min milled 
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Appendix IX 
3D dielectric loss spectra of a) un-milled and b) 2.5min, c) 5min, d) 7.5min, e) 10min, f) 15min, g) 30min, h) 
45min and i) 60min milled samples of Sucrose showing the plots of imaginary permittivity against temperature 
and frequency.(measured by BDS Novocontrol Alpha-Analyser). The left Y-axis represents log frequency in Hz, 
while the unit of temperature is °C. 
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